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ABSTRACT 
1). The effect of temperature, P 450 inhibitors (pyrazole and imidazole), 
sulphydryl reagents (iodoacetamide and N-ethyl maleimide) and 
glutathione on the activation of CCl4 in rat liver microsomes was 
studied. Spin trapping of CCI3', covalent binding of CCl4 to protein and 
CCl4-dependent MDA formation were used as indices of CCl4 
metabolism. Formation of PBN-CCI3 ' adduct, 14CCl4 covalent binding to 
protein and CCl4-dependent :MDA production were dependent on 
temperature range from 15-40°C. The transition temperature was at 
26.7 -27 .5°C when the activation was measured by formation of PBN-
CCl3 ' adduct and specific 14CCl4 covalent binding. The transition 
temperature was found to be 34.3°C when CCl4 -dependent MDA 
production was taken as the index of the activation of CCI4. Pyrazole, 
imidazole and iodoacetamide inhibited CC14 -dependent MDA formation 
only at high concentrations (10-20 mM), whereas glutathione showed a 
strong inhibitory effect on CCl4-stimulated lipid peroxidation. MDA 
formation was nearly 100°;6 inhibited by 1 roM GSH. GSH also delayed 
the onset of lipid peroxidation. N-ethyl maleimide (NEM) exerted 
biphasic effects on CCl4 -dependent MDA formation. The lower 
concentration of NEM (0.5 mM-l mM) reduced the :MDA prodUction, 
while the higher concentration of NEM (5-10 mM) enhanced the MDA 
formation. 
2). Ribonucleotide reductase was partially purified from juvenile 
normal rat liver. The enzyme was purified 30 fold after DEAE-cellulose 
chromatography. The CDP reductase activity in tissues with different 
growth states or rates was compared. The enzyme activity was 
developed well in juvenile rat liver, regenerating liver and hepatoma 
(cells), while the enzyme activity was undetectable in adult rat liver 
and sham-operated rat liver. The enzyme activity in Yoshida cells was 
3-fold of the activity in Morris 5123tc tumours. Dithiothreitol (DIT) 
activated the activity of CDP reductase from 48h and 60h regenerating 
liver, but DIT did not activate the enzyme activity of juvenile 'normal 
rat liver. The possible mechanism of the activation of enzyme activity by 
DIT was discussed and a mechanism of regulation of the 
ribonucleotide reductase activity in regenerating liver was suggested. 
3). The effect of the lipid peroxidation product 4-hydroxynonenal 
(HNE) on CDP reductase from juvenile normal rat liver was 
investigated. HNE inhibited the CDP reductase activity. The inhibition 
was dependent on the concentration of HNE and the incubation time. 
The enzyme activity was reduced 500/0 by 0.1 roM HNE. The inhibitory 
effect of HNE was irreversible. DIT protected the enzyme against HNE 
suggesting that HNE inhibited the activity of ribonucleotide reductase 
from rat liver through the mechanism of blockage of functional SH 
groups in the enzyme protein. 
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1. INTRODUCTION 
Carbon tetrachloride (CCIJ is a classic hepatotoxin that has been 
shown to be activated by enzymic processes to a reactive intennediate. 
Lipid peroxidation is involved in some of the damaging actions of CCI4 . 
Lipid peroxidation is a free radical mediated process and during the 
process of lipid peroxidation, a variety of products are produced. 
Among these products, 4-hydroxyalkenals have a very important 
biological activity. They have effects on DNA synthesis and cell 
proliferation. Ribonucleotide reductase is a key enzyme for DNA 
synthesis: it catalyzes the conversion of ribonucleotides to 
deoxyribonucleotides which are DNA precursors. It is well established 
that the activity of the enzyme correlates closely with tissue and cell 
growth. This introduction is divided into three sections, the activation 
of CCl4 and CCl4-induced lipid peroxidation, the biological activity of 
4-hydroxyalkenals and ribonucleotide reductase. 
1 
1. 1 PART I ACTIVATION OF CARBON TETRACHLORIDE AND 
LIPID PEROXIDATION 
Carbon tetrachloride (CCl~ is a very toxic substance that can 
cause liver injury in many species with a predictable dose-dependence. 
It is readily aVailable in pure form and its toxic effects have been 
studied for many years. The concepts emerged from such studies are 
helpful for understanding of biochemical mechanisms of other 
hepatotoxins (Slater, 1984; Slater et al., 1985; Cheeseman et al., 
1985). 
1. 1. 1 Activation of CCI,! 
1. 1. 1. 1 Activation of CCl4 
Although the damaging actions of CCl4 on the liver were 
recognised in 1930s, it only was in the 1960s that a fundamental 
theory was established that CCl4 has to undergo metabolic activation 
in order to exert its full range of hepatotoxic effects. The mechanism 
depended on the metabolism of CCl4 in the hepatic endoplasmic 
reticulum to a free radical product capable of initiating lipid 
peroxidation (Slater, 1966; Slater et al., 1985: Cheeseman, et al., 
1985). 
CCl4 is activated through interaction with the NADPH-
cytochrome P 450 electron transport chain, which is located in the 
endoplasmic reticulum in many types of cell and involves the 
flavoprotein NADPH-P 450 reductase and cytochrome P 450 together in a 
phospholipid environment (Slater, 1984). The activation of CCl4 
proceeds reductively. The first intermediate of the activation of CCl4 is 
believed to be a trichloromethyl radical (CCl3 ') (Slater, 1966,1982: 
2 
Slater et al .. 1985). 
CCl4 + e ---
In principle, the electron donor is NADPH and the electrons are 
transferred via cytochrome P 450 reductase to cytochrome P 450 (see Fig. 
1.1.1). 
The free radical of CCI3 · is very reactive and can undergo several 
secondary reactions (see Fig. 1.1.2). It reacts very quickly with oxygen 
to yield the trichloromethyl peroxyl radical (CCI30 2·) which is even 
more reactive than CCI3 · and is believed to be the species that initiates 
lipid peroxidation (Slater et al .. 1985). The CCI3 · radical is very 
efficient in forming stable covalent bonds with suitable molecules; 
proteins and lipids are frequent targets (Slater, 1982; Slater et al., 
1985). 
CC13 · cannot be measured directly but can be detected using 
ESR spectroscopy with the spin trap phenylbutyl nitrone (PBN) 
(Albano et al., 1982; Slater et al., 1985). PBN can react with reactive 
free radicals, like CC13 · to form a relatively stable spin-adduct which is 
detectable by ESR (see Fig. 1.1.3). The spin-trapping of CCI3 · by PBN, 
along with the covalent binding of radiolabelled CCl4 to microsomal 
macromolecules and CCl4-induced lipid peroxidation are useful 
methods to measure CCl4 activation indirectly (Cheeseman et al., 
1985). 
The site of activation of CCl4 is probably at cytochrome P 450. As 
reviewed by Cheeseman et al. (1985), the conclusion of the role of 
cytochrome P 450 in CCl4 action was drawn from the evidence outlined 
below: 1) after depletion of cytochrome P 450 by CoCl2 , 
3 
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Fig. l.1.1 Activation of CCl4 through the NADPH-P 450 
electron transport chain 
FP: flavoprotein (NADPH-P 450 reductase) 
(Modified from Slater, 1982) 
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allylisopropylacetamide and cobalt protoporphyrin in vivo, the 
metabolism of CCl4 in vitro is decreased; 2) the reconstituted systems 
containing the components of mixed-function oxidase (MFO) system do 
not metabolise CC14 unless the hemoprotein is included; 3) CC14 
activation is stimulated by the induction of cytochrome P 450 by drugs 
such as phenobarbitone, ethanol, benzene, or imidazole; 4) the 
covalent binding of CC14 to microsomal protein is largely to cytochrome 
P 450 molecules. Using purified enzymes, NADPH-cytochrome P450 
reductase and cytochrome P 450' Wolf et al. (1980) demonstrated that 
the enzyme responsible for the metabolic activation of CCl4 is 
cytochrome P 450 rather than NADPH-cytochrome P 450 reductase. 
Cytochrome P 450 can catalyse the reduction of CC14 , but NADPH-
cytochrome P 450 reducatse alone cannot reduce CC14 . 
However, the studies with classical inhibitor of the MFO system 
have yielded equivocal results concerning the precise locus of CCl4 
activation along the microsomal electron transport chain. The MFO 
inhibitors, p-chloromercuribenzoate (pCMB), SKF 525A. CO, 
menadione and metyrapone have little effect on CC14 activation. This 
may be because CC14 is not a typical substrate of P 450 and its 
metabolism depends on a specific P 450 isoenzyme that can be induced 
by several drugs (Cheeseman et al., 1985). For example, both 
phenobarbital (PB) and 3-methylcholanthrene (MC) can induce P 450' 
but metabolism of CC14 is enhanced only by PB-induction. MC-induced 
microsomes are equivalent to micro somes from untreated animals 
(Frank et al., 1982). The work of Noguchi et al. (1982) also 
demonstrates that the metabolism of CC14 to CC13' radical is not a 
general property of the multiple forms of cytochrome P 450 in 
microsomes of phenobartital-induced rats. It was limited to a particular 
form. the 52,000 dalton P 450 cytochrome which is the first 
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polypeptide to disappear in liver micros ames treated with CCI4 . 
Johansson and Ingelman-Sundberg (1985) indicated that the ethanol-
inducible form of liver microsomal cytochrome P 450 (P 450 lIEI) was 
responsible for CCl4-induced lipid peroxidation. P 450 lIEI can be 
induced by ethanol in rabbits liver and imidazole or pyrazole in rat 
liver. In reconstituted membrane system this type of P 450 was a 100-
fold more effective catalyst of CCl4 metabolism than either of the 
cytochrome P 450 LM2 or P 450 LM:4' Lauriault et al. (1992) have the same 
conclusion that ethanol inducible P 450 lIEI is a major catalyst of the 
microsomal metabolism of CCI4. Antibody to P 450 lIEI markedly inhibits 
the metabolism of CCI4 . 
There are other indications that the activation of CC14 is closely 
associated with P 450' Administration of CCl4 into the peritoneum 
produces necrosis mainly in the centrilobular zone of the liver (Slater 
et al., 1985). Very recent work of Azri et al. (1992) confirms this 
observation. Using precision-cut slices of liver as the experimental 
material, they further examined the damage to rat liver by CCI4. They 
observed that significant leakage of glucose-6-phosphate 
dehydrogenase and j3-glucuronidase from centrilobular hepatocytes 
occurred 9h following CCl4 administration. The content of the 
enzymes that are native to periportal (lactate dehydrogenase and 
sorbitol dehydrogenase) was unchanged in the same slices over the 
duration of the experiment. A major contribution to this lobular 
location of injury is the distribution of cytochrome P 450' It is known 
that cytochrome P 450 is more concentrated in the centrilobular 
regions of rat liver than in the periportal regions (Gooding et al., 1978; 
Slater et al., 1985). 
Covalent binding of 14CC14, adduct formation with the spin trap 
PEN and CC14 -stimulated lipid peroxidation in vitro are generally 
8 
correlated With the tissue distribution of P 450 (Slater et al., 1985). 4-
and 14-day-old rats are not as capable as adults in their ability to 
metabolize CCl4 measured by binding of 14CCl4 to microsomal protein 
and lipid (Cagen and Klaassen, 1980). The concentration of 
cytochrome P 450 in new born rat liver microsomes is 2-3 times lower 
than in adult rat liver (Benedetto, 1981). With microsome preparations 
from kidney, lung, brain. testis and adrenal, no significant activity for 
the CCl4 -stimulated peroxidation or of 14CCl4 covalent binding was 
found (Benedetto et al., 1981; Kornbrust and Mavis, 1980). The 
concentration of P 450 in microsomal suspensions from these tissues is 
very low in comparison With liver (Benedetto et al., 1981). 
The above discussion is particularly concerned with activation of 
CCl4 in microsomes. More recently, it has been observed that CCl4 can 
be activated to CCI3· in rat liver mitochondria (Tomasi et al., 1987). It 
is found that incubation of liver mitochondria in a medium containing 
succinic acid, ADP, PBN and in the presence of CCl4 resulted in the 
formation of a PBN -spin adduct and lipid peroxidation measured by 
conjugated diene production. Inhibitors of microsomal monooxygenase 
at high concentrations, SKF 525A (1 mM), metyrapone (0.2 mM) and 
p-CMB (0.1 mM) did not affect prodution of CCI3·. However, inhibitors 
of the respiratory chain such as antimycin A and KCN decreased free-
radical formation. Tomasi et al. suggested that the mitochondrial 
electron -transport chain was responsible for the activation of CCl4 and 
cytochrome a3 was involved in the reduction process, probably by a 
mechanism similar to that of cytochrome P 450-mediated activation. 
1. 1. 1. 2 Factors influencing the activation of CCl4 
Many factors, such as the activity of the drug -metabolizing 
9 
enzymes, temperature, oxygen concentration and hormones can affect 
the activation of CCl4 and therefore influence the liver injury induced 
by CCl4. 
As early as 1966, McLean and McLean showed that the 
hepatotoxic action of CCl4 was increased by prior induction of the 
drug-metabolizing enzyme system. Since cytochrome P 450 is the site 
of activation of CCl4, any effect which modifies P 450 activity will 
influence the activatiQn of CCl4. Cytochrome P 450 is a collective term 
for a large family of hemoproteins associated with the metabolism of 
drugs (Nebert and Negishi, 1982). P 450 may function as a 
monooxygenase, a dioxygenase, an oxidase and as a peroxidase (Bast 
and Haenen, 1990). 
The acute lesion (fatty degeneration and necrosis) can be 
modified by various pretreatments that affect the activity of the 
NADPH-cytochrome P 450 chain (Slater, 1984). Induction of microsomal 
cytochrome P 450 by drugs such as phenobarbital, ethanol, isopropanol, 
benzene and imidazole enhances the activation of CCl4 and increases 
its ability to cause lipid peroxidation in liver microsomes. These 
drugs can induce isoenzymes of liver microsomal cytochrome P450 
(Cheeseman et al., 1985; Noguchi et al., 1982; Ingelman-Sundberg and 
Jomvall, 1984; Johansson and Ingelman-Sundberg, 1985; Hung, et al., 
1983). Ethanol treatment of rats caused a 25-fold induction of the 
microsomal CCl4 -dependent lipid peroxidation. Imidazole and pyrazole 
enhanced the CCl4-induced lipid peroxidation in rabbit liver 
microsomes by 4-5-fold (Johansson and Ingelman-Sundberg, 1985). 
In some cases, inhibition of activity of the cytochrome P 450 
system leads to suppression of the activation of CCI4. Although 
"classical" inhibitors of cytochrome P 450 like SKF 525A. CO and 
metyrapone have little effect on the activation of CC14 at lower 
10 
concentration as discussed above, high concentrations of these 
inhibitors still show the effect of reducing CCl4-stimulated lipid 
peroxidation or 14CCl4 covalent binding to protein or spin trapping of 
CCI3 ' in rat liver microsomes (Cheeseman et al., 1985). Metyrapone at 
4 mM still had no effect on Fe2+ stimulated peroxidation, but lipid 
peroxidation induced by CCl4 was inhibited by 930/0 (Kornbrust and 
Mavis, 1980). For more examples, several other drugs are mentioned 
here to show inhibition of CCl4 activation due to decrease in the 
cytochrome P 450 activity. pCMB (200 nmol/mg protein) produced a 
900/0 loss of P 450 activities and caused a similar reduction in the extent 
of peroxidation induced by CCI4, although it had little or no effect on 
the cytochrome P 450 reductase (Kornbrust and Mavis, 1980). Cobaltic 
protoporphrin IX (CPP) profoundly decreased the level of cytochrome 
P 450 in rat liver microsomes; consequently, the associated mixed-
function oxidase systems were equally depressed and activation of CCl4 
was much lower in liver microsomes from CPP-treated rats 
(Cheeseman et al., 1984). Methoxsalen (8-methoxypsoralen) is one of 
the psoralen derivatives (Labbe et al., 1987). Cytochrome P450 content 
and monooxygenase activities decreased by 60-900/0 in mice 
administrated with methoxsalen (250 ~mol/Kg). Covalent binding of 
14CCl4 to protein and CCl4-induced lipid peroxidation were also 
inhibited by the same extent. However, lipid peroxidation mediated by 
reduced endogenous iron was not modified by methoxsalen showing 
that this drug does not act as a free radical scavenger but prevents CCl4 
activation by decreasing cytochrome P 450 activity ( Labbe et al., 1987). 
Silymarin is an extract from the wild thistle Si{y6um mananum( L.) Gartneri 
(Letteron et al., 1990). Silymarin has been shown to protect animals 
against various hepatotoxins including CCI4. It inhibits CC14 -mediated 
lipid peroxidation in mouse liver in vivo evidenced by exhalation of 
1 1 
ethane and in mouse liver microsomes in vitro shown by :MDA 
production. Treatment of silymarin also decreases the covalent binding 
of 14CCl4 to microsomal protein in vivo and in vitro. The inhibition 
mechanism is apparently due to its inhibition of some mono oxygenase 
activity (Letteron, et al., 1990). Thiol drug diethydithiocarbamate 
(DEDC) and its two metabolites, disulfiram (DS) and carbon disulfide 
(CS2) markedly decreased the activity of aniline hydroxylase, p-
nitroanisole-O-demethylase and pentoxyresorufin-O-dealkylase in rat 
liver microsomes (Lauriault et al., 1992). Hepatocytes isolated from 
rats treated with DEDC or DS and CS2 were resistant to CCl4-induced 
cytotoxicity and lipid peroxidation. 
The concentration of 02 influences the activation of CCI4. 
Kieczka and Remmer (1981) observed that in rat liver microsomes 
14CCl4 binding to protein and lipid increased continuously with 
decreasing oxygen concentrations. However, CCl4-induced MDA 
formation showed an atypical oxygen dependency with a maximum at 
about 7% 02 and a minimum at about 15% 02' De Groot and Noll (1988 
a, b) investigated this subject extensively. They also found that the 
CCl4-mediated lipid peroxidation was strongly dependent on the 
oxygen partial pressure (p02)' In NADPH -reduced microsomes it was 
maximal at p02 around 5 mmHg and markedly decreased at p02 below 
and above this value. In hepatocytes it was maximal at p02 of 7 mmHg. 
They proposed that this optimum curve resulted from the fact that the 
formation of CCl3' radicals at the haem moiety of cytochrome P 450 is 
inhibited by 02 while the formation of CCI3OO' and the propagation 
stage of lipid peroxidation require the participation of 02' The 
reductive activation of CCl4 by cytochrome P 450 takes place at the 
same site 02 normally becomes activated, so the activation of CCl4 is 
inhibited by °2, 
12 
Changes in body temperature may affect the activation of CCl4 
and protect liver injury induced by CCl4 (Slater, 1984). Temperature 
reduction can be made a great protection against CCl4 -mediated liver 
injury. Marzi et ale (1980) reported that a chlorpromazine (CPZ) 
induced reduction in body temperature of SOC prevented CCl4 induced 
hepatic necrosis at 24h. They suggested that CPZ delayed the onset of 
the process but did not prevent its final intensity since CPZ did not 
inhibit the covalent binding of 14CCl4 to cellular constituents or CCI4-
induced lipid peroxidation. Reddrop et ale (1983) observed that 
promethazine inhibited CCl4-stimulated lipid peroxidation in vivo when 
added in very low concentrations. The synergistic effects of 
promethazine and CCl4 in reducing the body temperature of rats may 
be one of particular Significance to the protective action of 
promethazine. Administration of promethazine gives a long-lasting 2-
3°C reduction in core temperature and this can be expected to lower 
the rate of metabolism of CCI4. Villarruel et ale (1990) made a similar 
observation. They found that thioridazine (TDZ) could partially prevent 
necrogenic effects in rat liver after administration of CCl4 at 24h. The 
protective effect of this drug was partly due to its reduction of the body 
temperature in CCl4-treated animals during the initial 24h. Lower body 
temperature decreases the rate of CCl4 metabolism. 
Cytochrome P 450 can be phosphorylated in a cAMP-dependent 
fashion (Mkrtchian et al., 1990). It is found that cAMP dependent 
phosphorylaytion increases the NADPH dependent production of 
malondialdehyde. The cytochrome P 450 inhibitor cyanide abolishes this 
activity. This observation implies a mechanism of increase in lipid 
peroxidation in response to hormonal signals (Mkrtchian, et al., 1990). 
13 
1. 1. 2. CCl4-stimulated lipid peroxidation and its pathological role 
One of the most important consequences of the activation of CCl4 
is initiation of lipid peroxidation as a damaging reaction of potentially 
great significance in cytotoxicity. Lipid peroxidation is described as an 
oxygen-dependent. autoxidative degradation of fats, particularly 
polyunsaturated fatty acids (PUFA). It is a chain reaction initiated and 
propagated by free radicals (Pryor, 1976). It comprises three stages: 
initiation, propagation and termination. The initiation stage occurs 
when a radical species abstracts one hydrogen from a PUFA to fonn a 
lipid radical. This lipid radical will then spontaneously react with 
oxygen to generate a lipid peroxyl radical. The second stage is a chain 
reaction leading to propagation. Finally, tennination occurs when two 
radicals react together producing lipid peroxides or when scavengers 
such as vitamin E act by interrupting this chain reaction. These 
peroxides can reinitiate the radical chain reactions if they breakdown 
to further radical species in the presence of a transition metal. They 
can also undergo rearrangements and cleavages generating different 
compounds. The whole process can be outlined as shown in Fig. 1.1.4 
taking the polyunsaturated fatty acid linolenic acid (18:3 ( n-3)) as an 
example and is fully described for CCl4-induced lipid peroxidation 
below. 
First CCl4 is activated by the hepatic NADPH-cytochrome P 450 
system to CCI3 ·. Second CCI3 ' radical reacts quickly with oxygen to 
yield the trichloromethyl peroxyl radical CCI3OO·. Because CCI3OO' 
reacts much faster with a PUFA (such as arachidonate) than does CCI3 ' 
it has been suggested that lipid peroxidation is preferentially initiated 
in the endoplasmic reticulum by CCI3OO' rather than CCI3·. Third, 
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INITIA TI ON CH3-CH2-CH=CH-CH2-CH=CH -CH2-CH=CH -(CH2)7-COOH (IH) 
(LINOLENIC ACID) 
HO' 
DIENE CONJUGATION 
CH3-CH2-~H -CH=CH -CH=CH-CH2-CH=CH -(CH2)7-COOH (L') 
PROPAGATION CH3-CH2-CH -CH=CH -CH=CH -CH2-CH=CH -(CH2) 7-ccx)H (LOO') I 
0-0' (PEROXY RADICAL) 
LH 
CH3-CH2-CH-CH=CH-CH=CH -CH2-CH=CH -(CH2)7-COOH (LOOH) I 
O-OH (HYDROPEROXIDE) 
CH3-CH2-CH-CH=CH-CH=CH-CH2-CH=CH-(CH2)7-COOH (LO') b. + HO- (ALKOXY RADICAL) 
ALKYL RADICALS 
---------------------------------------------------- -----------------------------------
TERMINATION 1 
ALKANES, ALKENES HYDROXY-ACIDS 
ALDEHYDES, KETONES 
Fig. 1.1.4 Scheme representing the peroxidation of linolenic acid 
(18:3 (n-3)) induced by hydroxyl radicals 
(Adapted from Vaca et al., 1988) 
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CCI3OO- reacts with PUFA in the endoplasmic reticulum and other 
hepatocellular membranes by abstraction of a hydrogen atom from 
PUFA to initiate the formation of lipid radicals (PUFA-)_ Lipid radicals 
interact with molecular oxygen to form the lipid peroxyl radicals 
PUFA- + 02 --..-... PUFA02-
This peroxyl-radical can oxidise its neighbouring molecules by 
hydrogen abstraction either from another molecule of PUFA or from 
some other hydrogen donor (XH) to form hydroperoxides and new 
radicals 
PUFA02- +XH ---... PUFAOOH + x-
In this way a chain reaction involving PUFA· is propagated - In the 
presence of transition metal ions, the hydroperoxides and lipid peroxyl 
radicals breakdown to form a complex variety of products 
PUFA02-, PUFA02H, metal ions ----. ... alkanes 
(Slater, 1984; Slater and Cheeseman, 1987). 
alkanals 
alkenals 
4-hydroxyalkenals 
etc. 
It has been proved that CCl4 induces lipid peroxidation in the 
livers of various species including rat, hamster, guinea-pig, chicken 
and mouse (Cheeseman, 1982 b; Lee et al., 1980)_ Liver microsomes of 
rabbit are resistant to lipid peroxidation in vitro. However, CCl4 
administration to rabbit in vivo promoted lipid peroxidation in their 
liver microsomes in vitro (Bernacchi et al., 1983). Rat liver microsomes 
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,', 
and hepatocytes have been used as the useful model of studying toxic 
effect of CCl4 (Slater and Sawyer. 1971 a. b. c; Poli et al .. 1987; Slater 
- -
and Cheeseman. 1987). 
Lipid peroxidation is involved in many biochemical and biological 
events such as the aging process. the various diseases and the toxic 
effects of certain xenobiotics (Slater. 1984; 1987; 1988). It is generally 
accepted that lipid peroxidation may be important in some types of 
tissue injury. 
Studies with liver microsomes and hepatocytes have clearly 
demonstrated that lipid peroxidation has a crucial role in the toxic 
effect of CCl4 on the liver (Slater et al., 1985; Poli et aI., 1987). Lipid 
peroxidation is strictly related to several CCl4 -induced damaging 
actions. namely reduction of cytochrome P 450 level (Glende et al., 
1976). alteration of the activity of enzymes including glucose-6-
phosphatase (Poli and Gravela. 1982), protein kinase C (Poli et al., 
1988 b; Pronzato et aI., 1990), Glycerol-3-phosphate acyltransferase 
(Thomas and Poznan sky. 1990), effect on several subcellular 
organelles and induction of liver necrosis. 
Glende et al. (1976) measured cytochrome P450 level and 
aminopyrine demethylase and glucose-6-phosphatase activities in 
suspensions of microsomes recovered after metabolism of 14CCl4 under 
anaerobic conditions. Massive covalent binding occured in the absence 
of oxygen. The level of cytochrome P 450 and the activities of 
aminopyrine demethylase and glucose-6-phosphatase were virtually 
unaffected by covalent binding in the anaerobic system, but they were 
markedly depressed by lipid peroxidation in an aerobic system. 
Poli and Gravela (1982) and Poli et al. (1989 a) reported that 
glucose-6-phosphatase was inactivated by the treatment of hepatocytes 
with CCl4 . There was a direct relationship between the degree of lipid 
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peroxidation and the degree of the enzyme inactivation. Promethazine 
completely prevented the decrease in this enzyme activity and strongly 
inhibits CCl4-induced lipid peroxidation in liver microsomes and liver 
cells. Promethazine is known to have protective activity in relation to 
CCl4-induced liver necrosis. The main effect of promethazine on CCI4-
mediated damage in microsomal and isolated hepatocytes is by 
scavenging CCI3OO' free radicals that would initiate lipid peroxidation. 
It has no inhibitory effect on covalent binding of CCl4 (Cheeseman, 
1982 a; Poli et al., 1989 b). Therefore, the inactivation of glucose-6-
phosphatase was not result of covalent binding of CCl4 to the enzyme 
protein but the result of lipid peroxidation (Poli and Gravela, 1982; 
Poli et al., 1989 b). De Groot et al. (1985, 1986) have the same 
conclusion that CCI3 ' radical does not damage glucose-6-phosphatase 
directly. They found that NADPH/CCI4 induced lipid peroxidation in 
microsomes and decrease of glucose-6-phosphatase activity only 
occurred in the presence of °2: under anaerobic conditions no lipid 
peroxidation and no alteration in enzyme activity occurred. 
Furthermore, Benedetti et al. (1980) could demonstrate that 4-
hydroxynonenal, a product of lipid peroxidation, was capable of 
inactivating glucose-6-phophatase possibly by reacting with essential 
thiol groups. 
Protein kinase C (PKC) is an important transmembrane signal 
transduction system of many short- and long-term cellular responses 
including cell proliferation and transformation. Poli et al. (1988 b) and 
Pronzato et al. (1990) observed that hepatocyte PKC activity was 
inhibited by CCI4 . Preincubation of hepatocytes with Trolox protected 
both cytosolic and microsomal PKC activity. Trolox completely 
inhibited CCl4-induced lipid peroxidation but did not affect the 
covalent binding of CCl4 to hepatocyte proteins. It is indicated that 
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CC14-induced lipid peroxidation inhibited PKC. Moreover, since the 
degree of inhibition of both PKC activity in microsomes and cytosol was 
the same, it is suggested that the effect of CC14 on PKC could be 
mediated by a factor able to diffuse from the site of activation of CC14 in 
the membranes of the endoplasmic reticulum to the cytosol. It was 
shown that products of lipid peroxidation, 4-hydroxyhexenal, 4-
hydroxyoctenal and 4-hydroxynonenal inhibit the PKC activity. 
Glycerol-3-phosphate acyltransferase (GPAT) is a enzyme of 
biosynthesis of glycerolipids. The results of Thomas and Poznan sky 
(1990) showed that CC14 inactivated GPAT in microsomes in the 
presence of NADPH. At the same time lipid peroxidation occurred. 
Addition of promethazine substantially recovered the lost of GPAT 
activity indicating that lipid peroxidation plays a role in inactivation of 
microsomal GPAT. Adding 1 mM DTI at the end of incubation 
protected the enzyme activity, therefore the sensitive SH groups might 
be damaged during lipid peroxidation, probably by products of lipid 
peroxidation. 
Damage to protein synthesis was involved in CC14 tOxiCity to rat 
liver slices and related to CC14 -induced lipid peroxidation (Fraga et al., 
1989). CC14 -induced lipid peroxidation and inhibition of protein 
synthesis occurred concurrently. 
CC14 -mediated lipid peroxidation has been shown to be involved, 
at least partly, in the several examples of CC14 -induced subcellular 
organelles damage. Examples are liver mitochondrial swelling and 
uncoupling of oxidative phosphorylation: inhibition of the uptake of 
c::a2+ by liver microsomes, severe impairment of plasma membrane 
structure resulting in the leakage of intracellular enzymes; 
interference with the lipoprotein assembly and maturation in the 
formative side of liver Golgi apparatus (Poli et al., 1987; 1990). 
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The ultimate consequence of inactivation of enzymes and 
alteration of functions of subcellular organelles induced by CC14-
mediated lipid peroxidation might be cell death. At present, the 
prevailing opinion is that lipid peroxidation plays an essential role in 
causing acute liver necrosis induced by CC14 . With isolated hepatocytes 
lipid peroxidation is shown long before the appearance of signs of cell 
damage such as the loss of Trypan Blue staining and leakage of 
cytoplasmic enzymes (Slater, 1985). Both lipid peroxidation and cell 
injury are prevented by the addition of antioxidants. For example, low 
concentrations of CC14 (0.1-0.15 mM) stimulate early lipid 
peroxidation. The initial cell death evidenced by the leakage of lactate 
dehydrogenase or transaminase happens much later. Antioxidants such 
as promethazine and vitamin E block the lipid peroxidation and 
prevent the hepatocyte damage (Smith et al., 1983; Poli et al., 1988 a; 
Mourelle et al., 1989). 
The mechanism of injury induced by lipid peroxidation is 
attributed to three aspects. 
First, primary reaction due to the interaction of reactive free 
radicals produced during lipid peroxidation with the surrounding 
system. It has been shown that reactive free radicals are able to 
produce chemical modifications and damage to proteins, lipids, and 
nucleotides (Slater, 1984). The consequence of these modifications is 
wide spread disturbances of cellular metabolism. 
Second, the toxic and pharmacological effect of products of lipid 
peroxidation. This mechanism is more important. Highly reactive free 
radicals are easily trapped in their microenvironment by virtue of their 
high chemical reactivity. However, the products of lipid peroxidation, 
like lipid hydroperoxides, aldehydes and 4-hydroxyalkenals can diffuse 
conSiderable distances. These products have toxic and pharmacological 
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activities. therefore they can spread disturbances throughout the cell 
and even into the extracellular domain (Slater. 1984; Willis, 1980). 
This mechanism is probably particular important for CCl4 tOxiCity. It 
has been shown by Kombrust and Mavis (1980) that microsomal lipid 
peroxidation induced by CCl4 is highly focal and limited, involving only 
about 10% of the available membrane fatty acids. The reason for this is 
a loss of the capacity of microsomes to activate CCI4 • attributed to 
inhibition of cytochrome P 450 by lipid peroxidation. Amplification of 
the toxic consequences of lipid peroxidation is achieved by the 
products moving from sites of lipid peroxidation on the endoplasmic 
reticulum to other parts of the cell. Evidence of this is given by Poli et 
al. (1988 b) and Pronzato (1990). As already mentioned they observed 
that PKC activity in microsomes and cytosolic was inhibited in 
proportion to CC14-induced lipid peroxidation. They suggested that 
prod ucts of lipid peroxidation which are able to diffuse from the site of 
activation of CCl4 to the cytosol were responsible for the inactivation of 
PKC. 
Third. disorganization of the membrane results from lipid 
peroxidation. Peroxidation of membrane lipids leads to a number of 
changes in membrane structure and composition, such as decreases in 
the unsaturation/ saturation ratio in membrane phospholipids, changes 
in the chain-length percentage distribution of fatty acids, and covalent 
crosslinks between adjacent lipid and protein molecules which are 
accompanied by increases in the molecular order of the membrane and 
decreases in its flUidity. Various membrane functions such as selective 
permeability, enzyme activity, and ion transport are impaired by lipid 
peroxidation (Slater, 1978: Pryor, 1980). De Groot et al. (1985, 1986) 
found that lipid peroxidation induced by iron or CC14 could lead to the 
loss of microsomal latency estimated by measuring the activity of 
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nucleoside diphosphatase and this only occurred when lipid 
peroxidation had reached a certain extent. Beyond this threshold lipid 
peroxidation led to severe disintegration of the microsomal membrane 
resulting in a loss of its selective penneability. The loss of latency 
evoked by lipid peroxidation was comparable to the loss of latency 
induced by detergent. They implied that inactivation of glucose-6-
phosphatase activity may relate to the loss of integrity of the 
microsomal membrane apart from the effect of products of lipid 
peroxidation. Glucose-6-phosphatase is a integral microsomal enzyme: 
the enzyme activity largely depends on an intact lipid bilayer. 
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1. 2. PART II BIOLOGICAL EFFECT OF 4-HYDROXYALKENALS 
Lipid peroxidation is involved in a range of pathological and 
biological events such as aging, certain diseases, tumour initiation and 
promotion and the cytotoxicity of certain xenobiotics (Slater, 1984, 
1987). A complex variety of products are generated during the process 
of lipid peroxidation. Some of them have important biological activities. 
Among them are the 4-hydroxy-2,3-trans-alkenals series. This is 
represented by 4-hydroxypentenal (HPE), 4-hydroxyoctenal (HOE), 4-
hydroxyhexenal (HHE) and 4-hydroxynonenal (HNE) (Esterbauer, 
1991). HNE represents 950/0 of the aldehyde production (Benedetti et 
al., 1980). The structure of these 4-hydroxyalkenals is shown in Fig. 
1.2.1. This class of products, especially HNE, has received particular 
attention because of their multiple biological activities. 
1. 2. 1 Chemical reactivity 
A striking chemical feature of 4-hydroxyalkenals is the fact that 
at neutral pH they react avidly with SH groups in both proteins and low 
molecular weight thiols such as glutathione, cysteine and coenzyme A. 
The reaction product initially formed is a saturated aldehyde with the 
glutathione residue bound by a thio-ether linkage at carbon atom 3. 
This primary aldehyde then becomes a very stable cyclic hemiacetal 
which is the main (950/0) end product in aqueous solution (see 
Fig.1.2.2) (Esterbauer, 1991; Benedetti and Comporti, 1987). The 
reaction rates of HNE with glutathione are: 
forward reaction ( HNE + GSH ~ adduct) 1.09 M-1 s-1 
reverse reaction (adduct -- HNE + GSH) 9.6 x 10-7 M-1 s-1 
equilibrium constant 8.85 x 10-7 M-1 
(Esterbauer, 1981). If isolated proteins and enzymes containing SH 
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groups are incubated with 4-hydroxyalkenals. the number of aldehyde 
molecules bound to the protein equals the number of SH groups lost 
during the incubation (Benedetti and Comporti. 1987). Apart from 
cysteine. 4-hydroxyalkenals can react with other amino acid residues. 
like lysine. histidine. serine and tyrosine (Esterbauer et al., 1991; 
Uchida and Stadtman, 1992). Under certain conditions (slightly 
alkaline pH, of 8.8, high concentration of the reactants 10 mM) 4-
hydroxyalkenals can react with nearly all amino acids. 
1. 2.2. Cytotoxicity 
Unlike reactive free radicals. 4-hydroxyalkenals have a relatively 
long life-time and can diffuse appreciable distances and thereby extend 
the cellular damage far from the site of initial toxin activation or even 
escape from the cell (Slater, 1987; Benedetti, et al., 1981). Therefore, 
such products generated in situ should not merely be considered as 
remnants or end-products of lipid peroxidation processes but rather as 
a kind of "second toxic messenger" which mediate and/or potentiate 
the damage initiated by primary free radicals (Slater, 1987). 
1. 2. 2. 1. Inhibitory effects on enzyme activity 
A wide range of enzymes on the Table 1.2.1 have been reported 
to be inhibited by HNE. 
The high reactivity of HNE with glutathione implies that HNE 
formed in biological systems, such as peroxidising microsomes will 
preferentially attack molecules with SH groups. All inhibitory effects of 
4-hydroxyalkenals on enzymes investigated so far can be explained by 
the inactivation of functional SH groups (Benedetti and Comporti, 
1987, Esterbauer. et al., 1988). The fact that most actions are inhibited 
by the previous addition of thiols in the incubation medium, whereas 
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Table 1.2.1. Inhibition of enzyme activity by HNE 
Enzyme 
Adenylate cyclase 
S-adenosylmethionine 
decarboxylase 
Glucose-6-phosphatase 
Glyceraldehyde-P-
dehydrogenase 
(l- and.f3- DNA 
polymerases 
5· -nucleotidase 
06-methylguanine 
DNA methyl transferase 
Protein kinase C 
Source HNE conctn. - range 
(~M) 
rat liver 13.4 - 26.8 
plasma membranes 
Yoshida ascites 250 - 1000 
hepatoma cells 
rat liver microsomes 
hepatocytes 
Ehrlich ascites 
tumour cells 
Yoshida ascites 
hepatoma cells 
rat liver 
plasma membrane 
human bronchial 
fibroblasts 
rat hepatocytes 
- 450 
- 250 
150 - 250 
210 - 460 
1300 - 4600 
-100 
-100 
Reference 
Dianzani et al.. 1982 
Paradisi et al .• 1985 
Dianzani et al.. 1982 
Benedetti et al .• 1980 
Esterbauer et al.. 1991 
Wawra et al.. 1986 
Dianzani et al.. 1982. 1989 
Paradisi et al .. 1985 
Eckl and Esterbauer. 1989 
Poli et al.. 1988b 
Pronzato et al .. 1990 
amino acids are generally inactive, paints in favour of this explanation 
(Schauenstein. 1982). HNE discriminates between different types of 
thiols. When acting in vitro on Ehrlich ascites tumour cells at 
concentrations exceeding 3 mM. the entire subcellular content of 
nonprotein thiols (which mainly consists of glutathione) is consumed 
by reaction with the hydroxyalkenals. whereas only 500/0 of the soluble 
cell protein thiols react (Schauenstein. 1982). This can explain the 
mechanism whereby low molecular weight thiols protect protein-thiols 
against HNE. Further evidence for the explanation that the inhibitory 
effect of HNE on enzyme activity is due to blockage of enzyme SH 
groups is that HNE binds to microsomal protein in vivo and in vitro and 
the binding mechanism is very likely to involve reaction with SH 
groups in the protein (Benedetti. et al .• 1982). Furthermore, the 
binding capacity of aldehyde to the protein is responsible for the 
inactivating capacity of the aldehyde (Benedetti et al., 1984). The lower 
binding capacity found for 4,5-dihydroxydecenal as compared to HNE 
correlated with its lower inactivating ability on microsomal glucose-6-
phosphatase. Recently polyclonal and monoclonal antibodies which 
specifically recognize HNE-modified proteins have been established. 
Immunocytochemical staining with such antibodies give a direct 
evidence that HNE-modified proteins are in fact formed in animals in 
vivo (Esterbauer et al .. 1991). 
Other enzymes. not listed in Table 1.2.1 such as hexokinase and 
lactate dehydrogenase are also inhibited by 4-hydroxyalkenals 
(Esterbauer et al., 1988). Mitochondral NAD-dependent aldehyde 
dehydrogenase and glucose-6-phosphate dehydrogenase might be 
inhibited by 4-hydroxyalkenals too. Kanazawa and Ashida (1991) 
reported that the two latter enzymes were inhibited by low-molecular 
weight component of products of linoleic acid peroxidation; the major 
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components in low-MW were aldehydes. 
HNE had a biphasic, dose- and time-dependent effect on 
adenylate cyclase in rat liver plasma membranes. Very low doses 
strongly stimulated the enzyme activity after 2 and 5 min of 
incubation, whereas a progressive, time- and dose-dependent 
inhibition was observed afterwards. HNE (0.1 JlM) elicited the highest 
enhancement without inhibition whereas 26.8 JlM was immediately 
inhibitory (Paradisi et al., 1985; Dianzani et aI., 1990). 
1. 2. 2. 2. Inhibitory effect on DNA, RNA and protein synthesis 
HNE inhibits protein synthesis, as observed in liver cells (250 
JlM), Ehrlich ascites tumour cells (140 JlM), rabbit reticulocyte lysate 
(480 ).lM) (Esterbauer et al., 1991), cells from guinea pig epidermis 
(guinea pig keratocytes) (100-200 JlM) (White and Rees, 1984), human 
diplOid fibroblasts (1-100 ).lM) (Michiels and Remade, 1991) and 
bovine aortic endothelial cells (30 ).lM) (Radu and Moldovan, 1991). It 
was reported that [14C]-valine incorporation into isolated hepatocytes 
was inhibited by 300/0 at 100 ).lM and by 70% at 250 ).lM HNE added in 
the incubation medium (D ianz ani , 1982). The inhibitory activity of 
HNE was about 10 times more effective than that of HPE. Treatment 
of guinea pig keratocytes in culture with HNE, incorporation of 3H-
leucine into protein was inhibited by 50-60% at 100 ).lM HNE (White 
and Rees, 1984). At 30 ).lM, HNE produces a gradual decrease in 
protein synthesis in bovine aortic endothelial cells during short (2-4h) 
incubations, followed by return to the control level at 6-8h (Radu and 
Moldovan, 1991). The protein synthesis was measured by 14C-Ieucine 
incorporation. It is suggested that the inhibition of protein synthesis in 
the reticulocyte lysate of rabbit is primarily due to an impairment of 
the protein synthetic machinery, probably by an interaction of the 
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carbonyl compounds with sulphydryl groups essential for protein 
synthesis (Benedetti, 1981). In support of this explanation, White and 
Rees (1984) observed that cysteine protects protein synthesis in 
guinea pig keratocytes against HNE. Addition of 400 ~M cysteine to the 
culture medium in the presence of 200 JlM of HNE gave complete 
protection whereas if the cultures were pretreated with cysteine 
followed by washing, no protection against the subsequent addition of 
HNE was obtained. 
One of the important effects of HNE is its inhibitory effect on 
nucleic acid syntheSiS. It is found that HNE stops or reduces DNA 
synthesis in Ehrlich ascites tumour cells (150-250 JlM) (Schauenstein, 
1982; Hauptlorenz, et al., 1985), guinea pig keratocytes (100 JlM) 
(White and Rees, 1984), Yoshida ascites hepatoma cells (40 JlM) 
(Wawra et al., 1986), malaria parasites (50 ~M) (Clark et al., 1987), 
human diplOid fibroblasts (0.1 JlM) (Michiels and Remacle, 1991), 
human lymphocytes 000-300 JlM) (Tessitore et al" 1987), and K562 
and HL-60 human leukemic cells (1 JlM) (Barrera et al., 1991). The 
inhibition of DNA synthesis was shown by the reduced incorporation of 
labelled thymidine or hypoxanthine into DNA. In cells from guinea pig 
epidermis (guinea pig keratocytes) inhibition of RNR syntheSiS 
(measured by 3H -uridine incorporation) was more sensitive to HNE 
treatment than protein synthesis whereas DNA synthesis was the most 
sensitive to HNE (White and Rees, 1984). In Ehrlich ascites tumour 
cells, the reduction of labelled thymidine incorporation actually 
results from the inhibition of tie novo DNA synthesis but not from an 
inhibition of the thymidine uptake. This was demonstrated by DNA 
pulse label experiments and 86Rb uptake experiments (Hauptlorenz, et 
al., 1985). 
It is suggested that HNE affects DNA synthesis due to inhibition 
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of some enzyme activity essential for DNA synthesis, for example DNA 
polymerases, and again the blockage of the SH groups by HNE plays an 
important role (Hauptlorenz, et al., 1985). This assumption is 
supported by the fact that low concentrations of HNE selectively attack 
protein SH groups contained in the nucleus. Whilst 3 mM HNE 
discriminates between non-protein and protein thiols as mentioned 
above, less than 0.2 mM HNE can diSCriminate between cytoplasmic 
and nuclear protein thiols: the latter are more sensitive to 
hydroxyalkenals than those of the cytoplasm. For example, after 
incubation of Ehrlich ascites tumour cells with HNE (0.2 mM) for 30 
min, cytoplasmic protein thiols decrease only 1.70/0 whilst nuclear 
soluble proteins thiols decrease 27%) (Schauenstein, 1982). When 
EATC are incubated with 200 JlM HNE, DNA synthesis is inhibited up 
to 900/0 after 30 min incubation, but respiration of the cell remains 
practically unaffected and glycolySis is inhibited only by some 150/0. 
Respiration and glycolysis are controlled by SH enzymes. This fmding 
is in accordance with the above observation (Schauenstein, 1982). 
There is another possibility of inhibition of DNA synthesis by 
HNE. The inhibition may result from block of some signalling events 
that are necessary for progression through the G 1 phase since HNE 
can alter the cell cycle as described below (Barrera, et al., 1991 a). 
1. 2. 2. 3. Altering cell cycle and mitOSis 
4-hydroxyalkenals are able to disturb cell cycling. 
Dianzani (1982) reported that HPE influences the cell cycle of 
ascites AH-130 Yoshida hepatoma cells in vivo during the exponential 
phase of growth. At a dose of 25 mg/kg and 50 mg/kg, HPE 
significantly increase the mean DNA synthetic period (S-phase) and 
decreases the number of cells participating in the cell cycle, especially 
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at the lower dose. Moreover. HPE decreased the peak of the mitotic 
wave, suggesting an impairment of the S-phase. 
Poot et aI., (1988) studied the disturbance of cell proliferation by 
HNE in close detail. Using amnitotic flUid fibroblast-like cells and 
human diplOid skin-derived cells they found that HNE (10-20 )lM) 
caused an accumulation of cells in the G 1 and G2 phase. This is due to 
the fact that HNE provokes a retardation of the transit of the cells from 
GO to G 1 and a rapid rate of exit from GO / G 1 and S phase but 
diminished rate of exit from G2. Additionally, HNE eliCited a 
permanent arrest in the G2 phase of the first cell cycle and in the G 1 
phase of the second cell cycle even if added to quiescent cell culture. 
These results indicate that HNE might cause proliferating cells to 
enter a quiescent state (Poot et aI., 1988). 
4-hydroxyalkenals are able to affect microtubules. Microtubules, 
together with microfilaments and intermediate filaments, are the 
major cytoskeleton components of mammalian cells. They playa role in 
the secretory processes, the distribution of cell organelles and the 
movement of chromosomes during mitosis (Olivero et al., 1990). It is 
observed that HNE affects the cellular distribution of microtubules 
(Olivero et al., 1990). At a low concentration (10 JlM) HNE slightly 
affects microtubules in 3T3 fibroblasts, which became smaller than 
their normal counterparts and the microtubule network appeared to be 
formed of short fibres. After treatment with 100 JlM HNE cytoplasmic 
microtubules disappeared. This effect of HNE may result from 
preventing tubulin polymerization or by provoking microtubule 
depolymerization. Tubulin is a main functional protein of microtubules. 
It was found that incubation of purified tubulin with HNE caused a 
reduction, both in the rate and the extent of polymerization. The 
inhibition showed a direct relationship between the amounts of HNE 
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and the degree of inhibition. The maximum inhibitory effect (780/0) was 
observed at 1mM of HNE (Olivero et al., 1990). Similar results were 
obtained by Miglietta et al. (1991). They observed that 0.5 mM HNE 
inhibited polymerisation of microtubular protein in calf brain in vitro. 
The mechanism of the inhibition may be the interaction of HNE with 
SH groups of tubulin since the inhibition was prevented by addition of 
cysteine. SH groups are fundamental for the polymerization of tubulin 
(Dianzani. 1982; Olivero et al .. 1990; Miglietta et al.. 1991). 
1. 2. 2. 4. Damage to DNA and DNA function 
. It has been demonstrated that free radicals induce DNA damage 
{l?J 
in liver systems. So far there is no direct evidence that 4-
hydroxyalkenals damage DNA or influence DNA function, however, 
recently there is increasing information that suggests lipid 
peroxidation is an important event in free radical induced DNA damage 
and products of lipid peroxidation may play an important role (Vaca, 
1988; Esterbauer. 1990). Several examples are given below to show the 
relationship between lipid peroxidation and damage of DNA and DNA 
function. 
A high dietary level of polyunsaturated fats in the absence of 
vitamin E resulted in decreased hepatic DNA template activity. It is 
presumed that peroxidative damage to the DNA occurred since DNA 
template activity of rats fed less polyunsaturated fats and vitamin E was 
normal (Summerfiedd and Tappe!, 1984). 
DNA isolated from liver slices after incubation with 1 mM t-butyl 
hydroperoxide (t-BOOH), 1 mM BrCCl3 or 50 ~M ferrous iron for 2h 
was damaged. The enhancement of ethidium bromide fluorescence by 
DNA from treated slices was decreased. Meanwhile. the TBARS 
released into the incubation medium from liver slices was increased. 
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DNA damage and TBARS release were both time dependent. In this 
experimental system BrCCl3 did not induce significant DNA damage 
and was the weakest TBARS inducer. Butylated hydroxytoluene (BIIT) 
at 1 mM inhibited both DNA damage and TBARS production. These 
results indicate that lipid peroxidation and DNA damage in liver slices 
were concurrent (Fraga and Tappe!, 1988). 
When mitochondria of rat liver were incubated in an in vitro lipid 
peroxidation system (NADPH-ferrous chlOride) marked lipid 
peroxidation occurred. DNA isolated from these mitochondria had a 
completely different Agarose gel electrophoresis pattern. The lipid 
peroxidation and DNA damage are not protected by scavengers of 
superoxide ani-en, hydrogen peroxide and hydroxyl radicals. However, 
alpha -tocopherol protected against both lipid peroxidation and 
mitochondrial DNA damage (Hruszkewycz, 1988). 
Transforming activity of plasmid pBR 322 DNA, as assayed by 
transforming T.. coei CSR 603 was inactivated by incubation of DNA with 
the reaction mixture for NADPH -dependent lipid peroxidation of 
liposomes. The inactivation was dependent on the extent of the lipid 
peroxidation as determined by measuring the production of TBARS. 
The DNA was broken by the incubation. ·OH scavengers exhibited only a 
weak effect on the formation of DNA strand breaks, but did not inhibit 
lipid peroxidation. The chloroform extracts from peroxiding liposomes 
caused inactivation of the transforming activity of plasmid DNA, but did 
not induce DNA strand breaks. These results indicate that the factor 
which inactivates the transforming activity is not a free radical since it 
could be extracted into chloroform, whereas the factor producing DNA 
breaks might be free radical intermediate since it was not extractable 
with chloroform (Akasaka, 1986). 
As illustrated in Fig. 1.2.3 damage to DNA may be produced in 
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(Adapted from Vaca et al.. 1988) 
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the various steps of lipid peroxidation. The third mechanism would be 
represented by the reaction of DNA with the variety of non-radical 
products of the lipid peroxidation process. These reactions lead to 
modification of nucleobases and to severe structural deterioration of 
DNA (Vaca et al., 1988). However, the interaction of products of lipid 
peroxidation with DNA has been disputed in the literature. According 
to Akaska (1986) in a system consisting of plaSmid pBR 322 DNA and 
[U-14C]-arachidonic acid-containing liposomes, no binding of 
peroxidation products of the radiolabelled fatty acid to DNA was 
observed. On the other hand, Vaca and Harms-Ringdahl (1989 a, b) 
reported that the products of lipid peroxidation do interact with 
chromatin inside the cell nucleus. Using rat liver nuclei labelled with 
3H -arachidonic acid which is a main substrate for lipid peroxidation, 
Vaca and Harms-Ringdahl (1989 a, b) found that the product of lipid 
peroxidation induced by ascorbate-Fe2+ and NADPH-ADP-Fe2+ 
interacted with DNA and nuclear proteins. Inhibition of lipid 
peroxidation by the iron chelator Desferrioxamine B prevented the 
association of peroxidation products to nuclear macromolecules. 
One of the lipid peroxidation products, malondialdehyde can 
interact with DNA. Its damage to DNA and genotoxicity have been 
extensively studied in vivo and in vitro (Vaca et al., 1988; Esterbauer et al., 
1991). It is possible that 4-hydroxyalkenals also react directly with 
DNA but to my knowledge no experimental evidence has been shown. 
There is only indirect evidence that suggest this class of product of 
lipid peroxidation may associate with DNA. The fonnation of 
fluorescent products from the interaction of peroxidizing lipid with 
DNA has been characterized in a series of studies (Vaca et al., 1988). A 
fluorescence spectrum was observed when DNA was reacted with 
peroxidizing arachidonic acid. This spectrum was different from that 
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obtained from the reaction between MDA and DNA. The results 
indicated that reactive carbonyls other than MDA, formed during the 
peroxidation of arachidonic acid, may also react with DNA. A similar 
experiment was performed by Frankel et al. (1987). They examined 
the fluorescence formation between DNA and a series of aldehydes, 
carbonyl compounds and other products obtained by thermal and 
catalytic (in presence of ferric chloride and ascorbic acid) 
'decomposition of pure methyl linolenate hydroperoxides. They found 
that the aldehydes gave the most reactive intermediates with DNA. In 
addition, it is observed that HNE can react with deoxyguanosine in vitro 
at pH 7.4 to form cyclic ad ducts (Winter et al., 1986) indicating that 
HNE has the ability of alkylating DNA (Witz 1989). Recently, it is 
observed that a potential activated metabolite of HNE, 2,3-epoxy-4-
hydroxynonenal (EH) modifies DNA and RNA. Endogenous HNE may be 
metabolised to form EH in vivo (Sodum and Chung, 1991). Reaction of 
EH with RNA and Single-strand DNA yielded different proportions of 
adenosine and guanosine adducts. In contrast to the single stranded 
nucleic acids, reaction with native DNA produced only deoxyguanosine 
adducts. In double-stranded DNA, yields of adduct were considerably 
lower than in single-stranded DNA or RNA (Sodum and Chung. 1991). 
1. 2. 2. 5. Lethal effects on cells 
Apart from the cytoxicity of 4-hydroxyalkenals discussed above, 
these compounds also alter respiration, Ca2+ uptake, phosphate 
transport, cytochrome P 450 and levels of cellular glutathione and onset 
of lipid peroxidation (Esterbauer. 1988; Esterbauer et al.. 1991). These 
toxiC effects can induce cell injury, suppression of cell growth and cell 
death. 
Cadenas et al. (1983) reported that HNE at 0.6-2.4 mM 
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enhanced oxygen-induced low-level chemiluminescence and ethane 
and n-pentane formation by hepatocytes. HNE at 2 mM enhanced these 
toxic indices over 7 -fold. HNE also caused a rapid loss of cellular 
glutathione in the form of a glutathione conjugate with the alkenal 
when it was added to a suspension to hepatocytes. White and Rees 
(1984) found that HNE at 0.5-1.5 mM initiated lipid peroxidation in 
rat liver microsomes. 
Morphological changes were also observed in the cells injured by 
HNE. Normal cultured hepatocytes have a polyhedral shape and 1-2 
prominent nuclei, and all cells are well attached to the surface of the 
dishes (Eckl and Esterbauer, 1989; Esterbauer et al., 1990). After 
treatment of cultures with 100 IlM HNE for 3h, a large number of 
spherical cells with an intense granular structure and pycnotic nuclei 
appeared. These cells also appeared to have lost contact with the 
surface. The cells did not recover from this damage and 24h later all 
the cells were dead. With higher concentrations (0.3-0.5 mM) of HNE 
it is observed that guinea pig keratocytes (cells from guinea pig 
epidermis) rounded up and became detached within Ih of treatment 
(White and Rees, 1984). 
The inhibition of cell growth is shown by decreases in cell 
number and viability. HNE at 1 IlM decreased human diplOid fibroblasts 
viability by 20% compared with control. At 100 IlM of HNE, the cell 
viability was totally lost (Michiel and Remacle, 1991). K562 cells 
growth was strongly inhibited by 100 IlM HNE. With treatment of cells 
with HNE for Ih, the cell number did not increase during 6 days 
culture period and was only 25°;6 of control. The viability of treated -cell 
culture lost 30% (Barrera et al., 1991 b). 
High concentrations of HNE can eventually cause the death of 
the cell. Ehrlich ascites tumour cells were killed by 3 mM HNE 
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(Schauenstein, 1982). 
Table 1.2.2 shows the concentration of HNE and time of 
treatment acutely toxic for mammalian cells. Most of the HNE effects 
described as inhibitory and toxic to cells are at relatively high 
concentrations, i.e. in the range of 0.1-10 mM. It seems most unlikely 
that this high concentration of hydroxyalkenals exists in biological 
systems, except perhaps in cell membranes (see below). The levels of 
HNE that can be expected in normal tissues are in the range of about 
0.1-3 ~ (Esterbauer et al., 1989), and under conditions of oxidative 
stress the HNE concentration can increase to 5-10 J.lM. Normal rat 
liver for example contains 0.5-2.5 J.lM nmol HNE/ g wet tissue, and 
under vitamin E deficiency this figure may increase to 5.4 nmol/ g wet 
tissue (Esterbauer et al., 1990). The intracellular steady state 
concentration of HNE in CCl4-intoxicated hepatocytes was found to be 
about 7 J.lM (Poli et al., 1985). 
The main reason for the need of relatively high concentrations to 
get an inhibition of the function in vitro is probably the fact that 
biological fluids contain a large amounts of masking substances 
preventing the contact of HNE with the enzyme targets. It is shown by 
the fact that when the aldehydes are assayed on purified enzymes, 
their active concentration decreases conSistently (Dianzani, et al., 
1990). 
Another reason may be the fact that aldehydes are quickly 
catabolized by cells and cell particles. Liver cell suspensions can 
tolerate exposure to a constant concentration (10 J.lM) of toxiC 
aldehydes (Poli et al., 1989 a). Incubation of isolated rat liver cells with 
HNE resulted in a rapid loss of the aldehyde from the incubation 
mixture as measured by h.p.I.c. Within 1 min 920/0 of 0.1 mM and 500/0 
of 1.0 mM HNE were consumed by 2 x 106 cells/mI. The rate of HNE 
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Table 1.2.2 CytotoxiCity of HNE towards different cell types 
Cell Type 
isolated rat hepatocytes 
culturated rat hepatocytes 
intraperitoneal Ehrlich ascites 
tumor cells 
culturated Ehrlich ascites tumor 
cells 
Chinese hamster ovary 
cells 
umbilical vein endothelial 
cells 
human skin fibroblasts 
glutathione synthetase deficient 
skin fibroblasts 
fibroblasts in logarithmic 
growth 
fibroblasts growth 
arrested 
( Adapted from Esterbauer et al., 1991 ) 
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LDso. Time 
1000 J-LM, 1 h 
100 J-LM. 20 h 
500 J-L~1, 2 h 
100 J-LM, 6 h 
100 J-LM, 1.5 h 
25 J-LM, 3 h 
> 40 J-LiY1. 1 week 
20 J-LM, 1 week 
18 J-LM, 20 h 
5 J-LM, 20 h 
loss increased linearly with the cell number over the range 5 x 104-5 x 
105 cells/ml (Esterbauer et al., 1985). 
On the other hand, the concentration of HNE may be very high in 
cell membranes. It is observed that aldehydes derived from lipid 
peroxidation are unequally distributed between the lipid and aqueous 
phases. Therefore, it is possible that liposoluble compounds such as 
HNE might reach concentrations in the membrane environment 
higher than those detected in whole cells. It is assumed that the 
membrane concentration of HNE is in the range of 4.5-100 JlM; this is 
enough to inhibit several enzyme functions and it has been proposed 
that HNE might attack critical target proteins within the lipid bilayer 
(Poli, et al., 1987). 
1. 2. 3. Genotoxicity 
The genotoxic activities of 4-hydroxyalkenals were investigated 
in Chinese hamster cells (Brambilla et al., 1988). Sister-chromatid 
exchange increased after treatment with HPE, HHE, HOE, while HNE 
and 4-hydroxyundecenal had a weak, although statistically Significant, 
effect. The concentration of 4-hydroxyalkenals was 20-60 JlM. DNA 
fragmentation increased after exposure to the five 4-hydroxyalkenals 
tested. The genotoxicity of HNE was also observed in rat hepatocytes 
(Eckl and Esterbauer, 1989; Esterbauer et al., 1990). After incubation 
with 0.1-10 JlM HNE for 3h, the percentage of cells with micronuclei, 
the frequency of chromosomal aberration and number of sister-
chromatid exchanges were significantly increased in primary cultures 
of rat hepatocytes. HNE at 10 JlM or below is not cytotoxiC towards the 
culture hepatocytes. Therefore the observed genotoxic effects are 
indeed induced by the aldehyde itself and not by some unknown factor 
produced by severely damaged or dying cells. 
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Mutagenicity of HNE was observed in V79 Chinese hamster lung 
cells at the hypoxanthine-guanine phosphoribosyltransferase locus. It 
was found that at the concentrations ranging from 10-45 J.1M, HNE 
induced a dose-dependent increase in the number of mutations to the 
6-thioguanine resistance (Vaca, 1988; Eckl and Esterbauer, 1989). 
Clastogenic factors (CF) are chromosome-damaging materials in 
plasma of irradiated persons and patients with so-called spontaneous 
chromosomal instability. CF have a molecular weight lower than 10,000 
Da. Exposure of human lymphocytes or Chinese hamster cells to 
superoxide-generating systems can produce CF. CF are produced or 
released by cells. In a recent report by Emerit et al. (1991) it was 
shown that when cultures of human lymphocytes exposed to 
hypoxanthine and xanthine oxidase (02 ·-generating system) CF were 
induced. HNE was formed in 500/0 of CF induction samples, while it 
was absent in all control samples. After addition of as low as 0.1 IlM 
HNE in the culture, clastogenic activity was observed. So it was 
suggested that HNE is a clastogenic component of CF. 
In direct contrast to reports of its mutagenicity, HNE has shown 
its ability to inhibit the mitogenic effect of another mitogen (Kiss et al., 
1992). In fibroblasts the mitogenic effects of sphingosine involves a 
rapid rise in the cellular content of phosphatidic acid (PtdOH). It is 
observed that in fibroblasts (NIH 3T3 cells), HNE selectively inhibits 
sphingosine-stimulated phospholipid hydrolysis resulting in the 
inhibition of Ptd OH formation (Kiss et al., 1992). 
1. 2. 4. Effect on cell proliferation 
HNE and other 4-hydroxyalkenals possess the capacity of 
blocking cell proliferation at concentrations where lethal effects are 
low or absent. Schauenstein (1982) and Hammer et al. (1988) reported 
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that HNE inhibited Ehrlich ascites tumour cell (EATC) proliferation. 
After incubation of EATC in vitro with 0.16 mM HNE for 120 min, the 
cell viability did not differ essentially from control cells, but when 
treated cells were reimplanted into healthy mice, considerable 
inhibition of tumour growth occurred: 90% of animals remained 
absolutely tumour-free after 10 days, and 100/0 of the animals showed 
considerable inhibition of tumour growth. No animal showed 
unchanged tumour growth. Hauptlorenz et al. (1985) also observed that 
during exposure of cultured EATC to concentration of 10-20 )lM HNE, 
the proliferation was strongly inhibited. These concentrations of HNE 
do not affect cell viability and membrane integrity as measured by the 
Trypan Blue exclusion method and rubidium uptake. Barrera et al. 
(1991b) found that repeated treatment of the HL-60 human 
promyelocytic cell line with HNE (1 )lM) caused a strong inhibition of 
cell growth without affecting cell viability. Moreover, HNE treatment 
induced differentiation of HL-60 cells. HL-60 cells can be induced to 
differentiate terminally into either monocyte/macrophage-like cells or 
granulocytes by a variety of chemical agents. Like a common inducer of 
HL-60 cell differentiation, DMSO, HNE induced chemiluminescence 
prodUction, phagocytosing capabilities and enzymatic changes. 
There are several possibilities that may explain the inhibition of 
cell proliferation induced by HNE: 
(1) Inhibition of the DNA polymerase system and DNA synthesis 
(Schauenstein, 1982; Hauptlorenz, et al .• 1985). DNA polymerase ex is 
an SH-containing enzyme, which can be blocked by sulphydryl reactive 
agents including a, ~-unsaturated aldehydes, such as HNE. However, 
isolated DNA polymerase a is rather resistant to HNE (ID50 = 21 )lM). 
it is therefore unlikely that inhibition of cell proliferation and overall 
synthesis of DNA results from inhibition of the DNA polymerase system 
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(Esterbauer et al., 1991). 
( 2 ) Disturbance of the cell cycle (Poot et al., 1988: Miglietta, et 
al., 1991) and alteration of the microtubular system (Olivero et al., 
1992). As mentioned above, HNE arrests cells in G2 and G 1 phase, 
delays onset of proliferation due to a retardation of the transit of the 
cells from GO to G 1 and prolongs the G 1 phase. This severe 
disturbance of the cell cycle indicates that HNE-treated cells show a 
diminished DNA synthesis and a diminished rate of proliferation. 
( 3 ) Interference of the expression of certain genes (Dianzani et 
al., 1990). 
The property of HNE interfering with the gene expression was 
displayed at very low concentrations. HNE specifically blocks c-myc 
oncogene expression by a human erythroleukemic cell strain (K 562) 
cultivated in vitro. This effect occurs at concentrations of 0.1-1 JlM and 
is accompanied by the increase of the expression of the gamma-globin 
gene (Dianzani, et al., 1990). The c-myc protein is involved in the 
regulation of cellular multiplication. 
Low concentration of HNE has also been suggested to reduce 
ornithine decarboxylase (ODe) gene transcription (Barrera et al., 
1991a). ODe is the first regulatory enzyme in the biosynthesis of 
polyamines. It plays a key role in proliferation both of normal and 
neoplastic cells and its induction seems to be a universal mechanism 
of growth stimulation by hormones, drugs and tumour promoters. It 
has been reported that the inhibition of ODe activity is associated with 
a block in cell cycle progreSSion at the G 1 phase. Barrera et al. found 
that HNE at 1-10 JlM inhibits the induction of ODe activity in 
leukaemic cells by foetal serum. Since HNE did not affect the half-life 
of ODe and the same HNE concentration did not inhibit ODe activity 
when added to cytosol, they suggested that HNE affects ODe synthesis 
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and may act by reducing ODC mRNA transcription. 
The mechanism involved in the regulation cell differentiation 
still remains relatively obscure (Barrera, 1991 b). It seems that HNE-
induced HL-60 cell differentiation is related to regulation of gene 
expression. HNE inhibits c-myc gene expression in K562 cell. The 
down regulation of this gene is a common feature of several 
differentiation processes (Barrera, 1991 b). Induction of HL-60 cell 
differentiation by DMSO enhanced synthesis of heat shock proteins 
(Barrera, 1991 a). This effect has also been observed after treatment of 
hepatoma cells with HNE (Cajone and Bernelli-Zazzera, 1989). It is 
reported that treatment of HeLa cells with HNE has the same effect as 
heat shock in causing the appearance of a protein that binds to the 
sequence of DNA specific for the induction of heat-shock gene 
expression (Cajone et al., 1989). 
However, in contrast to the inhibitory effect on proliferation of 
cells, HNE exhibits some stimulatory effects on gene expression and 
cell proliferation. 
AscorbiC acid has shown to stimulate collagen synthesis via 
stimulation of pro collagen gene transcription. Chojkier et al., (1989) 
reported that lipid peroxidation and aldehydes induced by ascorbic 
acid and iron accumulated in culture cells may be necessary for the 
stimulation of Type I collagen synthesis and collagen a( 1) gene 
transcription in cultured AF 2 human fibroblasts. They observed that 
cOincubation of cells with ascorbic acid and a-tocopherol blocked the 
production of TBARS, malonaldehyde-protein adducts and 4-HNE-
protein adducts as well as ascorbic acid stimulated-collagen production 
indicating that products of lipid peroxidation mediated the ascorbic 
acid-induced stimulation of collagen gene expression. They suggested 
that protein ad ducts formed with aldehydes derived from peroxidation 
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such as HNE may play a role in the increased transcription of the 
collagen gene. 
Adenylate cyclase and phosphatidylinositol-4,5-bisphosphate 
(PIP2)-phospholipase C (PL-C) are effecter enzymes coupled, through 
regulatory G proteins. to specific membrane receptors for hormones 
and growth factors. Their reaction products (cAMP for adenylate 
cyclase, diacylglycerol (DG) and inositol triphosphate (IP3) for PL-C) 
play a prominent role in the control of cell division and proliferation. 
HNE at very low concentrations stimulate both of these two enzymes 
(at higher concentration, HNE inhibits adenylate cyclase, see Table 
1.2.1). 0.1-1 ~M for adenylate cyclase in Fisher rats liver plasma 
membrane, 0.01-1 ~M for PL-C in rats liver (Dianzani, et al., 1990, 
Rossi, et al., 1990) and 0.01 ~M-1~M for PL-C in plasma membranes 
isolated from rat neutrophils (Rossi et al., 1991). 
Moreover, HNE (0.001-1 ~M) reduces junctional communication 
(JC) among bOvine aortic endothelial cells in culture. JC is reduced 
progressively with increasing concentration of HNE. The decrease in 
JC does not seem related to general. unspecific inhibition of protein 
syntheSiS. At concentrations between 0.001-1 ~M. there is no 
reduction in protein synthesis for up to 8h treatment with HNE. 
Intercellular communicating junctions are conSidered to be important 
for cellular homeostasis, regulation of cell growth and differentiation. 
Loss of JC, may help transformed cells to escape from growth control. 
Reduction of JC is conSidered to be a general mechanism, among 
others, for promotion of uncontrolled cellular proliferation (Radu and 
Moldovan, 1991). 
Clearly. there are contradictory reports concerning the effect of 
HNE on cell proliferation and this topiC needs further investigation to 
resolve this contradiction. 
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From the discussion above, it can be seen that 4-hydroxyalkenals, 
particularly HNE, have two different effects depending on the 
concentration. At 10-100 J.lM or above HNE cause acute and unspecific 
cytotoxic effects, such as inhibition of DNA-, RNA- and protein 
synthesis and leading to cell death. At 0.1-1 J.lM or below, HNE exhibits 
physiological functions, modulation of cell proliferation/differentiation 
by affecting associated enzyme activity and gene expression. HNE is a 
product of lipid peroxidation and under conditions of oxidative stress 
the concentration of HNE in tissues can increase to 5-10 J.lM 
(Esterbauer et aI., 1989). The membrane concentration of HNE may 
reach 100 J.lM (Poli et al., 1987). At this concentration HNE will show 
its toxic effects. In fact some cytoxicities of HNE, such as inhibition of 
glucose-6-phosphatase activity, reduction of P 450 content and 
alteration of Ca2+ uptake are observed under the condition of lipid 
peroxidation induced by chemicals, for example CCl4 . Lipid 
peroxidation also exists in normal tissues at very low level. The 
physiological concentration of HNE ranged from 0.1-3 J.lM (Esterbauer, 
1990; Esterbauer et al., 1989). At this concentration level, HNE plays a 
role in the control of cellular proliferation/differentiation. It has been 
suggested that lipid peroxidation has a very important role for control 
of cell proliferation (Cheeseman et al., 1986; Slater 1988). The fact 
that HNE has a regulatory function on cell proliferation supports this 
hypothesis. 
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1.3 PART III RIBONUCLEOTIDE REDUCTASE 
1. 3. 1 Ribonucleotide reductase of i£scfiericfiia cofi and mammals 
Ribonucleotide reductase (ribonucleoside diphosphate reductase, 
EC 1.17.4.1.) and ribonucleoside triphosphate reductase (EC 1.17.4.2.) 
catalyse the conversion of all ribonucleotides into their corresponding 
deoxyribonucleotides. Since the pool of deoxyribonucleoside 
triphosphates is relatively small compared to the rate of DNA 
synthesis, ribonucleotide reductase is considered to playa critical role 
for DNA synthesis, maintaining an adequate and balanced supply for the 
direct precursors of DNA (Thelander and Reichard, 1979; Lammer and 
Follmann, 1983; Cory, 1989). 
Based upon substrate specificity and cofactor requirements, the 
reductase can be classified into three types. The first type reduces 
ribonucleoside diphosphates and is best represented by the enzyme 
from i£scfiericfiia cofi ('E. coa). This type of enzyme is also found in 
mammals, higher plants and in some fungi (Thelander and Reichard 
1979; Wright et al., 1989; Lammers and Follmann 1983). The second 
type of enzyme reduces ribonucleoside triphosphates, requires 5 ~ -
deoxyadenosylcobalamin as a factor which is represented by the 
enzyme from Lacto6acif{us feicfimanni (Carell and Seeger, 1980). The third 
type is characteristic of '13aci![us megaterium and 1\..fiizo6ium me[ifate. This 
enzyme requires deoxyadenosylcobalamin as the co-factor but reduces 
the ribonucleoside diphosphates (Thelander and Reichard, 1979, 
Carell and Seeger, 1980). There is another type of enzyme in which 
manganese is involved in ribonucleotide reduction (Lammer and 
Follmann, 1983). 
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1.3.1.1. I£sclieridiia coli enzyme 
The well characterized ribonucleotide reductase from 'E. coli is 
composed of two non-identical proteins Bl and B2, both required for 
activity (see Fig. 1.3.1). Protein B2 (Mr=78,000) contains two identical 
polypeptide chains (~~), that do not dissociate except under 
denaturing conditions. Each chain contains a non-haem iron centre 
and an oxidized tyrosine free radical which is essential for the 
enzymatic reaction (Reichard and Ehrenberg, 1983; Atkin, et al., 
1973). This radical is derived from a tyrosyl residue of the polypeptide 
chain and is stabilised by the iron centre. The radical can be 
recognized by a sharp peak at 410nm in the optical spectrum and a 
characteristic electron paramagetic resonance (EPR) signal (Thelander 
and Reichard, 1979; Sjoberg and Reichard, 1977). Protein Bl 
(Mr= 160,000) is a dimer of polypeptides (aa#) which are identical in 
size but appear to differ in their N-terminal amino acid sequence. Bl 
contains two apparently identical binding sites for substrates (CDP, 
UDP, GDP and ADP) and four sites for allosteric effectors. Of four 
allosteric effector sites, two sites ('h' sites) bind dATP with high 
affinity and, in addition, bind ATP, dGTP, and dTTP and determine 
substrate specificity of the enzyme. The remaining two sites ('1' sites) 
bind dATP with low affinity and, in addition, only bind ATP and govern 
the overall activity of the enzyme (Thelander and Reichard, 1979; 
Reichard and Ehrenberg, 1983). The active enzyme contains B 1 and 
B2 in a 1: 1 stOichiometry. The catalytic site of the holoenzyme is at the 
interface of the two proteins comprised of residues from both subunits 
with B 1 contributing redox-active sulphydryl groups that donate the 
electrons necessary for the reduction and B2 contributing the tyrosine 
free radical and the non haem iron (Thelander and Larsson, 1976; 
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Fig. 1.3.1 Model for 'E. coG and mammaUan ribonucleotide reductase 
(a) 'E. co.G enzyme; (b) mammalian enzyme 
(Modified from Wright, 1989 and Whitfield and Youdale, 1989) 
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Thelander and Reichard, 1979; Lin et al., 1987). The cross-linking 
data support a model in which both of the p-subunits interact closely 
with only one of the two ex subunits (Mathews et al., 1987). C-terminal 
ends of the B2 protein are involved in the interaction with the Bl 
protein (Climent et al., 1991). 
1.3.1.2. The mammalian enzyme 
Mammalian ribonucleotide reductase appears to resemble the 'E. 
cofi enzyme with respect to its substrate, iron and free radical 
involvement. Studies on the enzyme from Ehrlich ascites hepatoma 
tumour of mice (Cory et al., 1978), rat Novikoff hepatoma (Moore, 
1977), human lymphoblast cell line (Molt-4F) (Chang and Cheng, 
1979), rabbit bone marrow (Hopper, 1972), calf thymus (Thelander et 
aI., 1980; Engstrom, et al., 1979), mouse fibroblast 3T6 cell (Larsen et 
aI., 1982), and rat regenerating liver (Youdale and MacMances, 1979; 
Youdale rt al., 1982) have revealed that several properties of the 
mammalian enzyme are Similar to those of the enzyme obtained from 
'E. corio 
In mammalian cells, the enzyme consists of two non-identical 
subunits called Ml and M2. These two components have functions 
equivalent to the B 1 and B2 proteins of the 'E. cofi reductase (Cory et 
aI., 1978, 1979; Thelander and Reichard, 1979; Thelander et aI., 
1985; Nutter and Cheng, 1989) (see Fig. 1.3.1). Protein Ml is a dimer 
and it contains two kinds of effector binding sites, one kind specific 
for ATP or dATP (activity site) and the other kind capable of binding 
ATP, dATP, dTIP and dGTP (specificity site), but only one catalytic site 
which forms, or becomes functional when Ml subunits couple with M2 
subunits. There is no indication of the presence of high- and low-
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affinity binding sites for dATP (Thelander et al., 1980). The M2 protein 
is a dimer too and it contains two non-haem iron centres and a tyrosyl 
free radical essential for activity (Thelander et al., 1985; Ochiai et al., 
1990). Both iron and radical centre seem to be the same as in the 
bacterial protein (Thelander et al., 1985; Akerblom et al., 1981; 
Graslund et al., 1982). Molecular weights of the intact enzyme and 
separated components of some mammalian reductases were 
summarised by Nutter and Cheng (1989) (see Table 1.3.1). 
1.3.1.3. Mechanism of ribonucleotide reductase reaction 
In 1£. cofi and mammalian cells the reduction of the four 
ribonucleotides occur at the diphosphate level, (NDP to dNDP) and 
involves the replacement of a hydroxyl group by a hydrogen. It appears 
likely that the enzyme reaction involves a direct replacement of the 
hydroxyl group at carbon 2# of NDP by a hydrogen (Thelander and 
Reichard, 1979; Lammer and Follmann, 1983). In addition to the 
ribonucleotide reductase, two small proteins, thioredoxin and 
thioredoxin reductase, which is a flavoprotein, also participate in the 
reduction process as hydrogen carriers. The electrons are originally 
from NADPH (Thelander and Larsson. 1976; Thelander and Reichard, 
1979). The scheme for the ribonucleotide diphosphate reduction in 1£. 
cofi is shown in Fig. 1.3.2. Reduced thioredoxins do not directly donate 
H to a substrate but first reduce an enzyme disulphide bridge. During 
enzymic catalysis, the B 1 subunit alternates between two forms, the 
active dithiol form and the inactive disulphide form, which is 
continuously regenerated by thioredoxin (Sjoberg and Reichard, 1977; 
Lammer and Follmann, 1983). There are at least 4 redox-active 
cysteine thiols in the reductase B1. The role of thiol residues in the 
reductase catalYSiS is much more complex: two pairs of thiols are 
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Table 1.3.1 Molecular weights of mammallan ribonucleotide reductase and their components 
Source 
Rat NovikofI ascites 
Regenerating rat liver 
Human lymphoblast 
Calf thymus 
Mouse Ehrlich 
tumour 
Mouse 
lymphc&lrcana 
Holoenzyme 
200,(XX) - 250,<xx> • 
280,OOOt 
210,000 EB 
340,00 § (CDP reduction) 
254,000 § (ADP reduction) 
Component 
Effector-binding (Ml) 
180,000 • 
90,000 # 
Non-haem iron (M2) 
45,000 #, t (CDP reduction) 120,000 t 
75,000 + 47,000 # 
100,000 EB 100,000 EB 
84,000 # 55,000 # 
98,000 EB 110,000 • , EB 
84,000 # 58,000 # 
127,<XX>§ 
95,000 § 
89,000 # 
81,000 § 
Methodological criteria: • gel filtration, # SDS-polyacrylamide gel electrophoresis, EB sedimentation velocity, 
§ sedimentation eqUilibrium, t molecular exclusion high perfonnance liqUid chromatography. 
(Adapted from Nutter and Cheng, 1989) 
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Fig. 1.3.2 Reduction of ribonucleotide diphosphate to deoxyribonucleotide 
diphosphate in 'E corio 
(Adapted from Thelander and Reichard, 1979) 
involved in catalysis, one being responsible for substrate reduction and 
the other for shuttling reducing equivalents from the external reducing 
system into the active site (Ashley and Stubbe, 1989). The role of the 
B2 free radical in the substrate reduction is not very clear, but it 
directly participates in the catalytic process together with the 
oxidation-reduction active dithiols of Bl (Thelander and Larsson, 
1976; Sjoberg and Reichard, 1977; Ashley and Stubbe, 1989). 
A single 1£. coCi reductase reduces all four ribonucleotides 
(Thelander and Reichard, 1979; Cory, 1989). The mammalian 
enzymes, on the other hand, seem to be more complicated. Youdale et 
al (1982) proposed that there are four different Ll (or Ml) subunits 
each specific for the reduction of a particular ribonucleotide (ADP, 
UDP, CDP and GDP) attached to one L2 (or M2) subunit in rat liver. A 
similar conclusion suggesting that there may be more than one kind of 
Ml subunit in rat liver comes from Whitfield (1989) who observed that 
the Ml C-terminal anti-serum inhibits CDP-reductase activity almost 
completely in extracts from 24h regenerating liver, but this anti-serum 
does not affect ADP reductase activity. Carter and Cory (1989) found 
that elevated CDP and ADP reductase activity in hydroxyurea-resistant 
cells (hydroxyurea is a specific inhibitor of the reductase, see below) 
are not coordinately increased indicating that the two enzymes are not 
identical. Based on the observations of the enzyme from Ehrlich 
hepatoma tumour cells, mouse L cell lines, and CRO cell lines, Cory 
and Fleischer (1982 a) suggested that the intact mammalian reductase 
is made of a non-haem iron component (M2) that is common to all 
substrates and an effector-binding component (Ml) which is specific 
for each substrate. There are conflicting conclusions. Chang and Cheng 
(1979) reported ADP- and CDP- reductase activity may exist in the 
same enzyme of human lymphoblast cells (Molt-4F) but have different 
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active sites. With the enzyme from calf thymus, Ericksson (1979) 
claimed that only one enzyme catalyses the CDP, UDP, GDP, and ADP 
reduction. However, their data are not sufficient for the conclusion that 
the four substrate are all reduced by the same enzyme (Cory and 
Fleischer, 1982 a). 
1.3.1.4. Location of the enzyme 
Although it was once postulated that the ribonucleotides were 
reduced in the nucleus, using immunohistochemical and subcellular 
fractionation techniques it has been demonstrated that the enzyme is 
exclusively localised in the cytoplasm and the activity is present in the 
cytoplasm (Elford et al., 1972; Chang and Cheng, 1979; Hansson et al., 
1986; Kucera and Paulus, 1986). 
1.3.2 Relationship between ribonucleotide reductase activity and the 
growth of tissues and cells 
The levels of deoxyribonucleoside triphosphates in cells are very 
low. It is found that the dNTP pools are suffiCient to support DNA 
synthesis for only 1-5 min (Elford. 1974). Therefore. the reductive 
conversion of ribonucleotides to deoxyribonucleotides is believed to be 
a crucial and rate-controlling step in the pathway leading to the 
biosynthesis of DNA and the enzyme that catalyses the reduction. 
ribonucleotide reductase is conSidered to play a key role in cell 
division and its activity closely correlates with the tissue growth 
(Elford, 1970,1972; Takeda and Weber, 1981). 
1.3.2.1 Activity in proliferating tissue 
Based on research into the relationship between reductase 
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activity and growth rate of hepatomas. Elford et al. (1970; 1972) found 
an excellent correlation between tumour growth rate. which is defined 
as the average time required for the development of a viable 
transplantable tumour. and the activity of the reductase (see Fig. 1.3.3). 
Differences of 200-fold in enzyme specific activity exist between the 
very fast- and the slow-growing hepatomas. The experiments of Takeda 
and Weber (1981) support this finding. They showed that the 
reductase activity is markedly increased in hepatomas compared to the 
normal liver and the rise in activity correlates pOsitively with the 
growth rate of the tumours. 
A strong correlation between the enzyme activity and tissue 
proliferation is also found in the profile of the enzyme activity during 
neonatal development in several rat organs. Rat foetal liver extract has 
a very high level of enzyme activity. At the time of birth. there is a 
sharp decrease in activity. One week after birth there is only a very 
small amount of activity remaining. 1/20 of the newborn liver activity 
and only 1/200 of the 18-19-day foetal liver extract activity. No activity 
can be detected in adult rat liver. In developing rat spleen. the 
• 
maximum activity occurs at a time when the onset of white cell 
production is initiated. at six days after birth. In the developing rat 
thymus. the enzyme is very low at the time of birth and then rapidly 
increases. The maximum peak of activity occurs at about the time that 
the thymus is able to colOnise the lymphoid system and synthesize a 
new pattern of immunoglobulins (Elford. 1972). The activity of the 
enzyme is also markedly increased in regenerating liver (King and 
Lancker. 1969; Elford. 1974; Cory and Fleischer, 1982 b; Takeda and 
Weber. 1981). The main events preceding cellular division and cellular 
multiplication after partial hepatectomy are DNA synthesis. which in 
the rat starts at 18h post operation. and mitosis which starts 6h later 
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Fig. 1.3.3 Relationship between tumour growth rate 
and ribonucleotide reductase activity 
(Adapted from Elford, 1972) 
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(King and Lancker, 1969). According to Elford (1974) there is no 
detectable activity in normal rat liver, or in 5h, 12h, and 18h 
regenerating rat liver. However, appreciable activity is seen 24h after 
hepatectomy and is further increased after 36h. 
Further evidence for the close involvement of reductase in 
replication is provided by the organ distribution of this enzyme activity. 
Among 14 different tissues of the rat the activity is highest in the 
organs of active cell renewal: namely, in the thymus, bone marrow, 
spleen, mucosa of small intestine, and colon mucosa. In other organs 
activity is only found in trace amounts in the brain and adipose tissue 
(Takeda and Weber, 1981). 
1.3.2.2. Activity during cell cycle 
Many investigations have uncovered a critical association between 
the mammalian reductase activity and cell growth. There is a strict 
relationship between the measured reductase levels and the fraction of 
the cell population that is replicating DNA (Turner et al., 1968). The 
activity of the enzyme has been shown to vary in cells at different 
phases of the cell cycle. The enzyme activity is low in resting cells 
during GO-G 1 and increases dramatically just prior to and during 
periods of DNA synthesis, S phase, and then returns to a low basal 
level near the end of S phase (Eriksson and Martin, 1981; Cheranne 
and Caldini, 1986; Rubin and Cory, 1986). 
The mammalian enzyme is composed of two proteins M 1 and 
M2. The proteins are associated but can be separated into two inactive 
components which constitute an enzymatically active complex when 
recombined. In contrast to the enzyme in 'E. co[~ the two subunits of 
the mammalian reductase are not coordinately increased and 
decreased during the cell cycle (Lammers and Follmann, 1983; Nutter 
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and Cheng, 1989). Although it is in agreement that the two subunits of 
mammalian enzyme are not coordinately expressed, there are two 
opposite conclusions concerning which subunit is the controlling or 
limiting component for enzyme activity in G 1 when holoenzyme is low. 
Cory and Fleischer (1982 b) reported that in Ehrlich ascites 
tumour cells, the decrease in CDP reductase activity which 
accompanies decreased proliferation in vivo, is correlated with the 
decrease in the effector-binding component (Ml) since the addition of 
this component to cell-free extracts stimulated CDP reductase activity, 
and the addition of non-haem iron content component (M2) had no 
effect. Rubin and Cory (1986) found that in L1210 murine leukemia G1 
phase cells, addition of exogenous effector-binding subunit markedly 
increased the level of CDP reductase activity indicating an excess of the 
non-haem iron subunit and a limiting amount of the effector-binding 
subunit. Whitfield et al (1989) demonstrated that in regenerating rat 
liver cells functional M2 subunits start accumulating rapidly around 2h 
before the onset of DNA replication. Only when the M2 subunits reach 
a certain level do M1 subunits appear and combine with waiting M2 
subunits to form the active reductase holoenzyme needed for DNA 
replication. Thus, from these results it is suggested that the Ml 
subunit controls the level of reductase holoenzyme. 
By contrast, another group of experiments show that Ml is in 
excess and the enzyme is controlled during the cell cycle by the level 
of M2 protein. The increased overall enzyme activity in cells from the 
S phase of the cell cycle is shown to be due to an increased M2 protein 
activity, and the M1 protein is practically constant in G 1 and S phase 
cells. When mouse S49 lymphoma cells are arrested by B~cAMP 
(N6,02_dibutyryI3'-5'-monophosphate) in the G1 phase, addition of 
M 1 protein gave no stimulation of the reductase activity from treated 
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cells t but the addition of M2 protein resulted in a stimulation of the 
activity indicating that the decreased enzyme activity in B~ cAMP-
treated t G I-arrested cells is mainly due to the limiting M2 protein 
activity. When a population of dividing cells was subfractionated as 
follows: 
(i) 900/0 cells in G 1 
(ii) 310/0 cells in G 1 and 680/0 cells in S/G2 
(iii) 950/0 cells in S/G2 
the specific activity of M 1 protein was found to be similar in all 3 
fractions and close to that of an unfractionated populationt howevert 
the specific activity of protein M2 is very similar in fraction (ii) and 
(iii) t but in the fraction (i) it is decreased to approximately one-third 
(Eriksson and Martin t 1981). In hydroxyurea-resistant t M2-over-
producing mouse mammary tumour TA3 cells t the concentration of the 
M2-specific tyrosyl radical increases when cells pass from the GO/G1 
phase to the S phase of the cell cycle. Using two independent methods 
to obtain a synchronized cell population t centrifugal elutriation and 
isoleucine starvationt it was found that both Sand G2 cells contain high 
levels of protein M2 t whereas very little is found in GO / G 1 cells 
(Erissson et al. t 1984). In bovine kidney MDBK cells, no correlation 
was observed between the protein level of M 1 which was determined 
by the use of a two-site monoclonal antibody-enzyme immunoassay and 
the number of cells in the S phase. Instead, M1 protein is constant 
through the cell cycle. However, M2 protein increases in S phase in 
parallel with an increase in reductase holoenzyme activity. Addition of 
an excess of pure Ml gave no stimulation of the enzyme activity. 
Addition of purified M2 protein resulted in a pronounced stimulation 
of enzyme activity (Engstrom, et al., 1985). These studies suggest that, 
at least in these cultured cell lines, the M2 protein is limiting for 
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ribonucleotide reductase activity during the cell cycle (Wright, 1989). 
Other evidence that supports the view that M2 controls the enzyme 
activity come from Strandart et al (1985, 1986) who showed that 
unfertilised clam and sea urchin maintain a pool of functional M 1 
subunits and a pool of untranslated M2 mRNA which translate only 
after fertilisation. 
Mann et al. (1988) defined the kinetic feature of M1 expression 
related to transitions into, within, and out of the cell cycle by directly 
studying its expression during a variety of cell kinetic events. They 
observed that the M1 subunit is continually expressed by rapidly-
cycling cultured cells throughout the cell cycle. The level in G 1 is even 
slightly higher than in later parts of the cell cycle, whereas quiescent 
(GO) cells have virtually no Ml. Their data further reinforce the view 
that M1 protein levels do not limit activity during G l. These results 
indicate that when proliferation ceases, M1 falls in these 'out of cycle' 
cells. This is in agreement with the result that protein M 1 is not 
present in all cells, it is only present in proliferating cells of rat tissues 
(Engstrom et al., 1985). A similar observation was made by Whitfield et 
al., (1989). They observed that cells in intact rat liver make functional 
M 1 protein only when replicating DNA. When quiescent, or after 
finishing DNA replication the liver produces a fragment of the 
functional M1 protein. This fragment in the quiescent, intact liver is 
not functional. 
However, the precise relationship between the changes in the 
M 1 and M2 level during the cell cycle has not yet been determined 
(Sato and Cory, 1986). 
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1. 3. 2. 3 The relationship between other enzymes associated with 
DNA metabolism and cell proliferation 
Apart from ribonucleotide reductase, other enzymes are involved 
in pyrimidine and purine metabolism, such as thymidylate synthetase, 
thymidine kinase, uri dine kinase, and uridine 
phosphoribosyltransferase etc. However, ribonucleotide reductase plays 
a pivotal role in the biochemical programme of proliferation. Elford et 
al. (1970) indicated that although thymidine kinase is markedly 
elevated in the hepatomas and that the increases are related to growth 
rate, discrepancies were observed and this enzyme is a salvage pathway 
enzyme and not a ae novo synthetic one. The activity of thymidylate 
synthetase appears elevated in hepatoma tumours, but the degree of 
correlation between this enzyme activity and growth rate of the tumour 
is quite limited, especially in the rapidly growing tumour (Elford et al., 
1970). The largest measurable difference in thymidine kinase and 
thymidylate synthetase activities between the fast-growing, poorly 
differentiated tumours and slow-growing, well-differentiated tumours, 
are less compared with the difference in ribonucleotide reductase 
activity, only about 20-fold in the case of thymidylate synthetase and 
50-fold in the case of thymidine kinase (Elford, 1972). Ribonucleotide 
reductase activity in fast-growing tumours is 200-fold higher than the 
enzyme activity in slow-growing tumours. Takeda and Weber (1981) 
observed that when cells are freshly plated and allowed to grow for a 
96h period, ribonucleotide reductase is the first enzyme activity to 
rise at 6h among the enzymes mentioned above. The only other 
parameters measured that rise as early as 6h after plating are the 
incorporation of cytidine and deoxycytidine into macromolecules. 
These results indicate that the correlation of the ribonucleotide 
reductase activity with DNA synthesis and tissue growth rate is much 
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closer than the other enzymes associated with DNA synthesis. 
Additionally, the physiological reducing complex, thioredoxin/ 
thioredoxin reductase is also shown not to be the rate-limiting factor 
accounting for the large differences in the reductase activity observed 
between the various hepatomas (Elford, 1972). 
1. 3. 3. Regulation of ribonucleotide reductase activity 
Ribonucleotide reductase from all sources so far examined 
exhibits complex control by different mechanisms of regulation from 
holoenzyme activity level to the molecular level. 
1. 3. 3.1 Product feed back regulation 
The enzyme activity has been shown in both mammalian and 
bacterial systems to be regulated in a very strict allosteric fashion by 
nucleoside 5' -triphosphates and nucleoside 5' -diphosphates that can 
serve as positive and negative effectors (Thelander et al., 1980; 
Eriksson et al., 1981; Cory, 1973; Cory et al., 1985 b; Hards and 
Wright, 1984). There are two genetically independent regulatory 
domains on the protein M1 molecule, one responsible for regulating 
substrate specificity of the enzyme and the other for regulating its 
overall activity (Erikson et al., 1981) (see Table 1.3.2). 
The most widely cited regulatory model for the mammalian 
reductase is that described by Thelander and Reichard (1979) and 
Thelander et al. (1980). According to this model, the regulation of 
enzyme activity is proposed to occur as follows. The holoenzyme is 
activated when ATP causes the formation of an M1 dimer containing 
two kinds of effector sites and one kind of catalytic site. When ATP 
occupies both of the effector sites, the M1 catalytic site switches to its 
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Table 1.3.2 Regulation of E. coli and mammalian ribonucleotide 
reductase by ribonucleoside triphosphate 
Activity site Specificity site 
Binds Effects Binds Substrate reduced 
ATP activation ATP CDP 
} 
dATP inhibition dATP UDP 
dTIP GDP 
dGTP ADP 
(Adapted from Eriksson et al., 1981) 
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CDP/UDP reductase mode. However, when the increasing amount of 
dTIP formed from dUDP eventually displaces ATP from one of the M1 
effector sites, the catalytic site switches from its CDP IUDP reductase 
mode to its GDP reductase mode. The increasing amount of dGTP 
displaces dTIP from the effector site and stops GDP reduction by 
Switching the catalytic site to its ADP reductase mode. Finally, the 
cycle or pulse ends when dATP displaces ATP from one 
of the effector sites and switches off the enzyme. However. this model 
was constructed using data obtained with cell-free extracts, and there 
are indications that in vivo regulation of the enzyme may not entirely 
agree with this model. Using an intact cell assay system, Hards and 
Wright (1984) modified the model. They suggested that GTP, or 
perhaps dCTP, should be included in the model for the enzyme 
regulation (for activation of CDP and ADP reduction). Since it is 
indicated that mammalian reductase consists of one of four distinct M 1 
subunits plus one M2, in the new modified model, it is assumed that all 
four possible M 1 subunits would possess a Similar regulatory site to 
which dATP binds to inhibit enzyme activity. Each subunit should also 
possess a nucleoside specific site but, unlike the in vitro model, it is 
proposed that each Ml subunit can bind only those nuc1eotides which 
activate the particular substrate it binds. Cory et al., (1985 b) 
demonstrated that nucleoside 5~ -diphosphates and the direct products 
of the enzyme reaction, deoxynucleoside 5-diphosphates can also serve 
as positive and negative effectors respectively. dNDPs act as non-
competitive inhibitors with respect to the substrate. 
The question arises whether the difference in reductase activity 
between the various tissue and cell phases are the consequence of an 
alteration in the enzyme from an inactive to active state as mediated by 
allosteriC agents. or whether they represent an increase in enzyme 
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synthesis. Takeda and Weber (1981) suggested that it is unlikely that 
the enzyme activity in rapidly proliferating tissues is controlled by 
modulation of the enzyme activity by feedback inhibitors. In most 
mammalian systems the inhibition of purified enzyme activity achieved 
by dNTPs was not verified in the actual cellular concentration of these 
metabolites. In normal, regenerating and newborn rat liver and in 
slowly and rapidly growing hepatomas, there is a growth-rate-related 
increase in the levels of dATP, dGTP, and dTTP. The concentrations 
required to inhibit 500/0 of the activity of CDP reductase from 
regenerating liver and rapidly growing hepatoma are much higher than 
those normally found in tissues. Thus, Takeda and Weber proposed that 
the activity of reductase in the liver and in hepatoma is controlled 
chiefly by the amount of the reductase present in the cell. Elford et al .. 
(1970) believed that the gross changes in enzyme activity observed in a 
series of hepatoma tumours represent different rates of enzyme 
synthesis and degradation in response to the cell requirement for DNA 
synthesis rather than response to an alteration in the state of the 
enzyme from an inactive to an active state. The allosteric control 
probably exerts a fine control on the reaction by assuring that a 
balanced supply of deoxyribonucleotides is synthesized and preventing 
an excess supply of free deoxyribonucleotides since excess 
deoxyribonucleoside triphosphates are cytotoxic to cells (Cory, 1989). 
However, Albert and Gudas (1985) claimed that the increased 
reductase activity seen in mouse T-Iymphoma S49 S phase cells 
compared with G 1 arrested cells is not due to a large induction of the 
synthesis of either the M1 or M2 subunit. Allosteric control of the 
enzyme accounts for some changes in dNTP pools, or enzyme activity 
during the cell cycle. especially in G 1 phase. 
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1. 3. 3. 2 Regulation through free radical activation 
The enzyme activity of protein M2 depends upon the presence of 
the tyrosyl radical. The regeneration of the radical is an intrinsic 
property of M2 protein provided that iron, dithiothreitol and oxygen 
are present (Thelander et al., 1983;1985). The thymus enzyme might 
not permanently contain a free radical species but instead forms such a 
species only during the reaction (Engstrom et al., 1979). These facts 
imply that cells may have a mechanism for controlling reductase 
activity by generating the free radical of M2. Two experiments support 
this proposal. Using a cell line (mouse fibroblast 3T6) resistant to 
hydroxyurea, Akerblon et al. (1981) and Graslund et al. (1982) 
observed a 20-fold increase in M2 tyrosine free radical content 
compared to that seen in non-resistant cells, but only about a 3-fold 
increase in the amount of M2 protein indicating that part of the 
increase of enzyme activity is due to the modulation of the free radical. 
Probast et al. (1989) observed that the radical concentration in 
cultured Ehrlich ascites cells decreased under hypoxia and increased 
again upon re-aeration. At the same time, CDP reductase activity 
changed in the same way as the radical concentration: CDP reduction 
was greatly diminished and reactivated respectively under hypoxia and 
re-aeration. However, it is suggested that normally there is no pool of 
radical-free M2 protein present in cells (Eriksson et al., 1984; 
McClarty et al., 1987 b). There is still no concrete evidence whether 
the balance between radical containing and radical-free enzyme 
reflects an additional regulatory mechanism. 
1. 3. 3. 3 Regulation through the changes of the level of enzyme 
protein 
It is suggested that perhaps in the cell the components of the 
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reductase do not exist as a tightly bound entity because the subunit 
components of the enzyme are dissociable (Cory and Fleischer, 1979). 
This may be an important factor in the regulation of this enzyme in the 
intact cell. This suggestion plus the fact that M1 and M2 can exist 
independently in the cell cycle indicate that M 1 and M2 are able to be 
regulated differently in the cell. In recent years, some studies concern 
in particular the molecular regulation of M1 and M2. Usually these 
studies have used a valid model, hydroxyurea-resistant mutant cells, 
since these cells have an elevated activity of ribonucleotide reductase 
and the increased enzyme activity is related to an increase in the 
enzyme level rather than to marked alterations in activity (Choy et al., 
1988; McClarty et al., 1987 a,b; Hurta and Wright, 1990 a, b; Bjorklund 
et al., 1990). Mutants altered in the reductase activity would be 
val uable tools for analyzing the complex structural, regulatory, and 
functional properties of the mammalian enzyme (Wright, 1989). In 
general, compared with wild -type cells, M 1 protein and M2 protein 
levels are increased in the mutant cells though the increase in the M2 
level is much higher than in Ml. For example, hydroxyurea-resistant 
mutant mouse L cells contain apprOximately 50-fold more M2 than its 
wild-type counterpart whereas M1 protein is over-produced 2-3-fold 
in mutant cells compared to wild-type cells (McClarty et al., 1987 a, b). 
Both protein increases are accompanied by corresponding elevation in 
the levels of mRNA for both subunits and increased rates of 
transcription of both genes. Usually the M2 mRNA transcript was 
dramatically overproduced in the mutant cell while only the most 
highly resistant lines show increases in M1 mRNA as well (McClarty et 
al., 1987 a, b; Choy et al., 1988; Hurta and Wright, 1990 a,; Albert et al., 
1990). The increased level of M2 mRNA is frequently associated with 
amplification of the M2 gene. In contrast, M1 gene amplification in 
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hydroxyurea resistant cell lines appears to occur only rarely, and seems 
to be associated with the most highly drug resistant cells, for example 
in the cells which are resistant to 15 and 30 mM hydroxyurea 
(McClarty et al., 1987a; Wright, 1989; Hurta and Wright, 1990 b). 
Moreover, Ml and M2 protein levels are further elevated when the 
drug (hydroxyurea) is present, i.e. mutant cells grown in the presence 
of hydroxyurea contain more M 1 and M2 protein than the same cells 
grown in the absence of the drug. However the levels of M 1 and M2 
mRNA are essentially unchanged when the mutant cell line is grown 
under two different conditions, one is presence of HU and the other is 
absence of HU (McClarty et al., 1987 a; 1988). These results suggest 
that these kinds of change in M 1 and M2 proteins occur by a post-
transcriptional mechanism, such as an increase in half-life or through 
an increase in protein biosynthetic rate (Choy et al., 1988). It is 
observed that when mutant cells are cultured in the presence of 
hydroxyurea, the half-lives of both proteins Ml and M2 are increased 
by approximately 2-fold but the increase in the rate of M1 and M2 
biosynthesis occurs slowly. The level of protein M2 rises much more 
rapidly than protein M1 (McClarty et al., 1988). These observations 
show that multiple mechanisms are involved in the regulation of the 
two proteins of the enzyme. 
The regulation of M 1 and M2 protein levels through the changes 
of mRNA concentrations seems to be a common mechanism for a 
increase of enzyme activity in hydroxyurea -resistant mutant cells for 
achieving resistance to hydroxyurea (McClarty, 1987 a, b). Perhaps this 
is also an important regulation mechanism which accounts for both the 
S phase dependent reductase activity expressed as the cell pass 
through the cell cycle, and the enzyme elevation in rapidly dividing 
tissues. From the results of measuring the levels of M 1 and M2 mRNA 
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during the cell cycle in centrifugally elutriated cells and cells 
synchronized by isoleucine or serum starvation, it has been shown that 
the levels of both transcripts are very low or undetectable in GO / G 1 
phase, have a pronounced increase as cells progress into S phase, and 
then decline when cells progress into G2 + M phase (Bjorklund et al., 
1990). Many investigations have shown that ae novo synthesis of the 
reductase is a major contributor for the increase of the enzyme activity 
in rapidly proliferating tissue since the protein synthesis inhibitor 
prevented expected increases in enzyme activity during the neonatal 
development of spleen and thymus in the rat (Elford , 1972) and when 
cells approached S phase (Lammers and Follmann, 1983). 
1. 3. 4 Inhibition of ribonucleotide reductase activity 
1. 3. 4. 1 Chemical inhibitors 
The complex structure and molecular mechanism of the 
reaction of ribonucleotide reductase enzymes make them vulnerable to 
many kinds of disturbances (Lammers and Follmann, 1983). The 
enzyme from all sources is easily inhibited by one or more of the 
following inhibitors. 
i) inhibitors which destroy or hinder generation of the radical. 
ii) inhibitors which affect the metal ion which has structural 
or catalytic function. 
iii) inhibitors which affect the effector-binding component (M1 
or B 1) or specially inactivate the catalytically-active dicysteine 
system. 
iv) inhibitors which block the substrate or the effector-
nucleotide binding sites and require a functional enzyme. 
v) inhibitors which cause disturbance of the native protein 
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structure which is important for activity. 
Several different compounds have been shown to be relatively 
specific inhibitors of ribonucleotide reductase (see Fig. 1.3.4). 
i) Free radical scavengers and inhibitors of free radical formation 
( a ) Hydroxyurea (HU) 
HU is a known antineoplastic drug employed in clinical 
chemotherapy for solid tumour as well as acute and chronic leukemia 
and a widely used tool for reversible inhibition of replicative DNA 
synthesis in cell synchronization in vitro and in vivo (Lammers and 
Follmann, 1983; Wright, 1989). It is a highly specific and extenSively 
studied inhibitor of ribonucleotide reductase. It is generally agreed 
that its mechanism of action is by scavenging and destrOying the 
tyrosine free radical of the M2 or B2 subunit of the reductase. In 
studies using homogeneous 'E. coCi reductase in vitro. Atkin et ale (1973) 
observed that the drug was shown to scavenge and destroy the radical 
of protein B2 resulting in an inactive enzyme. Meanwhile the iron is 
not removed nor apparently affected in any way by the treatment with 
HU. The experiments of Larsen et al. (1982) gave further support that 
the free radical in protein B2 is the target of HU. Using a model system 
using the free radical salt, (S03S)2NO' , replacing the tyrosine free 
radical of the reductase, they found that there was a positive 
correlation between the free radical scavenging ability of HU and its 
analogues, and the ability to inhibit ribonucleotide reductase activity. In 
an analogous mode of action such as with the bacterial enzyme, HU also 
acts as a radical scavenger of the tyrosyl radical of the M2 subunit of 
mammalian reductase as well (Lammers and Follmann, 1983). After 
incubation of HU-resistant, M2 overproducing mouse fibroblast 3T6 
cells with 50 mM HU for 15 min. The EPR spectrum of free radical 
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,', 
disappeared completely (Akerblom et al., 1981). When HU-resistant 
mutant mouse L cells were grown in the presence of HU the free 
radical concentration decreases dramatically compared with the same 
cell line grown in the absence of drug. This is the result of HU 
destrOying the M2 tyrosyl free radical, leading to the loss of the EPR 
signal (McClarty, 1987a). 
The reductases from regenerating liver (King and Lancker, 
1969), calf thymus (Engstrom et al., 1979), human cells (Chang and 
Cheng, 1978; Larsen et al., 1982), mouse cells ( Akerblom et al., 
1981), 'E..coli (Atkin et al., 1973). bacteriophage T4 (Yeh and Tessman, 
1978; Vant~t Riet et al., 1979 ) are all inhibited by HU. Reduction of 
CDP, ADP, and GDP by different mammalian enzymes is as sensitive to 
HU (IC50 = 2-4 x10-4 M) as is the 1£. cofi enzyme (Lammers and 
Follmann, 1983). HU inhibits the homogeneous calf thymus enzyme in 
a concentration dependent fashion. The activity is inhibited 900/0 by 
1 mM HU (Engstrom, et al., 1979). This degree of inhibition is very 
similar to that observed with homogeneous 1£. cofi reductase (Engstrom 
et al., 1979). The M2 activity in HU-resistant mouse fibroblast 3T6 
cells is increased 30-fold. The reductase isolated from such cells 
shows the same sensitivity towards HU inhibition as the enzyme from 
normal cells (Akerblom et al., 1981). However, mouse TA3 cells, 
selected for resistance to HU, also overproduce the M2 subunit of the 
reductase and the enzyme from such cells is more resistant to HU than 
the enzyme from parent cells (Larsen et al., 1982). The mechanism of 
HU inhibition is different for enzymes from different sources. The 
effect of HU on the thymus enzyme is reversible (Engstrom et al., 
1979). After removal of the drug by gel filtration, the enzyme regained 
its original activity. Like the intact calf thymus reductase, isolated M2 
of thymus enzyme was affected reverSibly by treatment with HU 
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(Thelander et al., 1980). The same, reversible inactivation of the 
reductase occurred during preincubation of T4 enzyme or its isolated 
subunits with HU (Bergland and Sjoberg 1979). However this 
reversible effect is in strong contrast to what happens with the 
enzymes from Ehrlich ascites tumour cells and 1£. coli. HU inhibits 1£. coa 
enzyme in an irreversible -fashion (Atkin et al., 1973; Thelander and 
Reichard, 1979). For the partially-purified reductase from Ehrlich 
ascites tumour cells, HU is an irreversible inhibitor (Cory et al., 1978; 
Cory and Fleischer, 1979). 
The reductase of phage T4 and 1£. coli is a single enzyme 
controlling the reduction of four common nucleotides: CDP, ADP UDP 
and GDP. The effect of HU on each reduction activity of T4-infected 
cells has been investigated. Yeh and Tessman (1978) found that HU 
inhibited reduction of the four common substrates in T 4' but HU had 
considerably smaller effect on the reduction of UDP and GDP than on 
the reduction of CDP and ADP. Contrary to this, Bergland and Sjoberg 
(1979) found that HU was a potent inhibitor of the reduction of all four 
ribonucleotide substrates in phage T 4; the differences between the four 
substrates were negligible. The same investigations were performed on 
the enzymes from 'E. coli and human cells. Bergland and Sjoberg 
reported (1979) that there is no difference in the effect of HU on 
reduction of GDP and CDP in 'E. co{i. Chang and Cheng (1978) reported 
that CDP reductase activity from human cells (Molt-4F and KB cells) 
was more sensitive to inhibition by HU than was ADP reductase activity. 
HU inhibits DNA synthesis in eukaryotic cells and also in 
prokaryotes. This effect is mediated via inhibition of ribonucleotide 
reductase leading to decreased dNTP pools (Skog et al., 1987; Yeh and 
Tessman, 1978). A consequence of the depletion of the necessary DNA 
precursors is inhibition of cellular growth (Platz and Sjoberg, 1984). In 
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most mammalian cells, HU concentration of about 2x10-3 M prevents 
DNA replication, cell proliferation, and in vitro ribonucleotide reduction 
(Lammers and Follmann, 1983). HU at 200}.lM will inhibit the growth 
of L1210 cells in culture (Sato et al .. 1982). In the presence of 60}.lM 
of HU, the growth rate of mouse S49 T-Iymphoma and human CEM T-
lymphoblastoid cells was diminished by about 250/0 (Skog et al .. 1987). 
Therefore, HU has been widely used in chemotherapy to inhibit the 
growth of neoplastic cells, especially in the treatment of leukemia (Yeh 
and Tessman, 1978). 
( b ) Other inhibitors 
2,3-dihydro-1H-pyrazolo-(2,3-~-imidazole (IMPy) is a relatively 
potent and selective inhibitor of DNA synthesis without affecting RNA 
or protein synthesis. It inhibits the reductase from HEP-2 cells and 
L1210 cells (Cory and Fleischer. 1980; Goddard et al., 1987). The 
results from Cory and Fleischer indicate that the site of the IMPY 
target is on M2. The ADP reductase activity was inhibited to a greater 
extent than was CDP reductase activity by IMPY and the inhibition is 
irreversible. IMPY is also shown to be a inhibitor of HSV -1 reductase, 
but the effect is reversible (Spector and Jones. 1985). 
Guanazole inhibits the mammalian enzyme by a mechanism 
Similar to HU. acting as a radical scavenger and destroying the tyrosine 
free radical of protein M2 (Larsen et al .. 1982). The inhibitory effect of 
guanazole on the mammalian enzyme (human epidermoid carcinoma 
cells) is 10-fold more effective than on the HSV -1 enzyme (Spector 
and Jones. 1985). 
Thiosemicarbazone derivatives comprise the most active 
inhibitors of the mammalian enzyme (Lammers and Dollmann. 1983). 
Formylisoquinoline thiosemicurbazone (MAIQ) and 1-formylisoqui-
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nolinethiose thiosemicarbazone (IQ-1) are more potent inhibitors than 
HU on human cell reductase activity and cell growth (Chang and 
Cheng. 1978). MAIQ is at least 100 times more active than HU (Carter 
and Cory. 1989). In the presence of oxygen both of them can destroy 
the tyrOSine free radical of the M2 subunit of purified calf thymus 
reductase (Thelander and Graslund. 1983). This is in consistent with 
the observation using Ehrlich tumour enzyme that only the addition of 
exogenous M2 subunits to the MAIQ-treated intact enzyme and the 
enzyme from the MAIQ-treated cells can restore enzyme activity (Cory 
and Fleischer. 1979). Although MAIQ and IQ-1 act directly on the M2 
su bunit. they may have different mechanisms of inhibition of the 
reductase compared with HU (Carter and Cory. 1989). The iron 
chelates of these two drugs are the active form of the inhibitor rather 
than the drugs themselves (Thelander and Graslund. 1983; Moore and 
Startorelli. 1989). 
The aminoguanidine (HAG) derivatives are inhibitors of CDP 
reductase activity of L1210 cells (Cory et al .. 1985 a; Matsumoto et al .. 
1990; Weckbecker et al" 1988). These derivatives. which have a core 
structure resembling HU. are supposed to act through the same 
mechanism as HU (Matsumoto. et al .. 1990). However. the reduction 
activity in extracts from drug-treated L1210 cells was not restored by 
the addition of either exogenous non-haem iron or effector-binding 
subunits (Cory et al .. 1985 a). 
EDTA acts as an inhibitor of the enzyme only at high 
concentrations (Lammers and Follmann. 1983). and this effect is due 
to the inhibition of the enzyme regeneration. Once the radical-iron 
centre is formed. the enzyme seems to be stable to EDTA (Thelander. 
et al .• 1983). 
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ill Inhibitors affecting iron centre 
(1-aziridinyl)-2,4-dinitrobenzamide (CB1954) inhibits the 
enzyme from Walker carcinoma in rats. At the same concentration of 
CB 1954, the degree of inhibition of the enzyme was proportional to 
the enzyme concentration in the assay. This suggests that the cytosolic 
protein contains a fIxed number of enzyme sites that are titrated out by 
CB 1954. The inhibition is irreversible and from structure-activity 
studies it is likely that the amide group becomes bound to the enzyme, 
possibly by chelation of iron ion (Tisdale and Habberfield, 1980). 
iii) Inhibitors of component Ml or Bl 
Oxidized inosine (in ox) is one of the periodate-oxidized 
dialdehyde derivatives. It inhibits Ehrlich tumour CDP reductase. The 
inhibitory effect of inox on CDP reductase is stronger than on ADP 
reductase activity and the inhibitory mechanism of inox is probably 
irreversible (Cory et al., 1976). Cory and Fleischer (1979) reported 
that addition of exogenous M1 can restore the enzyme activity which is 
decreased by inox, and suggested that inox inactivates the M 1 subunit. 
Cisplatin is one of the most widely used anticancer drugs. 
Cisplatin inhibits the CDP reductase from 'E. cofi. Under anaerobic 
conditions, using the dithiol-reduced form of the enzyme it was found 
that ribonucleotide reductase is extremely sensitive to cisplatin. 
Inhibition was essentially instantaneous and irreversible. Inhibition 
occurs specifIcally by reaction of cisplatin with the dithiol at the active 
site and other dithiol pairs in the B 1 subunit (Smith and Douglas, 
1989). 
The intact enzyme from Ehrlich tumour cells loses the activity by 
treatment with the sulfhydryl agent, pCMB and NEM . The effector-
binding subunit is much more reactive with these agents (Sato and 
78 
Cory, 1986). 
Iv) Inhibitors requiring functional enzyme 
Unlike the inhibitors discussed above, 2'-chloronucleoside 5'_ 
diphosphates cytidine (CcIDP) and 2' -azidonucleoside cytidine (CzDP) 
comprise another class of ribonucleotide reductase inhibitor that 
requires a functional enzyme (both subunits) to generate the inhibitor. 
Thelander and Larsson (1976) have extensively studied CclDP and 
CzDP effect on 'E. coli enzyme. CclDP inactivates the Bl subunit. The 
inactivation of B 1 showed an absolute requirement for active B2 and is 
prevented by normal substrate CDP. The interaction of CclDP with the 
enzyme is controlled by allosteric effectors in the same way as the 
binding of CDP. So the interaction occurs at the substrate binding site 
of the enzyme. CclDP irreversibly modifies the active dithiols in Bl. 
CzDP inactivates protein B2, the activity of protein B 1 was not 
decreased by CzDP. In the absence of functional Bl, no inactivation of 
B2 occurs. The inactivation is due to the selective destruction of the 
free radical of B2. CDP protects protein B2 against CzDP-inactivation. 
In inactivating the reductase both CclDP and CzDP behave like 
irreversible enzyme inhibitors. Since the enzyme had to be in an active 
conformation in order to be inactivated by CclDP and CzDP, it is 
suggested that a reaction product of CclDP or CzDP, but not the 
compounds themselves inactivated Bl or B2, i.e. CclDP and CzDP are 
suicide inhibitors (Thelander and Larsson,1976). CzDP also decreased 
the calf thymus ribonucleotide reductase, but it acts as a reversible 
inhibitor competitive with the normal substrate, CDP (Engstrom et al .. 
1979). Similarly the inactivation of CDP reductase of T.. coG. by 2'-
methylene-5' -diphosphate cytidine (CmdDP) and 2' -methylene 
uridine(UmdDP) appears to be irreversible. CDP reductase is capable of 
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catalyzing the interconversion of both compounds to a reactive species 
capable of enzyme inactivation (Baker et al., 1991). 
The reductase isolated from rat NOvikoff tumour is inhibited by 
arabinonucleotides. aADP acts as a competitive inhibitor with respect 
to substrate indicating it interacts with the substrate sites. The enzyme 
from T.. cou also interacts with arabinonucleoside triphosphates at the 
triphosphate-specific effector sites: aATP is a potent inhibitor, but 
aCTP stimulates substrate reduction (Ludwig and Follmann, 1979). 
v) Inhibitors causing disturbance of the protein structure 
The nonapeptide YAGAVVNDL, which in sequence is identical to 
the C-terminus of HSV component 2, can inhibit HSV ribonucleotide 
reductase in vitro, and the inhibition is accompanied by a dose-
dependent diSSOCiation of the enzyme subunits. These data imply that 
the nonapeptide inhibits enzyme activity by competing with 
component 2 for a critical binding site and effectively prevents the 
formation of the active holoenzyme (Pierrette et al., 1987; McClements 
et al., 1988). The peptide corresponding to the C-terminal region of 
the B2 subunit inhibits the enzymatic activity and binds to the B 1 
subunit indicating that the peptide inhibits 'E. eoa enzyme by binding to 
the heterodimer interface in competition with the B2 subunit 
(Bushweller and Barttelt, 1991; Climent et al., 1991). This type of 
inhibition is also found to occur in the mammalian enzyme. The NU-
acetyl derivative of FTLDADF which represents the C-terminal 
heptapeptide of component 2 of the mouse enzyme is a potent 
inhibitor of calf thymus ribonucleotide reductase (Yang, et al., 1990). 
1. 3. 4. 2 Natural inhibitors 
There are also some common natural inhibitors such as negative 
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allosteric effectors dATP, dTTP, and to a lesser extent, dGTP 
(Lammers and Follmann, 1983), RNA (Cory, 1973), proteases (Sato and 
Cory, 1986), some phenolic metabolites isolated from mushroom 
(Fitzgerald et al., 1984) and gossypol from cotton seed oil (McClarty et 
al., 1985). 
RNA markedly inhibits ribonucleotide reductase from mouse 
Ehrlich ascites tumour cells, at concentrations which could be of 
physiological significance, (I50 = 5 )lM). The inhibition appeared to be 
dependent on the base composition of the RNA (Cory, 1973). The 
enzyme is inhibited by tRNA and rRNA from Ehrlich ascites cells, by 
yeast tRNA and by poly (C). Poly (I), poly (G) and poly (U) are only 
slightly inhibitory. Poly (A) does not inhibit the enzyme activity. 
The activity of CDP reductase from Ehrlich tumours was rapidly 
lost from the intact enzyme treated with trypsin. This is due to the 
great sensitivity of the non-haem iron subunit to trypsin. When the 
trypSin-treated enzyme was supplemented with exogenous non-haem 
iron subunit, conSiderable reductase activity was restored. On the other 
hand, the effector subunit was more sensitive to chymotrypsin than 
was the non-haem iron subunit, and the loss of reductase activity in the 
intact enzyme was due to the specific loss of the effector-binding 
subunit (Sato and Cory. 1986). 
y-L-Glutaminyl-4-hydroxybenzene is a substance that has been 
implicated in the induction of sporulation in the common mushroom. 
It inhibits the enzyme from L1210 leukemia cells reversibly and this 
inhibition is responsible for inhibition of DNA synthesis in the L1210 
cell line (Fitzgerald et al.. 1984). 
Gossypol is in relatively common use in several countries as a 
male contraceptive and may be useful as an antitumour agent. Gossypol 
is a potent inhibitor of the reductase activity of mouse L cell on the 
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reduction of CDP and ADP (McClarty et al .. 1985). 
1. 3. 4. 3 Physical effectors 
Some physical effectors also decrease the enzyme activity. The 
Ml subunit of the Ehrlich tumour enzyme loses its activity rapidly at 
55°C while M2 is remarkably stable (Sato and Cory. 1986). The whole-
body y-irradiation of mice with a dose of 6 Gy and the whole-body X-
irradiation of 18h post-partially-hepatectOmised rats causes a decrease 
in enzyme activity (Avakyan. 1987; King and Lancker. 1969). 
Ribonucleotide reductase plays a critical role in DNA synthesis. 
4-hydroxynonenal inhibits DNA synthesis and affects cell proliferation. 
It has been found that the level of lipid peroxidation is very low in 
dividing tissues and cells (Slater et. al.. 1990). Therefore, this thesis 
relates studies into the activity of ribonucleotide reductase in 
regenerating liver; livers taken from rats at different stages of 
development and cells from hypatomas were also studied. The 
inhibitory effect of the lipid peroxidation product, HNE on 
ribonucleotide reductase was also investigated. This thesis also details 
investigation into the activation of CCl4 as an agent capable of inducing 
lipid peroxidation. 
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2. MATERIALS AND METHODS 
2. 1 MATERAL 
Reagents were purchased from the following suppliers: 
BDH Chemicals Ltd., Poole, England: Thiobarbituric acid (TBA) , 
sucrose, magnesium chloride, ethanol, ether, chloroform, 
trichloroacetic acid (TCA) , toluene, potassium chloride, sodium 
carbonate, cupric sulphate, acetic acid, potassium hydroxide, 
ammonium sulphate, perchloric acid, metaphosphoric acid, 
ethylenediaminetetra acetic acid disodium (EDTA-Na2), sodium 
chloride, sodium hydroxide, hydrochloric acid, disodium hydrogen 
orthophosphate, potassium dihydrogen orthophosphate, potassium 
tartrate, Folin & Ciocalteu's phenol reagent, tri-sodium citrate (Na3-
citrate), sodium dodecyl sulphate (SDS)' glycerol, 2-.13-
mercaptoethanol. 
Sigma Chemical Company Ltd: Bovine serum albumin, Trizma 
base (Tris) , glucose-6-phosphate, acetamide, glutathione (GSH), 
dimethyl sulphoxide (DMSO), imidazole, pyrazole, N-ethyl maleimide 
(NEM),iodoacetamide, dithiothreitol (DTI), ATP, 2'-deoxycytidine 5'-
monophosphate (dCMP), 5,5'-dithiobis (2-nitrobenzoic acid) (DTNB), 
phosphate-buffered saline (PBS), acrylamide, N,N'-methylene-bis 
acrylamide, N ,N ,N' ,N' -tetramethylethylene-diamine (Temed), 
Bromophenol blue, glycine, Brilliant Blue G-colloidal, MES (2-[N-
morpholino]ethanesulfonic acid), high molecular weight standard 
protein mixture, N-a-p-tosyl-I-Iysine chloromethyl ketone (TLCK), 
Trypsin inhibitor (type II-S : Soybean), DEAE-cellulose (fine mesh), 
Dowex 50W-(+H) (200-400 mesh), Sephadex-G25, CM-sephadex C-25 
(40-120 Jl). 
Phannacia: ATP-Agarose (AGATp1N Type 3). 
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Calbiochem: Flake polyethylene-glycol (Aquacide III). 
NEN Research Products: Proteosol. Econofluor. 
Packard, Canberra Company: Opti -fluor. 
Bethesda Research Laboratories, Inc: Ammonium persulphate. 
Boehringer Mannheim GmbH: NADP (sodium salt), glucose-6-
phosphate dehydrogenase. 
Amersham International PIc.: 14C-CCI4, (5-3H)cytidine 5'-
diphosphate, ammonium salt (3H-CDP) (18.4 ci/m mol). 
4-hydroxy-trans 2,3-nonenal (HNE) was kindly provided by 
Professor H. Esterbauer, Institute fur Biochemie, University of Graz, 
Austria. 
Male Wistar rats from Harlan Olac Ltd. were used in all 
experiments. The animals had access to food and water ab libitum. 
The animals for regenerating liver were housed for a minimum of 
three weeks under a strict lighting regimen of an inverse 12 hour 
light: 12 hour dark cycle with food only available for 8h in the dark 
period. All partial hepatectomy operations were performed under light 
anaesthesia by the procedure of Higgins and Anderson (1931) and 
always at 7:00 pm. In each case the left and right lobes, equivalent to 
approx. 2/3 of the original weight of the liver were removed. For each 
operation 4-10 rats (250-320g body weight) were used. When 
ribonucleotide reductase was to be prepared from the regenerating 
and sham livers the animals were sacrificed at 12 hourly intervals 
following the operation. In the sham group only the minor lobes were 
taken. 
Yoshida ascites hepatoma cells were maintained by 
transplantation every 5 days into the abdomen of male Wistar rats. 
Cells were passaged by removing 1 ml of ascitic fluid from the host rat 
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and injecting the cell suspension into the next carrier animal. The 
cells were harvested at the end of the passage period. The cell 
suspension was centrifuged at 800 x g for 5 min. and the supernatant 
was discarded. The cell pellet was washed 3 times with phosphate-
buffered saline (PBS). The viability of cells was always ~ 900/0. 
MOrris Hepatoma 5123tc solid tumours were obtained from S. M. 
Clutton, Department of Biochemistry, BruneI University. Tumours were 
transplanted in male Buffalo rats (bred in BruneI University) every 21 
days by injecting 0.5 g of minced tumour material into the thigh-
muscle of rats. 
Cultured Yoshida ascite hepatoma cells were obtained from 
Dr. Marie-Luce Carrie, Department of Biochemistry, BruneI University. 
Cells were cultured in MEM medium at 37°C. The culture medium was 
changed every 1-2 days. 
2.2 METHODS 
Preparation of micro somes from rat liver 
The rats used for making microsomes were males of the Wistar 
strain, 7 weeks-old and 200-220g body weight. Rats were starved 
overnight prior to the preparation of microsomes. Livers were removed 
immediately after the rats were killed by cervical dislocation, weighed 
and put into ice-cold 0.25M sucrose solution. After washing with 
0.25M sucrose. livers were minced using scissors and rinsed further 
with 0.25M sucrose to remove blood. The minced livers were 
homogenized in 0.25M sucrose (1 :4-5, w Iv) using a loose-fitting 
Potter-Elvehjem (glass-Teflon) homogeniser. The homogenate was 
centrifuged twice at 14.000 x g (MSE-18) for 10 min. The pellet was 
discarded and the supernatant was centrifuged at 165,000 x g (MSE-
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65) for 40 min. The pellet was rinsed with 0.1 M Tris/HCI (pH 7.4) 
and then gently homogenised in the same buffer by hand using a small 
glass homogeniser. The microsomal pellet was collected by 
centrifugation at 165,000 x g for 25 min. and stored at -70°C (Slater 
and Cheeseman, 1987). 
Lipid peroxidation initiated by CCl4 /NADPH in rat liver microsomes 
In this system the NADPH was generated using glucose-6-
phosphate, NADP+ and glucose-6-phosphate dehydrogenase, so the 
stock solution of lipid peroxidation incubation mixture contained 83.5 
mM KCI, 37 mM Tris/HCI (pH 7.4), 5.5 mM glucose-6- phosphate 
(sodium salt), 0.25 mM NADP+ (sodium salt), 106 mM acetamide and 
8 international units of glucose-6-phosphate dehydrogenase. The 
microsomal pellet was resuspended in ice-cold 0.15M KCI, so that 1 
ml of suspension contained microsomes equivalent to 19 wet weight of 
original liver. The standard 3 ml reaction mixture contained 2.2 ml 
stock solution, 0.3 ml microsomal suspension, 0.5 ml H20 or test drug 
solution under study and 10 ~l CCI4 . The reaction was started by 
adding the microsomal suspension with or without addition of 10 ~ of 
a CCl4 solution in dimethyl sulphoxide (CCI4 /DMSO, 1 :4, v Iv) to the 
tube fitted with a ground glass socket and stopper containing stock 
solution. The incubation was carried out in a water bath at the required 
temperature for 15 min. with gentle shaking and in the dark. (Slater 
and Sawyer, 1971 a; Slater and Cheeseman, 1987). 
To stop the reaction, 6 ml of 10% TCA was added to the medium 
at the end of incubation. After leaving on ice for 15 min. the mixture 
was centrifuged at 800 x g for 10 min. and 2 ml of supernatant was 
taken for assay of content of MDA 
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Malonaldehyde (MDA) estimation 
To estimate the MDA content, 2 ml of protein-free sample was 
mixed with 2 ml of 0.67% thiobarbituriC acid and heated at 100°C for 
10 min. The absorbance of the solution was read at 535 nm using a 
Beckman DU -62 spectrophotometer. The MDA content was calculated 
using the molar extinction coefficient of 1.49 x 105 M-1 cm -1 (Slater 
and Cheeseman, 1987). 
Extraction of PBN ICCI3· produced during lipid peroxidation induced by 
CCl4 in rat liver microsomes 
The standard reaction mixture in this experiment was essentially 
the same as that used for the general lipid peroxidation induced by 
CCl4 in rat liver microsomes except 0.5 ml 18 mM PBN was used 
instead of 0.5 ml H20. The fmal concentration of PBN was 3 mM. The 
reaction was started by the addition of the microsomal suspension with 
or without CCI4/DMSO and took place in the dark at certain 
temperatures between 20-40°C for 15 min. Ice-cold toluene (1 ml) was 
mixed well with the reaction mixture at the end of incubation. The 
upper phase of toluene containing PBN/CCI3 · was separated by 
centrifugation at 800 x g for 10 min. and immediately frozen in liqUid 
nitrogen for later analysis by ESR spectroscopy. 
Covalent binding of 14C-CC14 to rat liver microsomal protein 
The method was essentially the same as that used for the general 
CCl4-induced microsomal lipid peroxidation, but using 14C-Iabelled 
CCI4. The incubation was at certain temperatures for 15 min and kept 
in the dark. The reaction was terminated with 6 ml ice-cold 100/0 TCA. 
Two controls were required. One was for the non-specific covalent 
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binding in which microsomes were incubated with reaction stock 
solution without' the NADPH generating system and 14C-CCI4. The other 
was for CCl4 -stimulated lipid peroxidation in which liver microsomes 
were incubated in the presence of NADPH but in the absence of CCI4. 
After the reaction was terminated, the protein precipitate was 
collected by centrifugation at 800 x g for 10 min. The pellet was 
suspended in 5 ml of 50/0 TCA and the suspension was heated at 100°C 
in open tubes for about 10 min. and then centrifuged to remove 50/0 
TCA. The protein pellet was suspended in 7.5 ml of the mixture of 
ethanol/ ether / chloroform (2:2: 1, v /v Iv) and allowed to stand at room 
temperature for 45 min. with occasional mixing. The protein pellet 
was collected and washed with acetone and ether in the same way as it 
was washed with the ethanol/ether/chloroform mixture as described 
above. The remaining ether was removed by placing the tube in cold 
water and gradually warming the water until the ether was completely 
removed. The dried protein pellet was weighed and put into a mini-
scintillation vial. H20 (0.1 ml) and Protosol (0.5 ml) were added to 
the vial in order to disslove the protein. The mixture was kept at 37°C 
until the protein was fully dissolved. Econofluor scintillation liquid 4.5 
ml was used to check the radioactivity of the liver microsome protein 
on the liqUid SCintillation counter (Cheeseman, 1984). 
Determination of NADPH production 
NADPH was generated from the system of glucose-6-phosphate, 
NADP+ and glucose-6-phosphate dehydrogenase. NADPH production 
was checked by recording the changes of absorption at 340nm using a 
Cary 219 spectrophotometer. A standard incubation medium was 
prepared which contained 36 ml 0.15M KCI, 24 ml O.lM Tris/HCI (pH 
7.4). 102 mg glucose-6-phosphate, 3.6 ml H20 and 6~1 glucose-6-
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phosphate dehydrogenase (5 mg protein/ml, 0.26 units/ml). 3 ml of 
this stock solution were dispensed into control and test quartz 
cuvettes. The cuvettes were put in the spectrophotometer which was 
kept at the appropriate temperature as required in the experiments. 
Then the baseline was checked to be flat. Afterwards 0.2 ml of 
KCI:Tris/HCI (pH 7.4) mixture (0.15M:0.1 M = 3:2) and 0.2 ml of 3 
mg/ml (in KCl:Tris/HCI mixture) NADP+ were mixed in to the control 
and test cuvettes, respectively. The cuvettes were left in the chamber 
of the spectrophotometer for certain times as required in the 
experiments, then the spectrum from 450-300 nm was scanned at the 
conditions of range=2.0, scan rate=2.0 nm/sec., period=10 sec. and 
display=10. The absorption at 340nm was measured. 
Isolation of ribonucleotide reductase (RNR'ase): crude extract 
The medium for the isolation of RNR'ase contained 0.25M 
sucrose, 10 mM potassium chlOride, 5 mM magnesium chloride and 2 
mM dithiothreitol (DTT) (final concentrations) in 0.1 MTris/HCI (pH 
7.4). The ratio of tissue to medium was 1:4-5 (w/v) when the enzyme 
was prepared from livers or solid tumours. If the enzyme was isolated 
from Yoshida cells, the medium volume was the same as the volume of 
the pelleted cells after centrifugation at 800 x g for 5 min. The 
materials (livers, tumours, cells) were homogenized in the medium 
using a loose-fitting Potter-Elvehjem (glass-Teflon) homogeniser and 
the slurry was centrifuged at 100,000 x g (MSE-65) for 1h. The 
preCipitate was discarded and the clear supernatant was kept as the 
crude enzyme extract. All procedures were carried out below 4°C 
(Youdale and MacManus, 1979). This crude enzyme extract, about 20 
mg protein/ml, was usually used for the further partial purification, but 
if the material was too small, for example cultured Yoshida cells, the 
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crude extract was used directly for determination of the 
ribonucleotide reductase activity. 
Partial purification of ribonucleotide reductase 
A. Precipitation with ammonium sulphate: 
Solid ammonium sulphate (0.25 g/ml, corresponding to 45% 
saturation) was slowly added to crude extract under stirring at O°C. 
After 30 min. of additional stirring at 4°C, the suspension was 
centrifuged at 100,000 x g for 20 min. The pellet was dissolved in a 
small volume (usually 100/0 of original volume of crude extract) of O.IM 
Tris/HCI (pH 7.4) containing 2 mM DTI and 5 mM MgCl2 (Youdale 
and MacManus, 1979, Engstrom et aL, 1979). The protein solution was 
desalted by either passing through a Sephadex G-25 column (sample 
to column 1: 15, v/v) equilibrated with the same buffer or dialysing 
overnight against the same buffer with two buffer changes. The 
dialysate was centrifuged at 800 x g for 10 min. to remove remaining 
preCipitate. The resulting protein solution was used for routine 
determination of the enzyme activity and the effect of inhibitor on the 
activity. 
B. Chromatography on DEAE-cellulose: 
If the enzyme preparation was used for further purification, the 
protein preCipitate resulting from 45% saturation of ammonium 
sulphate was dissolved in a small volume (100/0 of original crude 
extract) of 20 mM Tris/HCI (pH7.4) containing 2 roM DTI and 5 roM 
MgCl2 and dialysed overnight against the same buffer with two buffer 
changes. Usually 10 ml of dialysate (from 20 g of liver of 7-10 rats aged 
three weeks) was adsorbed to a DEAE-cellulose column 
(2 x 22 cm) eqUilibrated with 10 mM potassium phosphate buffer 
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(pH 7.0) (Engstrom et al., 1979) The protein was eluted in a stepwise 
manner with 
(1) 10 mM potassium phosphate buffer (pH 7.0), 
(2) the same buffer containing 0.08 M KCl, 
(3) the same buffer containing 0.16 M KCI 
(4) the same buffer containing 0.25 M KCI 
at a rate of 1 ml/min until the optical density at 280 nm of the eluate 
was less than 0.100 (Mattaliano et al., 1981). The fractions of eluate 
containing protein were pooled according to the value of optical 
density at 280nm. Proteins were concentrated by adding ammonium 
sulphate to 800/0 saturation (0.56 g/ ml). The protein precipitate was 
collected by centrifugation and dissolved in O.IM Tris/HCl (pH 7.4) 
containing 2 mM DIT and 5 mM MgCl2. The salt in the protein 
solution was removed by using a Sephadex-G25 column. The protein 
content in this enzyme preparation was about 10 mg/ml. 
C. Chromatography on ATP-Agarose column 
The enzyme preparation after DEAE-cellulose chromatography 
was further purified by using an ATP-agarose column as described by 
Spector and Averett (1983). The protein solution (about 105ml, 12.5 
mg prot/ml) was applied to a 1x12.5 cm ATP-agarose column 
equilibrated with O.IM Tris/HCI (pH 7.4) containing 2 mM DIT and 5 
mM MgCI2. The column was then washed with the same buffer and the 
effluent was collected. This protein solution is referred as the ATP-
Agarose enzyme preparation. After the absorbance at 280nm of the 
eluate from the column was less than 0.100, the washing buffer was 
changed to the buffer containing 0.5M KCl. Then the column was 
washed with the buffer containing 2 mM ATP and this protein solution 
was also collected. 
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D. Chromatography on CM-Sephadex 
The enzyme preparation after DEAE-cellulose chromatography 
(about 2.4 ml of 15.8 mg prot/ml protein solution) was diluted 1: 1 with 
H20 and the pH was reduced to 5.2 with acetic acid. The resulting 
preCipitate was pelleted by centrifugation at 10,000 x g and the 
supernatant (5 ml) was added to CM-Sephadex (6 ml) which was 
equilibrated with a solution of 20 mM MES-HCI (pH 6.0) containing 2 
mM DIT and 5 mM MgCI2. The gel was removed and washed by the 
same buffer till the protein free. The protein solution was collected 
(CM-Sephadex fraction 1). Then the gel was further washed with the 
buffer containing 1M NaCl. The resulting solution from the wash with 
the buffer plus 1M NaCI was dialysed against two changes of 200 ml of 
water containing protease inhibitor (TLCK, 60 mg/L; soybean trypsin 
inhibitor, 30 mg/L) and mercaptoethanol (0.1 ml/L) for 15h (CM-
Sephadex fraction 2). After drying with flake polyethylene glycol, 
proteins of both CM-Sephadex fractions were resolved in 0.1 M 
Tris/HCI containing 2 mM DIT and 5 mM MgCl2 (Youdale et al., 1982). 
The whole scheme of purification of RNR'ase from rat liver is 
shown in Fig. 2.1. 
Assay of CDP reductase activity 
The CDP reductase activity was assayed with the method of 
Elford (1974), measuring the reduction of 3H-CDP. The standard 
incubation solution contained 5 JlCi 3H-CDP (specific activity 18.4 
Ci/mmol, final concentration in the incubation solution 0.787 JlM), 
3.3 mM ATP, 1.4 mM MgCI2, 10 mM DIT, 20 mM Tris/HCI (pH 7.4) 
and enzyme protein 0.5-1 mg in a total volume of 0.345 ml. Incubation 
was at 30°C for 1h. The reaction was stopped by the addition of 1 mlof 
l.25 M perchloric acid and 2.5 Jlmol of cold (unlabelled) carrier dCMP. 
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Rat liver 
isolation medium 
Crude enzyme extract 
ammonium sulphate (45% saturation) 
Ammonium sulphate fraction 
chromatography on DEAE-cellulose 
DEAE-cellulose fraction 
ATP-agarose 
ATP-agarose fraction 
chrcmatography on 
CM-Sephadex 
CM -Sephadex fraction 1 and 2 
Fig. 2.1 Scheme of purification of ribonucleotide reductase 
from rat liver 
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The mixture was left on ice for 10 min and denatured protein was 
removed by centrifugation. The nucleotide in the deproteinised 
supernatant was converted to the monophosphate by 20 min. 
incubation in a boiling water bath. Then the solution was neutralised 
with 4N KOH and stood on ice for 2-12 hours. Mter removal of 
preCipitated potaSSium perchlorate. the solution was transferred to 
13.5 x 0.5 cm column of Dowex 50W-(H+) (200-400 mesh) resin and 
eluted with 0.2N acetic acid. All CMP was removed in the first 40 ml of 
eluant and the dCMP was collected in the next 16-20 ml. The 
radioactivity of the eluent which contained dCMP was read on a liquid 
SCintillation analyser (Tri-carb 2000CA. United Technologies Packard) 
using aqueous Opti-fluor SCintillation liquid. All the radioactivity 
determinations were corrected for a small amount of radioactivity that 
was present with a control containing no enzyme. One unit of activity of 
enzyme was defined as that amount of enzyme that catalyses the 
conversion of 1000 DPM (about 0.024 p moles) of CDP to dCDP in 1 h 
at 30°C (Richard et al .. 1961; Steeper and Steuart. 1970; Elford. 
1974). 
Effect of compounds on CDP reductase activity 
Unless otherwise stated. the compounds were incubated with 
the enzyme under the standard reaction conditions. Then the activity 
of the enzyme was determined as normal. 
Regeneration of DEAE-cellulose 
DEAE-cellulose was first soaked in water (for new cellulose) or in 
O.5N NaOH-0.5N NaCl (for used cellulose) for about 12 hours. Mter 
drying by using a Buchner funnel fitted with two filter papers, the 
cellulose cake was treated as follows: 
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(1) Resuspending in IN NaOH for 3 hours with 
occasionally mixing, 
(2) washing with water, 
(3) resuspending in 0.5N HCI for 1 hour, 
(4) washing with wa ter, 
(5) resuspending in IN NaOH again for 2 hours, 
(6) washing with water. 
The pH of the suspension should be 7.0 when washing with water. The 
pH was checked using pH test paper (pH 1-14 and pH 6-8) 
(Himmelhoch, 1971). 
Regeneration of Sephadex-G25 
Sephadex-G25 was used to remove excess HNE in the HNE-
enzyme mixture and ammonium sulphate salt when the enzyme was 
partially purified. Mter HNE or ammonium sulphate had passed though 
the column, 3 volumes of water was passed down the column. The gel 
was poured out and washed with water several times. If the gel was not 
white and translucent, it was soaked overnight in 0.5N NaOH-0.5N 
NaCI, then washed with water. 
Regeneration of Dowex 50W -(H+l: 
New or used resin was washed 3 times with 2N NaOH, followed 
by water, then 3 times with 2N HCI (the last time for 12 hours), fmally 
with water. Each time when washing with water the pH of the resin 
suspension should be pH 7.0. 
SDS gel electrophoresis 
Casting separating gel: 
7.50/0 acrylamide, 0.10/0 SDS, 0.375M Tris/HCI pH 8.8 separating 
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gel was made by combining the reagents as following: 10 ml 300/0 
acrylamide/bis (29.20/0 acrylamide and 0.8% N,N - methylene-bis-
acrylamide), 10 ml 1.5M Tris/HCI (pH 8.8), 0.4 ml 100,.1> sodium 
dodecyl sulphate (SDS), 2.0 ml 1.5%) ammonium persulphate and 17.6 
ml H20. After degassing the mixture under vacuum for 5 min., 20 ~ of 
Temed was added and immediately poured into a glass plate sandwich 
(16 x 20 cm) to a depth of 13-14 cm. The polymerization mixture was 
overlayed with about 2 ml of H20. This mixture was allowed to 
polymerize for 1 hour at room temperature, then the water and the 
unpolymerized gel mixture were removed from the gel surface. 
Casting stacking gel: 
4.0% acrylamide, 0.1% SDS, 0.125M Tris/HCI pH 6.8 stacking 
gel was prepared as follows: 1.3 ml 300/0 acrylamide/bis, 2.5 ml 0.5M 
Tris/HCl (pH 6.8), 0.1 ml 10% SDS, 0.5 ml 1.5 OA> ammonium 
persulphate, 5.65 ml H20 were mixed. The mixture was degassed 
under vacuum for 5 min and 7.5 Jll Temed was added. The resulting 
mixture was immediately added to the glass sandwich to a depth of 2.5 
cm. A comb was carefully inserted into the mixture. The gel was 
allowed to polymerize for 45 min. at room temperature. The 
ammonium persulphate solution for the two gels was freshly prepared 
(O'Farrell, 1975, Hames and Rickwood, 1990). 
Preparation of the sample: 
Protein samples were diluted to 2.5 mg protein/ml with sample 
buffer which contained 4.0 ml H20, 1.0 ml 0.5M Tris/HCl (pH 6.8), 0.8 
ml glycerol, 1.6 ml 100/0 SDS, 0.4 ml 2-J3-mercaptoethanol and 0.2 ml 
0.050/0 Bromophenol blue (sodium salt) in a total volume of 8.0 ml. 
Diluted protein solutions were heated at 95°C for 4 min (O'Farrell, 
1975, Hames and Richwood, 1990). 
After washing the wells of the stacking gel with water, 20 ~ or 
96 
10 ~l of samples and 10 ~ of standard protein mixture were loaded 
onto the gel. Electrophoresis was carried out at 60 V for stacking gel 
and 100 V for separating gel in the running buffer of 4.5g Tris. 21.6g 
glyCine and 1.5g SDS in 1.5 L H20, cooling with running tap water 
(20°C). The time of running in stacking and separating gel were about 
1.5h and 12h respectively. When the samples had migrated to a level of 
1.5 cm above the bottom of the separating gel, the electrophoresis was 
stopped. The gel was carefully taken off the glass and put into fIxing 
solution (70/0 acetic acid in 40% methanol v Iv). After 1 hour of fixing, 
the gel was transferred to the staining solution and remained in 
staining solution for 2 hours. The staining solution was prepared from a 
mixture of 200 ml Brilliant Blue G-colloidal and 800 ml deionized H20. 
Afterwards 120 ml of this mixture was mixed with 30 ml methanol. 
The stained gel was destained by washing with 100/0 acetic acid in 25% 
methanol for 60 sec and 25% methanol for up 24 hours with several 
changes of 250/0 methanol (O'Farrell, 1975. Hames and Rickwood, 
1990). 
Determination of protein content 
Protein content of microsome suspension and enzyme 
preparation was determined by the method of Lowry (1951) using 
bovine serum albumin as a standard. 
Determination of cell viability 
Yoshida hepatoma cells' viability was assessed by using Trypan 
Blue. 4 volumes of diluted cell suspension was mixed with 1 volume of 
0.040/0 Trypan blue. The numbers of viable and non viable cells were 
counted using a microscope and haemocytometer. 
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Viability = 
No. oj viable cells 
-----------------x 100% 
No. oj viable cells + No. oj non viable cells 
Detennination of the content of acid soluble thiol 
The content of acid soluble thiol groups in enzyme preparation, 
liver homogenate and DIT solution was determined by the method of 
Beutler et al (1963). Precipitation solution which was 1.69g glacial m-
phosphoric acid, 0.2g EDTA-Na2 and 30g NaCI in 100 ml H20 (1 mIl 
was added to a mixture of 0.2 ml enzyme preparation (about 1.7 mg 
protein) and 0.2 ml H20 or drug solution. The resulting mixture was 
left on ice for 5 min. Following centrifugation at 800 x g for 10 min, 1 
ml supernatant was mixed with 4.0 ml 0.3 M Na2HP04 (pH 9.0) and 
0.5 ml DTNB-reagent (0.040/0 5,5'-dithiobis-(2-nitrobenzoic acid) and 
1 % Na3-citrate). The absorption at 412nm of the mixture was read 
within 5 min on the Beckman spectrophotometer. The concentration 
of SH (mM) was calculated by comparing to a standard curve produced 
using GSH as standard. DIT (1 ml) solution was directly mixed with 
4.0 ml 0.3M Na2 HP04 and 0.5 ml DTNB-reagent. The absorption at 
412nm was read within 5 min. 
Determination of the content of protein thiol 
Liver homogenate or enzyme preparation 0.2 ml was mixed with 
2.0 ml TCAjEDTA solution (1 vol. of 5 mM EDTA plus 1 vol. of 50/0 
TCA). The mixture was allowed stand on ice for 10 min follOwing 
centrifugation at 800 x g for 10 min. The supernatant was discarded 
and the protein pellet was washed with TCAjEDTA solution again as 
above. Afterwards the protein pellet was resuspended in 5 ml or 
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Tris/EDTA/SDS (0.1 M, pH 7.4/5 mM/ 0.50/0). The suspension (l mI) 
was mixed with 2 mI Tris/EDTA (0.2 M, pH 8.6/2 mM) and 0.03 mI 
DTNB (10 mM in ethanol) and left at room temperature in the dark 
for 15 min. Then the absorption at 412nm and 550nm was readed on a 
Beckman spectrophotometer. The concentration of thiol was calculated 
from the difference of absorption at 412nm and 550nm by comparing 
to a standard curve produced using GSH. 
Preparation of aqueous 4-hydroxy trans 2,3-nonenal(HNEl 
50 ~l of HNE/CH2CI2 solution (about 8-10 mg HNE/ml) was 
taken and the CH2Cl2 was almost completely evaporated at room 
temperature under N2 . 1 ml H20 was added and shaken for 1 to 2 min. 
Traces of CH2Cl2 were removed under vacuum and afterwards the 
solution was filtered through folded filter paper. The concentration of 
this solution was checked by the absorption at 223nm using a Beckman 
DU -62 spectrophotometer. The concentration of this aqueous HNE 
solution was approximately 3.1 mM and stable for one week if kept at 
4°C. 
Removal of excess HNE from RNR'ase preparation 
In some experiments HNE and the RNR'ase preparation were 
pre-incubated together. In order to remove HNE the mixture of 
enzyme and HNE was put down a Sephadex G-25 (21 x 1 cm) and the 
protein eluted with 0.1 M Tris/HCI (pH 7.4) containing 2 mM DTI at 
4°C. Fractions were collected and the fraction containing the protein 
was used for the reductase assays. 
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3. RESULTS 
3.1 CARBON TETRACHLORIDE ACTIVATION IN RAT LIVER 
MICROSOMES 
3. 1. 1 Effect of temperature on the activation of CCl4 by rat liver 
microsomes 
The effect of temperature on the activation of CCl4 in 
microsomes from normal rat liver was studied. Spin trapping of CCI3 ' 
and ESR spectrometry. covalent binding of CCl4 to protein and MDA 
formation were used as indices of CCl4 metabolism. 
3. 1. 1. 1 Production of CCI3 ' 
The free radical CCI3 ' can be spin-trapped with phenyl-t-
butylnitrone (PBN) to form PBN-CCI3 ' adduct which is a relatively 
stable free radical detectable by ESR (Albano. et. al. 1982). The ESR 
spectrum obtained from incubating liver microsomes with CCl4 and 
PBN in a standard lipid peroxidation reaction mixture (see "Methods") 
at 37°C is shown in Fig.3.1.1a. The spectrum showed a triplet of 
doublets with g value of 2.006. The effect produced by omitting CCl4 is 
shown in Fig. 3.1.1 b. The intensity of signals without CCl4 was much 
lower than that with CCI4 . These signals may come from the 
background free radicals. It is possible to quantitate production of CCI3 ' 
by measuring the intensity of the signal due to the PBN-CCI3 ' adduct. 
Fig. 3.1.2 demonstrates the effect of temperature on the formation of 
PBN-CC13 ' adduct in liver microsomes. The results of the formation of 
the PBN adduct produced during the incubation of liver microsomes 
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A 
g = 2.006 
10 G 
--""-------------
B 
Fig. 3.1.1. ESR spectra of PBN-CC13 · adduct in rat liver microsomes 
This represents a scaled down version of the ESR spectrum of PBN-
CC13" adduct. Rat liver micro somes were incubated with or without CC14 
at 37°C for 15 min in the presence of PBN. Spectrometer setting: 
Temperature=213K, Microwave power =10dB (20.5 mW), Modulation 
amplitude=2 Gauss, Mod. frequency = 1 00 kHz, Microwave 
frequency=9.51 GHZ. gain=1.25 x 106. A) with CC14 ' B) without CC14 . 
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Fig. 3.1.2. Temperature effect on the activation of CC14 in 
rat liver microsomes determined as PBN-CC13· 
adduct formation 
Lipid peroxidation was carried out for 15 min. in the dark. 
Mean values are given + S.E.M. for four separate 
experiments. ( 0 ) without CCI4 ; ( A ) with CCI4. * P< 
0.05; ** P< 0.01; *** P < 0.001 (Student's t-test) for 
differences between samples with and without CCI4 . 
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with or without CC14 in the presence of 3 mM PBN were expressed in 
arbitrary units as the height of the middle peak of the PEN adduct ESR 
triplet signals. It can be seen that the formation of PBN adducts 
increases as the temperature of incubation was increased up to 37°C. It 
was shown that only when the temperature was ~ 30°C. could a 
significant difference of PEN adduct formation above control levels be 
stimulated by CCl4 addition. However at 40°C. the formation of PEN 
adduct was less than that at 35°C and 37°C (Fig. 3.1.2). This 
phenomenon was apparent both with and without CCI4. Although PEN 
adduct signals were observed in the absence of CCI4• there was no 
significant difference in the intensity of signals at different 
temperatures except at 40°C. Fig. 3.1.3 shows an Arrhenius plot of 
PBN-CCI3 ' adduct formation. It exhibited a discontinuity at 27.5°C. The 
energies of activation were calculated by linear regression analysis of 
the slopes of the Arrhenius plots and found to be 6.80 and 1.66 
kcal/mol below and above the temperature break. respectively. 
3.1.1.2 Covalent binding of CCl4 to hepatic microsomal protein 
Using 14CCl4 the amount of covalent binding of 14C-CC14 to 
hepatic microsomal protein can be estimated by measuring the 
protein-bound radioactivity. Fig. 3.1.4 shows the effect of temperature 
on covalent binding of CCl4 to microsomal protein. Throughout the 
range of temperature used (20°C-40°C). the binding of 14C-CC14 to the 
protein increased gradually in a temperature-dependent fashion. At 
lower temperatures (20°C and 25°C), the binding of CCI3 ' derived from 
CCl4 activation was not significantly elevated above non-specific 
(NADPH-independent) 14C-CC14 covalent binding. The Arrhenius plot 
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Fig. 3.1.3. Arrhenius plot ofPBN-CCls · adduct fonnation 
The data were from Fig. 3.1.2. fl signal height = signal height 
of samples with CC14 - signal height of samples without CC14 . 
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Fig. 3.1.4. Temperature effect on the activation of CC14 in 
rat liver micro somes measured as covalent 
binding to protein 
Lipid peroxidation was carried out for 15 min in the dark. 
Mean values are given + S.E.M. for three experiments. 
( 0 ) non-specific binding( no NADPH in the incubation 
mixture); ( • ) specific binding. * P < 0.05 (Student's t-
test) for differences between specific and non-specific 
binding. 
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for 14CCl4 covalent binding to microsomal protein was shown in Fig. 
3.1.5. It broke at 26.7°C. The activation energies for 14CCl4 binding 
were 11.83 kcal/mol and 3.36 kcal/mol at temperatures below and 
above 26.7°C. 
3. 1. 1. 3 Malondialdehyde production 
In microsomal systems, the measurement of MDA by the 
thiobarbituric acid reaction has been widely used as an index of CCI4-
induced lipid peroxidation and, by implication, of the activation of CCI4. 
The production of MDA at different temperatures from 15°C to 40°C in 
the presence or absence of CCl4 is illustrated in Fig. 3.1.6. It was 
demonstrated that when the temperature was higher than 25°C, MDA 
was produced even without CCI4, but only when the temperature was 
higher than 25°C, did CCl4 show a significant stimulatory effect on 
MDA production. The degrees of stimulation as compared to the 
control (without CCI.J were 17.5%), 56.50/0, 123.50/0 and 145.50/0 at 
25°C, 30°C, 35°C, and 40°C respectively. Fig. 3.1.7 showed Arrhenius 
plot for CCl4 -stimulated MDA fonnation. The break in the Arrhenius 
plot occurred at 34.3°C. The activation energies of CCl4-stimulated 
MDA fromation was 2.83 kcal/mol at the temperature higher than 
34.3°C, and 9.8 kcal/mol at the temperature lower than 34.3°C. 
3. 1. 1. 4 Temperature effect on NADPH generation 
NADPH is required for the activation of CCI4. In the model used 
here, NADPH was generated from a glucose-6-phosphate 
dehydrogenase dependent system: 
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Fig. 3.1.5. Arrhenius plot of the amount of 14CCl4 covalent 
binding to microsomal protein 
The data were from Fig. 3.1.4. II 14CC14 binding = specific 
binding - nonspecific binding. 
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Fig. 3.1.6. Temperature effect on activation of CC14 in rat 
liver microsomes determined as stimulation 
of MDA production 
Lipid peroxidation was carried out for 15 min. in the dark. 
Mean values are given + S.D. for two experiments with total 
4 replicates. ( 0 ) without CCI4 ; (.) with CCI4 . • P< 0.05; 
•• P<O.Ol; ••• P< 0.001 (Student's t-test) for differences 
between samples with and without CC14. 
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Fig. 3.1.7. Arrhenius plot of CCl4-stimulated MDA production 
The data were from Fig. 3.1.6. fl MDA = MDA of samples 
with CCl4 - MDA of samples without CCI4. 
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gZucose-6-phosphate glucose-6-phosphate 6-phospho gZuconate 
+ 
NADP+ dehydrogenase 
+ 
NADPH 
It is important therefore to check the effect of temperature on 
NADPH generation. The results are shown in Fig. 3. LB. The higher the 
temperature, the faster the generation of NADPH, as expressed by 
absorbance at 340nm. 
3. 1. 2 Effect of selected agents on the activation of CCl4 by rat 
liver microsomes 
The effect of two inhibitors of the cytochrome P 450 system, 
(pyrazole and imidazole), two sulphydryl reagents, (iodoacetamide and 
N-ethyl maleimide, NEM) and glutathione (GSH) on the activation of 
CCl4 in rat liver microsomes was investigated. The activation of CCl4 
was measured by lipid peroxidation as determined by the production 
of MDA. The degree of inhibition of MDA production by each 
compound was compared to the control samples. The indicated 
concentrations of the compounds are the final concentrations used in 
the incubation mixture. 
The data in Fig. 3.1.9-12 and Table 3.1.1 illustrate the effect of 
these selected agents on the formation of MDA. Pyrazole, 
iodoacetamide and imidazole are weak inhibitors. Even at the highest 
concentrations used, 10 mM or 20 mM, they failed to produce 500/0 of 
inhibition (Fig. 3.1.9, 3.1.10 and Table 3.1.1). Pyrazole inhibited lipid 
peroxidation by 300/0 at 10 mM and iodoacetamide only inhibited lipid 
peroxidation by 15% at 10 or 20 mM. No increase in inhibition 
occurred when the concentration of iodoacetamide was increased to 
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Fig. 3.1.8 NADPH production rate in NADPH generaing 
system at different temperature 
16 
NADPH content, as expressed in absorbance at 340nm, 
was checked in the NADPH generating system of glucose-
6-phosphate, NADPH+ and glucose-6-phosphate 
dehydrogenase at the indicated time at different 
temperatures as described in "Materials and Methods." 
Mean values are given + S.D. with duplicate. (0) 15°C; ( b.) 
20°C; ( • ) 25°C; ( 0 ) 30°C; ( • ) 35°C; ( • ) 40°C. 
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Fig. 3.1.9. Effect of pyrazole on lipid peroxidation 
stimulated by CC14 in rat liver micro somes 
Lipid peroxidation was carried out at 37°C for 15 min. in 
the dark and estimated by measuring MDA production. 
MDA content in control (without pyrazole) was 257.9 
pmol/mg prot./min. Each concentration point represents 
the mean of 4 determinations. 
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Fig. 3.1.10. Effect of iodoacetamide on lipid peroxidation 
stimulated by CC14 in rat liver microsomes. 
Lipid peroxidation was carried out at 37°C for 15 min in 
the dark and estimated by measuring MDA production. 
MDA content in control (without iodoacetamide) was 171.6 
pmol/mg prot./min. Each concentration point represents 
the mean of 2 determinations. 
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Table. 3. 1. 1 Effect of imidazole on lipid peroxidation 
stimulated by CCI+ in rat liver microsomes 
Concentration 
of imidazole 
(mM) 
o 
1 
5 
10 
20 
Malonaldehyde 
( pmollmg prot./min. ) 
267.8 + 28.2 
259.7 + 36.0 
290.4 + 25.5 
273.7 + 34.6 
188.0 + 91.6 
Inhibition 
( % ) 
2.9 
- 8.6 
- 2.7 
29 
Lipid peroxidation was carried out at 37° C for 15 min. as 
described in "Materials and Methods ". Mean values are 
given + S.D. for two separate experiments with a total of 4 
replicates. 
114 
-~ 0 
---
0 
0 
• .-4 
.+oJ 
'.-4 
.c 
'.-4 
.d 
0 
-
100 
90 
80 
70 
60 
50 
40 
30 
20 
10 
0 
-10 
0.0 0.5 1.0 1.5 2.0 2.5 3.0 3.5 4.0 4.5 5.0 
Concentration of NEM ( mM ) 
Fig. 3.1.11. Effect of N-ethyl maleimide (NEM) on lipid 
peroxidation stimulated by CC14 in rat liver 
microsomes 
Lipid peroxidation was caried out at 37°C for 15 min. and 
estimated by measuring MDA production. MDA content in 
control (without NEM) was 306 pmol/mg prot./min. Each 
concentration point represents 4 replicates. 
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Fig.3.1.12. Effect of reduced glutathione on lipid peroxida-
tion stimulated by CCl4 in rat liver microsomes 
Lipid peroxidation was carried out at 37°C for 15 min and 
estimated by measuring MDA production. MDA content in 
the control (without GSH) was 187.7 pmol/mg prot/min. 
Each concentration point represents the mean of 4 
detenninations. 
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more than 10 mM. Low concentrations of imidazole had no inhibitory 
effect on lipid peroxidation, but increasing the concentration 
eventually produced 29%) inhibition at 20 mM (Table 3.1.1). For NEM, 
the effect on lipid peroxidation was different. As shown in Fig. 3.1.11, 
low concentrations of NEM had a slight inhibitory effect on MDA 
production. The highest inhibition extent was about 200/0 at 0.5-1.0 
mM of NEM. However, when the concentration of NEM was higher 
than 1.0 mM, the inhibition decreased and at 5 mM NEM had a slight 
stimulatory effect on MDA production. Fig. 3.1.9 represents the results 
obtained for the inhibitory effect of GSH on lipid peroxidation. It can 
be seen that GSH strongly inhibits lipid peroxidation in a 
concentration-dependent fashion. MDA production was inhibited 500/0 
by a concentration of less than 0.2 mM. 
Using GSH as the inhibitor, the time course of the inhibitor 
effect on lipid peroxidation was studied. An illustration of the effects of 
different concentrations of GSH on CC14 -stimulated lipid peroxidation 
in liver microsomes at different incubation times is given in Fig. 3.1.13. 
It can be seen that throughout the incubation time employed, 3 min. 
to 30 min., MDA production was inhibited by 0.08 mM, 0.2 mM, and 
0.5 mM GSH. Although CC14-dependent lipid peroxidation increased 
with the incubation time under both conditions of with and without 
GSH, the extent and rate of increase above control levels was much 
lower when GSH was present, especially at higher concentrations. For 
example at 0.5 mM GSH, MDA production no longer increased after 10 
min. incubation whilst in the absence of GSH lipid peroxidation 
continued to increase for at least another 5 min. GSH prolonged the 
initiation period of lipid peroxidation and this effect was 
concentration-dependent. In the absence of GSH, a 3 min lag was seen 
before MDA production increased at a higher rate. The presence of 
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Fig. 3.1.13. Effect of reduced glutathione on the production 
of malondialdehyde in rat liver microsomes 
stimulated by CCl4 at different incubation times 
The temperature of lipid peroxidation incubation was 
37°C. GSH concentrations represent final concentrations 
in the incubation mixture. Mean values are given ± S.D. 
( 0 ) without GSH; ( !J. ) 0.08 mM GSH; (A ) 0.2 mM GSH; 
( • ) 0.5 mM GSH. 
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0.08 mM and 0.2 mM GSH increased the lag phase to 5 and 7 min 
respectively. No further delay of onset of lipid peroxidation was found 
when the highest concentration of GSH (0.5 mM) was present, but the 
rate of lipid peroxidation was strongly decreased. 
3. 2 RIBONUCLEOTIDE REDUCTASE 
3. 2. 1 Purification of ribonucleotide reductase 
The purpose of this aspect of the investigation was 
(i) to prepare a partially purified enzyme for determination of 
RNR'ase in a variety of tissues and under a variety of conditions, and 
(ii) to develop a method of purification for obtaining a pure 
preparation of the enzyme with the intention of raising an antibody to 
it. 
The rats used for the preparation of ribonucleotide reductase 
were 3-4 weeks old. The body weight of these rats was generally about 
6Sg although values as low as SOg or as high as 92g were observed. The 
liver weights were in the range of 2.2-3.Sg. One gram of liver usually 
yielded 41 mg of crude extract protein, 11 mg of 4S% ammonium 
sulphate fractionation protein and 0.76 mg protein of enzyme 
preparation after chromatography on DEAE-cellulose (Table 3.2.1). A 
typical purification of the rat liver up to and including chromatography 
on DEAE-cellulose column is summarized in Table 3.2.2. The apparent 
recovery of total enzyme activity after ammonium sulphate 
precipitation step was about 2200/0. This was an inaccurate estimation 
probably due to the underestimation of the ribonucleotide reductase 
activity in the sample of crude extract, because of RNA and nucleoside 
kinase (NDP kinase) activity (Cory, 1973; Spector and Averett, 1983). 
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Table 3.2.1 Ribonucleotide reductase yield and activity of different preparations from 3-4 weeks old rat liver 
Body Wt. Liver Wt. Crude extract 
---_._---
__ Ammonium sulphate fraction D EAE-cellulose 
( g) ( g) mg prot./ml units/mg prot. mg prot./g liver mg prot./ml units/mg prot. mg prot./g liver mg prot./ml units/mg prot. mg prot./g liver 
65±6 3.l±O.3 20.8±O.7 25.5±2.7 41.3±lO.5 40.6±2.8 185.3±26.5 11.5±3.2 12.5±2.8 940±114.2 0.76±O.3 
( 7) ( 7 ) ( 7 ) ( 7) ( 7) ( 6 ) ( 6 ) ( 6 ) (4 ) ( 4 ) ( 4 ) 
Mean values are given ± S.E.M. with the number of animal groups and enzyme preparations shown in parentheses. Each animal group contained 5-10 rats, and 
each enzyme preparation was obtained from 5-10 livers. The value of inhibition extent of crude extract by 4 mM HU was from two separate experiments. The 
determination of enzyme activity was performed under standard reaction conditions as described in "Material and Methods". Each assay was carried out in 
duplicate. 
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Table. 3. 2. 2 Purification of rat liver ribonucleotide reductase from 36 g of juvenile normal rat liver. 
Volume Total protein Total activity Specific activity Recovery Purification 
(ml) (mg) (units) (units/mg prot.) (0A» (fold) 
Crude extract 38 908.2 29788.4 32.8 + 0.9 100 
450/0 ammonium 
sulphate precipitate 6.0 260.7 66081.4 253.4 + 5.6 221.7 7.7 
DEAE-cellulose 1.5 22.5 23935.5 1063.8 + 96.1 80.3 32.4 
The enzyme activity was detennined under standard reaction conditions as described in "Methods". 
The mean values of specific activity of enzyme are given + S. D. with each assay was carried out in 
triplicate. 
This will be discussed later. This is also the reason that the recovery 
after chromatography on DEAE-cellulose was so high, about 800/0; 
sometimes 100% was observed. However when compared with the 
preparation of ammonium sulphate fractionate extract, the recovery of 
the enzyme protein after DEAE-cellulose chromatography was 
reasonable. This was about 36%. 
After precipitation with ammonium sulphate, the resulting 
enzyme preparation was chromatographed using a DEAE-cellulose 
column. Usually 260 mg protein (6-9 mll in 20 mM Tris-HCI 
containing 2 mM DTT and 5 mM MgCl2 was applied to a 2 x 22 cm 
DEAE-cellulose column equilibrated with 10 mM potassium phosphate 
buffer (pH 7.0). The protein was eluted from the column in a stepwise 
manner with 10 mM potassium phosphate containing different 
concentrations of KCl. Ribonucleotide reductase activity was eluted 
with 10 mM potassium phosphate buffer containing 0.16 M KCI (Fig. 
3.2.1). There was a little activity in the fractions of eluate of the buffer 
containing 0.25 M KCl. The elution pattern was very reproducible. 
The whole procedure, from the homogenising of the liver to a 
purified enzyme preparation after chromatography on DEAE-cellulose, 
required two and a half days. The activity of three different 
preparations of the enzyme were stable for at least one month at 
-70°C when stored in O.IM Tris/HCI (pH 7.4) containing 2mM DTT 
and 5 mM MgCI2 . 
In Fig. 3.2.2 the results of analysis of the enzyme by sodium 
dodecyl sulphate-polyacrylamide gel electrophoresis (SDS-page) is 
shown. The rat liver enzyme preparation after chromatography on 
DEAE-cellulose yielded several major bands on SDS-page and, in 
addition, some minor components. The results indicate that this kind 
of enzyme preparation was far from homogeneous. 
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Fig. 3.2.1. DEAE-cellulose chromatography of rat liver 
ribonucleotide reductase 
This represents a standard DEAE-chromatography profile 
as described in the text. The eluate buffer was 10 mM 
potassium phosphate. The volume of the eluate of each 
fraction was 6.0 ml. Fractions containing protein( indicated 
by the absorption at 280nm) were collected and the CDP 
reductase activity was determined under standard reaction 
condition as described in .. Materials and Methods." ( - 0- ) 
A280: ( --- ) enzyme activity. 
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Fig. 3.2.2. Sn5-polyacryJamide gel electrophoresis of prepara-
tions of ribonucleotide reductase from rat liver 
I 
Samples from left to right: DEAE-cellulose eluted with 
buffer + 0.16M KCl (2 and 3); DEAE-cellulose eluted with 
buffer + 0.25M KCl(4 to 7); CM-Sephadex fraction 1 (8 and 
9); CM-Sephadex fraction 2 (10 and 11); ATP-agarose 
eluted without ATP (12); and ATP-agarose eluted with 2 mM 
ATP (13). 
Standards (1 and 14) are from the top: j3-Galactosidase 
(Mr= 116, OOO), Phosphorylase (Mr=97,4 4 00), Bovine 
serum Albumin (Mr=66,000), Egg Albumin (Mr= 45 ,000), 
Carbonic anhydrase (Mr=29,000) . 
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Chromatography on an ATP-Agarose affmity column was tried in 
an attempt to further purify the protein after chromatography on 
DEAE-cellulose. This procedure was not very successful and not 
pursued further. The enzymic activity of the resulting enzyme 
preparation from the ATP-Agarose column eluting with the same buffer 
lost about 80% compared to the enzyme preparation of the DEAE-
cellulose fraction (see Table 3.2.3). There were still several kinds of 
protein in this preparation (Fig. 3.2.2). Attempts were also made to 
purify the enzyme preparation resulting from the DEAE-cellulose 
column using CM-Sephadex. The yield was very low: 41.9g liver only 
gave 1 ml of the resulting preparation with a protein content of lower 
than 1.6 mg/ml and specific enzymic activity of 132 units/mg protein. 
This enzyme preparation was not homogeneous either (Table 3.2.3 and 
Fig. 3.2.2). 
3. 2. 2. Ribonucleotide reductase in tissues of different growth 
states or rates 
Using a partially-purified enzyme preparation, (45% ammonium 
sulphate fractionation) as the experimental sample, the CDP reductase 
activity in different tissues of different growth rate was determined 
and compared. 
3. 2. 2. 1 Ribonucleotide reductase activity in juvenile and adult 
normal rat liver. 
Table 3.2.4 gives a comparison of the ribonucleotide reductase 
activity in juvenile (3-4 week-old) and adult 01-12 week-old) rat 
liver. It is evident that there was a marked difference between the 
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Table 3.2.3 Rat hepatic ribonucleotide reductase yield and 
activity after chromatography on ATP - Agarose 
and CM-Sephadex 
ATP - Agarose CM-Sephadex 
Fraction 1 Fraction 2 
Volume 
(ml ) 2 1 1.5 
Protein content 
(mg prot. / ml ) 2.2 1.6 undetectable 
Enzyme activity 
(units/mg prot.) 233.3, 181.4 132.5 undetectable 
The data are from a single purification experiment. Fractions 1 
and 2 of CM-Sephadex represent, respectively the enzyme 
preparations which were obtained by washing the CM -Sephadex 
with buffer only and with buffer plus 1M NaCl. The protein 
solutions applied to ATP-Agarose column and CM-Sephadex were 
the enzyme preparations obtained from DEAE-cellulose 
chromatography. The specific activity of the enzyme was 1063 
units/mg prot. prior to being applied to the ATP-Agarose and 
973 units/mg prot. prior to being applied to CM-Sephadex. 
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Table. 3.2.4 Ribonucleotide reductase activity in juvenile and 
adult rat liver 
Body Wt. (g) 
Liver Wt. (g) 
3-4 weeks 
65 + 6 ( 7) 
3.1+0.7(7) 
Age 
11-12 weeks 
323 + 14 ( 5) 
12.3 + 1.2 (5) 
Enzyme activity 
(units/mg prot.) 185 + 26,0 (4) undetectable 
The enzymic activity was determined under standard reac-
tion conditions as described in "Materials and Methods ". 
Mean values are given + S.E.M. with the number of experi-
ments shown in parentheses. For the 3-4 week-old group, 
each experimental sample was from 5-10 rats. For the 
11- 12 week-old group, each experimental sample was 
obtained from an individual rat. All assays of enzyme 
activity were performed in duplicate. 
127 
juvenile and adult rat liver in the enzymic activity. In liver of 3-4 week-
old rats, the specific activity was 185 units/mg protein. However, no 
enzyme activity could be detected in livers of 11-12 week-old rats. 
3. 2. 2. 2 Ribonucleotide reductase activity in hepatoma tumours 
CDP reduction was detected in Yoshida ascites hepatoma cells 
and Morris 5123tc solid tumours carried in Wistar rats. From the 
results of Fig. 3.2.3 it is indicated that an ammonium sulphate 
fractionation from MorriS 5123tc tumours showed only 130/0 of the 
CDP reductase activity as compared to a similar fraction from Yoshida 
cells. The range of enzyme activities found in the Yoshida cells under 
study was from 1379.5 to 4215.9 units/mg prot. In Morris 5123tc 
tumours activities ranged from 255.7 to 452.8 units/mg prot. 
The viability of the freshly collected Yoshida cells was generally 
greater than 90%. The weight of Morris 5123tc solid tumours ranged 
from 2.73 g to 7.02 g. There was no correlation between the CDP 
reductase activity and the weight of the solid tumour. 
3. 2. 2. 3 Ribonucleotide reductase activity in cultured Yoshida 
hepatoma cells 
The Yoshida ascites hepatoma cells were collected from the host 
rat. After washing with PBS, the cells were cultured in MEM culture 
medium at 37°C. At the indicated time, the cells were collected and 
washed with PBS by centrifugation and cell-free extracts prepared as 
deSCribed in "Methods". CDP reductase was measured directly in the 
crude extract. The results are shown in Fig. 3.2.4. For freshly harvested 
cells from the host rat, the CDP reductase in crude extract enzyme 
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Fig. 3.2.3. Ribonucleotide reductase activity in Yoshida ascites 
hepatoma cells and Morris hepatoma 5123 tc solid 
twnours 
The CDP reductase activity was determined under standard 
reaction conditions as described in "Materials and Methods." 
Mean values are given + S.E.M. for 5 batches of Yoshida cell 
suspensions and 5 Morris hepatoma 5123 tc tumours. Each 
assay was carried out in duplicate. 
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Fig. 3.2.4. Time course of ribonucleotide reductase activity 
in Yoshida ascites hepatoma culture cells 
CDP reductase activity was determined under standard 
reaction conditions as described in "Materials and 
Methods". Mean values are given + S.D. 
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preparation was about 149 units/mg prot. During 6 days of culture 
period the activity of reductase activity increased over 4 days. At day 
two, the enzymic activity was markedly elevated, 9 fold compared to 
the activity at day O. At day four, the activity peaked at 2669 units/mg 
prot., 17 fold above the day 0 value. Afterwards the activity started to 
decline. On day 6, it had returned to a level only slightly above that 
found in freshly harvested cells. Since the reductase activity was 
measured in the crude extract, the specific activity was lower than in 
the ammonium sulphate fraction sample. The enzymic activity at Day 0 
was 149 units/mg prot. in the crude extract, but it was 1358 units/mg 
prot. in the 450/0 ammonium sulphate fraction. 
3. 2. 2. 4 Ribonucleotide reductase activity in regenerating liver 
Following partial hepatectomy, the remaining minor lobes of the 
liver grow rapidly in order to restore the original mass of the liver. As 
shown in Table 3.2.5, the net weight of minor lobes of liver from 
partially hepatectomised rats increased compared with sham operated 
control livers. The amount of regeneration of liver mass relative to 
sham operated liver was increased by 69.70/0 at 36h, 92.7% at 48h, 
116% at 60h and 93.60/0 at 72h post operation. In the sham operated 
rats the weight of the minor lobes was on average 2.69g during the 
period of study. 
At intervals of 12 hours, the partially hepatectomized and sham 
operated rats were killed and the minor lobes of liver were sampled. 
Ammonium sulphate fractions were prepared from the minor lobes for 
CDP reductase activity determination. Fig. 3.2.5 illustrates the time 
course of the CDP reductase activity in regenerating liver. The enzyme 
activity increased in liver tissue following partial hepatectomy. The 
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Table 3. 2. 5 Weight of the minor liver lobes following either partial 
hepatectomy or sham operations 
Time post 
operation 
Weight of minor 
lobe of liver ( g ) 
Regenerating 
liver 
Sham -operated 
liver 
36h 
4.26 + 0.33 
(4) 
2.51 ± 0.35 
(2) 
48h 60h 72 h 
5.03 + 0.54 5.44 + 0.72 6.06 + 0.51 
(2) (5 ) (4 ) 
2.61 + 0.37 2.51 + 0.19 3.13 ± 0.54 
(2 ) (2) ( 4) 
Mean values are given + S.E.M. with the number of animals shown in 
parentheses. 
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Fig. 3.2.5. Ribonucleotide reductase activity in regenerating 
rat liver 
Rats were subject to partial hepatectomy at '0 hours' and 
liver was sampled for ribonucleotide reductase activity at 
the times shown. The CDP reductase activity was 
determined under standard reaction conditions as 
described in "Materials and Methods". Mean values are 
given + S.E.M. The number of rats was 10 at 24h, 9 at 36h, 
11 at 48h, and 4 at 72h post operation. Each assay was 
carried out in duplicate. 
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time course appears to exhibit a periodic cycling with two peaks, one 
at 48h post operation and another at 72h post operation. The maximal 
reductase activity was observed at 48h post operation which was 4-5 
fold higher than the activity at 24h, 36h and 60h post operation. The 
enzyme activity of regenerating liver at 72h was 2-3 fold higher than 
that at 24h, 36h and 60h post operation. CDP reductase activities were 
undetectable in all sham operated livers. 
Table 3.2.6 demonstrates the CDP reductase activity of the 
mixture of enzyme preparations from 48h and 60h regenerating rat 
liver. The activity of the mixture was 292 units/mg protein. This value 
was very close to the calculated activity of the enzyme mixture which 
was 282 units / mg protein. This result indicated that there was only 
additive effect when these enzymes were mixed together. 
3. 2. 3 Elevation and inhibition of the activity of ribonucleotide 
reductase from juvenile rat liver and regenerating liver 
Dithiothreitol (DTI) is necessary for CDP reductase activity as a 
reducing agent in this assay system. In this study it was found that 
there were differences in the optimal DTI concentration for exerting 
the full CDP reduction activity between the enzyme from juvenile 
normal rat liver and regenerating liver. Fig. 3.2.6 illustrates the 
dependence of the activity of CDP reductase from juvenile normal rat 
liver and regenerating rat liver (48h and 60h post operation) on DTI 
concentration ranging from ImM to 15 mM. It can be seen that higher 
concentration of DTT can elevate regenerating liver's CDP reductase 
activity. The enzyme activity of 48h regenerating liver was enhanced 
1600/0 when DTI concentration was increased to 5 mM. The 
enhancement was not significantly increased when the DTT 
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Table 3.2.S CDP reductase activity in the mixture of 
enzyme from 48h and SOh regenerating rat 
liver 
Enzyme Activity (units/mg prot./h) 
calculated observed 
48h 428.8±21.9 
60h 136.7±11.2 
48h+60h 282.7 292.8+17.8 
The activity of CDP reducatse was determined under 
standard conditions as described in "Material and 
Methods". The DTT concentration in the reaction 
solution was 10 mM. The reaction time was 1h. Protein 
content in the reaction mixture was 1 mg. For the 
measurement of the CDP reductase activity of mixed 
enzymes from 48h and 60h regenerating liver, 0.5 mg 
protein of each enzyme preparation was added to the 
CDP reduction mixture. Mean values are given + S.D. 
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Fig. 3.2.6. Dependence of CDP reductase activity on DTT 
concentration 
The CDP reductase activity of enzyme from juvenile normal 
rat liver and regenerating rat liver (48h and 60h) was 
determined at different concentrations of DTT. The 
enzyme activity at 1 mM DIT was taken as 1000/0. Mean 
values are given + S.E.M. Each assay was carried out in 
triplicate. (0) juvenile normal rat liver; (.) 48h 
regenerating rat liver; ( b. ) 60h regenerating rat liver. 
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concentration increased further to 15 mM. For the enzyme from 60h 
regenerating liver the degree of activity enhancement by DIT was 
lower than for the enzyme from 48h regenerating liver. Comparing to 
the activity at ImM DIT, the activity at 5 mM DIT and 10 mM DIT 
were increased 270/0 and 810/0 respectively. No further enhanced 
activity was observed when the DIT concentration was increased to 15 
mM. In contrast to the enzyme from regenerating liver, the enzyme 
activity of normal juvenile liver did not respond to changing of the DIT 
concentration. In the range of 1 mM to 15 mM DIT there was no 
significant difference in the reduction activity (Fig. 3.2.6). 
To investigate if continual higher DIT concentration was 
necessary for the reductase from regenerating rat liver to exert its full 
activity, the effect on the CDP reduction by the enzyme from 48h 
regenerating liver of addition of higher concentration of DIT (10 mM) 
to the enzyme assay mixture which contained lower DIT (1 mM) at 
different incubation times was studied (Fig. 3.2.7). At 10 mM DIT the 
dCDP formation was 2.2 fold of the value at 1 mM DIT during 60 min. 
incubation time. Addition of 10 mM DIT to the 1 mM DIT-containing 
enzyme assay mixture 20 min. and 40 min. after the reaction started, 
the rate of the dCDP production was completely restored indicating 
that the activity of the enzyme had returned to full level. 
The function of DIT as an activator of CDP reductase activity was 
further studied. First the enzyme protein was preincubated with a 
higher concentration of DIT (10 mM) and 8 mM MgCl2 at 30°C for a 
certain time. Then the preincubation mixture was transferred to CDP 
reduction mixture for regular activity assay in which the DIT 
concentration was diluted to 1 mM. The results are shown in Fig. 
3.2.8-10. After preincubation the activity of CDP reductase from 48h 
and 60h regenerating liver was enhanced (Fig. 3.2.8 and Fig.3.2.9). 
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Fig. 3.2.7. Effect of addition of a high concentration of DTT 
on CDP reductase activity from 48h regenerating 
rat liver 
Enzyme protein from 48h regenerating rat liver was 
incubated with CDP reduction mixture containing 1 mM 
DIT at 30°C. At the indicated time point (shown by the 
arrow in the figure) 3 of the samples were stopped for 
dCDP determination, 3 of the samples received 5 ~l 630 
mM DIT solution to make the DIT concentration in the 
assay 10 roM and incubation was continued to 60 min. The 
amount of enzyme protein in assay was 0.39 mg. The mean 
values are given + S.D. All assay were carried out in 
triplicate. (-------) 1mM DIT; (--) 10 roM DIT. 
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Fig. 3.2.B. Effect of preincubation of enzyme protein from 
4Bh regenerating liver with DTT /Mg2+ 
(lOmM/BmM) on CDP reductase activity 
The protein (3.7 mg) of enzyme preparation from 48h 
regenerating liver was preincubated with 10mM DTT and 
8 mM MgCl 2 in total volume of 330 III at 30°C for 20, 40 
and 60 min. At the time indicated 34.5 III aliquots of this 
incubation mixture were added to the CDP reduction 
mixture (310.5 Ill) for the regular activity assay in which 
the DTT concentration was diluted to 1 mM. The amount 
of enzyme protein in assay was 0.39 mg. Mean values are 
given ± S.D. ( [2] ) without preincubation, DTT concentration 
in assay was 1 mM; (II) without preincubation, DTT 
concentration in assay was 10 mM; ( 0 ) preincubation for 
20min.; ( []] ) preincubation for 40 min.; ( • ) preincubation 
for 60min. 
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Fig. 3.2.9. Effect of preincubation of enzyme protein from 
60h regenerating liver with DTT /Mg2+ 
(lOmM/8mM) on CDP reductase activity 
The protein (l.8 mg) of enzyme preparation from 60h 
regenerating liver was preincubated with 10mM DIT and 
8 mM MgCl 2 in total volume of 11 0 ~l at 30°C for 20 min. 
Then 34.5 ~l aliquots of this incubation mixture were 
added to the CDP reduction mixture (310.5 ~l) for the 
regular activity assay in which the DIT concentration was 
diluted to 1 mM. The amount of enzyme protein in assay 
was 0.58 mg. Mean values are given + S.D. (.) without 
preincubation, DIT concentration in assay was 1 mM; 
( m ) without preincubation, DIT concentration in assay 
was 10 mM; ( m ) preincubation for 20min. 
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Fig. 3.2.10. Effect of preincubation of enzyme protein 
from juvenile normal rat liver with DTT /Mg2+ 
(10mM/BmM) on CDP reductase activity 
The protein (3.9 mg) of enzyme preparation from juvenile 
normal rat liver was preincubated with 10mM DTT and 8 
mM MgCl2 in total volume of 110 J.lI at 30°C for 20 min. 
Then 34.5 J.lI aliquots of this incubation mixture were 
added to the CDP reduction mixture (310.5 J.ll) for the 
regular activity assay in which the DTT concentration was 
diluted to 1 mM. The amount of enzyme protein in as~ay 
was 1.23 mg. Mean values are given + S.D. (m) without 
preincubation, DTT concentration in assay was 1 mM; (0) 
without preincubation, DTT concentration in assay was 10 
mM; ( • ) preincubation for 20min. 
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The activity was increased about 29% for 48h regenerating liver 
enzyme (Fig. 3.2.8) and 10SCA) for 60h regenerating liver enzyme (Fig. 
3.2.9) after 20 min preincubation compared to the enzyme activity 
without preincubation. Longer preincubation did not produce more 
enhancement of the enzyme activity of 48h regenerating liver (Fig. 
3.2.8). In contrast, the activity of CDP reductase from normal juvenile 
rat liver was not activated by the preincubation (Fig. 3.2.10). 
In an attempt to fmd an explanation for the different responses 
of the activity of CDP reductase from regenerating rat liver and normal 
juvenile rat liver to DIT concentration, the content of acid soluble 
thiols in the 4S% ammonium sulphate fraction and in the homogenate 
of the livers and also the protein thiols in the liver homogenates were 
measured. The samples prepared for this purpose were made in the 
same way as the samples for CDP reductase activity determination but 
the buffer was O.lM Tris/HCI (pH 7.4) without 2 mM DIT and S mM 
MgCl2• The results are shown in Tables 3.2.7. 3.2.8 and Fig. 3.2.11. The 
content of acid -soluble thiols in the 4S% ammonium sulphate fraction 
of 48h regenerating liver was significantly higher than that from 60h 
regenerating liver. There were no significant differences in acid soluble 
thiols content between 48h regenerating liver and juvenile normal rat 
liver or between juvenile normal rat liver and 60h regenerating liver 
(Table 3.2.6). Similarly, there were no differences of the content of 
protein thiols in homogenates of normal juvenile rat liver and 
regenerating rat livers (Table 3.2.7). However, the content of acid 
soluble thiols in homogenates from regenerating liver exhibit a 
periodic cycle. The thiol content exhibited maxima at 24h, 48h, and 
72h post operation compared to minima at 36h and 60h post 
operation (Fig. 3.2.11). 
The inhibitory effect of hydroxyurea, a specific inhibitor of 
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Table 3.2.7 The content of acid soluble thiols in enzyme 
preparation of 45% ammonium sulphate fraction 
from juvenile normal rat liver and regenerating rat 
liver 
Juvenile nonnal liver 
48h regenerating liver 
60h regenerating liver 
Thiols content (nmoles/mg prot.) 
5.1 + 0.7 (4) 
6.9 + 0.5 (5) 
4.2 + 0.5 (5) 
The enzyme preparation was prepared as the same as for CDP 
reductase activity determination except the buffer was O.lM 
Tris/HCI (pH7.4). The content of acid soluble thiols was 
measured as described in "Methods". Mean values are 
given+S.E.M with the number of animal shown in parentheses. 
Thiols content in fraction of 45% ammonium sulphate from 60h 
regenerating liver was significantly lower (P < 0.005) compared 
to 48h regenerating liver. 
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Table 3.2.8 Content of protein thlols in the homogenate from 
juvenile normal rat liver and regenerating rat liver 
(nmoles/mg protein) 
Juvenile normal Regenerating liver 
liver 24h 36h 48h 60h 72h ~=-----===-----~=-----~~----~~--
94.5 + 1.3 94.5+3.7 90.5+2.9 90.3+4.6 89.5+3.0 92.8+3.5 
(4) (5) (5) (5) (6) (5) 
Homogenates were made from juvenile normal rat liver and from 
regenerating liver at various times post operation with O.lM 
TrisjHCl (pH 7.4). The content of protein thiols was measured as 
described in "Methods". Mean values are given±S.E.M with the 
number of animal shown in parentheses. 
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Fig. 3.2.11. Content of acid soluble thiols in homogenate of 
regenerating rat liver 
Homogenates were made from regenerating liver with 
O.lM Tris/Hel (pH 7.4). The content of acid soluble thiols 
was measured as described in "Methods". Mean values are 
given ± S.E.M. The number of animals was 5 for each point. 
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ribonucleotide reductase, on activity of CDP reductase from normal 
juvenile rat liver and 48h and 60h regenerating rat liver was also 
investigated. All the enzymes investigated displayed a similar sensitivity 
to hydroxyurea. The activity was inhibited about 60-700/0 by 4mM 
hydroxyurea and 10 mM hydroxyurea nearly completely inhibited the 
enzyme activity (Fig. 3.2.12). 
3. 3 PROPERTIES OF 4-HYDROXYNONENAL (HNE) AS AN 
INHIBITOR OF RIBONUCLEOTIDE REDUCTASE FROM 
JUVENILE NORMAL RAT LIVER 
Previous work has demonstrated that lipid peroxidation products 
damaged DNA or affected DNA synthesis. In rapidly dividing 
cells/tissues, for example in tumour cells, the lipid peroxidation levels 
are very low. Since ribonucleotide reductase is a critical enzyme for 
DNA synthesis, the effect of the lipid peroxidation product 4-
hydroxynonenal (HNE) on ribonucleotide reductase from normal rat 
liver was investigated. The enzyme preparation used for this work was 
the 450,,-6 ammonium sulphate fraction stored in O.lM Tris/HCI (pH 
7.4) containing 2 mM DTT and 5 mM MgCI2 . 
3. 3. 1 Inhibition of CDP reductase activity by HNE 
The data of Fig. 3.3.1 demonstrate that HNE inhibited the activity 
of CDP reductase of rat liver when added to the CDP reduction mixture 
for enzyme activity assay without pre-incubation under standard 
conditions (incubation time 60 min.). HNE (0.1 mM, final 
concentration) decreased the activity by 500/0. 
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Fig. 3.2.12. Effect of hydroxyurea on activity of CDP reductase 
from juvenile normal, 48h and 60h regenerating 
rat liver 
CDP reductase activity was measured in the absence or 
presence of hydroxyurea (4 mM and 10 mM, final 
concentration) as described in "Methods". The number 
shown in the figure present the inhibition degree by 
hydroxyurea compared to control. Mean values are given ± 
S.D. 
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Fig. 3.3.1. Inhibition of CDP reductase by 4-hydroxynonenal 
(HNE) 
The CDP reductase activity was measured in the presence 
of HNE. The reaction conditions were as described in 
"Materials and Methods" except the DTT concentration 
was 1 mM. The activity of control was 204.9 units/mg 
prot. All assays were carried out in duplicate. 
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Further investigation showed that the inhibition was related 
to the incubation time. Fig. 3.3.2 shows the extent of inhibition as a 
function of the incubation time. Over 60 min. the degree of inhibition 
increased. The percentage of inhibition was 30.8% at 15 min., 40.70/0 
at 30 min., 480/0 at 45 min. and 51 % at 60 min. 
The inhibitory effect of HNE on the enzyme was enhanced by 
preincubation of the reductase with HNE before the enzymic reaction 
started (Table 3.3.1). When O.lmM HNE was present during a 10 min. 
preincubation (resulting in a final concentration of 0.0174 mM during 
assay), the enzyme activity was inhibited by 600/0. Without 
preincubation, 0.1 mM HNE (final concentration during assay) reduced 
the activity by 500/0 and 0.017 mM HNE (final concentration during 
assay) inhibited the activity by 15%. When the enzyme was 
preincubated with 0.575 mM HNE at 30°C for 30 min, there was no 
measurable activity left. In this case the final concentration of HNE 
during assay was 0.1 mM. However, the preincubation enhancement of 
inhibition was not affected significantly by the time of preincubation 
above 10 min. (Table 3.3.1). 
In an attempt to determine if the HNE inhibition was reversible, 
the enzyme was exposed to HNE at O°C for 1 hour, then excess HNE 
was removed using a Sephadex-G25 column. Afterwards the activity of 
this "treated" enzyme was tested. Two treatments were carried out for 
this purpose. 
(0 the original enzyme preparation containing 2 mM DTT and 5 
mM MgCl2 in O.lM Tris/HCI (pH 7.4) was incubated with HNE 
(final concentration was 0.1 mM) on ice for 1h. The incubation 
mixture contained 10 mg protein in a total volume of 400 J.1l 
(equivalent 25 mg protein/mI). After removal of HNE, the CDP 
reductase activity was determined. DTT concentration during 
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Fig. 3.3.2. The effect of incubation time on inhibition of 
CDP reductase by HNE (O.lmM). 
The CDP reductase activity was determined as describeed 
in "Materials and Methods" except the DIT concentration 
was 1 mM. Mean values are given + S.D. ( 0 ) Control; ( • ) 
+0.1 mM HNE. 
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Table 3.3.1 Effect of preincubation of enzyme protein with lINE on the degree of inhibition of CDP 
reductase activity 
CDP reductase activity (units!mfi! prot.) 
Preincubation Control O.lmM HNE in Inhibition 0.575 mM HNE in Inhibitlon 
time preincubatlon(0.017mM (0/0) preincubatlon(O.lmM (0/0) 
(min) in assay) in assay) 
0 204.9+11.0 15* 99.0±4.2 50 
10 271.5+1.7 92+0.3 66 
20 238.3+8.6 86+3.2 63 
30 174.9±5.9 71+0.9 60 2.7+0.5 98 
The enzyme protein was incubated with HNE at 30°C. At the time indicated aliquots of this mixture 
were added to the CDP reduction mixture to initiate the regular activity assay under standard 
reaction conditions except the DIT concentration was 1 mM. Control incubations were carried out 
in the presence of H20 during the preincubation. The assays were carried out in triplicate. 
* The datum was from Fig. 3.3.1. 
assay was 1 mM. The reaction time was 60 min. 
(ti) DIT was removed from enzyme preparation firstly by using a 
Sephadex-G25 column. Then the DIT -free enzyme preparation 
was incubated with 0.25, 0.57 and l.0 mM HNE (fmal 
concentration) on ice for 1h. The incubation mixture contained 
3.8 mg protein in total volume of 235-267 Jll (equivalent 16.1-
14.2 mg protein/ml). After removal of HNE, the CDP reductase 
activity was measured under the condition of 1mM DIT and 15 
min reaction time. 
The results are shown in Fig. 3.3.3 (for treatment (i)) and Fig. 3.3.4 
(for treatment (ti)). As seen in Fig. 3.3.3, the enzyme activity was 
reduced by 33% after HNE treatment compared to the control sample 
which was incubated with ~O. Compared with the enzyme without any 
incubation, the activity of the control sample (incubated with H20) was 
not changed. The activities were 204 and 190 units/mg protein 
respectively. Fig. 3.3.4 shows that the extent of inhibition of enzyme 
activity by HNE was dependent on HNE concentration. CDP reductase 
activity was inhibited 750/0 by l.OmM HNE compared to control. 
Removal of DIT from the enzyme preparation decreased the enzyme 
activity even without HNE addition. The activity of the original enzyme 
preparation (without removal of DIT) was 69.3 units/mg protein, the 
activity of control sample (removal of DIT and then incubated with 
H20) was 49.7 units/mg protein. 
Fig. 3.3.5 shows the separation of enzyme and HNE using the 
Sephadex-G25 column. Fraction nos. 4-5 were collected for enzyme 
activity assays. In these fractions there was no excess HNE. Thus the 
inhibition of the enzyme could not be attributed to an inhibition by free 
HNE being carried through to the enzymic reaction mixture. 
The inhibitory effect of HNE against CDP reductase activity in 
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Fig. 3.3.3. Inhibition of CDP reductase activity by lINE 
The enzyme protein (10 mg) was incubated at O°C for 
1 hr in the presence or absence (H 20 instead) of 
O.lmM HNE (final concentration) in total volume of 400 ~l. 
Then the mixture was passed down a Sephadex G-25 
column (21x1 cm) using O.lM Tris-HCl (pH7.4) containing 
2 mM DTI and 5 mM MgCl2 as an eluant at 4°C. In the 
peak fraction of protein eluting from the column, the 
CDP reductase activity was determined as described in 
"Material and Methods" except the DIT concentration 
was 1mM. (m): control, the enzyme was incubated with 
H20; ( EM ): the enzyme was incubated with O.lmM HNE; 
( D): the enzyme without any incubation. The number in 
the figure present the activity left compared to control. 
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Fig. 3.3.4. Inhibition of CDP reductase activity by HNE 
DTT was removed from the enzyme preparation previously 
by using a Sephadex G-25 column. The protein (3.8 mg) of 
DTT -free enzyme preparation was incubated at O°C for 1h 
with different concentrations of HNE in total volume of 
235-267 Ill. Then the mixture was passed down another 
Sephadex G-25 column for removal of HNE. The CDP 
reductase activity was determined under the condition of 
1mM DTT in CDP reduction mixture and 15 min. reaction 
time. The number in the figure present the activity left 
compared with control. (II) without removal of DTT; (~) 
control (incubated with H 20); ([£J) incubated with 0,25 mM 
HNE; (~) incubated with 0.47mM HNE; (D) incubated 
with 1,0 mM HNE, 
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Fig. 3.3.5. Chromatography of separation of enzyme and 
liNE on Sephadex G-25 column (21x1 em). 
( -0-) 200 J,ll enzyme (l1.8mg protein) + 200~1 H20; (-.-) 
200 J,ll O. 2mM HNE + 200JlI H20. The mixtures were 
passed down the Sephadex G-25 columns (21x1 em) using 
0.1 M Tris/HCI as an eluant. The eluted fractions (1 ml) 
were collected and 2ml O.02MTris-HCl was added. The 
absorbance of this mixture was checked at 280 nm ( 0 ) 
and 223nm ( • ). 
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the crude extract of enzyme was also studied. The results are shown in 
Fig. 3.3.6. HNE had a very weak inhibitory effect on the crude extract 
of enzyme compared to partially purified enzyme preparation (45% 
ammonium sulphate fraction). 1 mM HNE inhibited the activity by 
500/0, 10 times weaker than its effect on the ammonium sulphate 
fraction. 
3. 3. 2 Effect of dithiothreitol (DTI) on the inhibition by HNE 
The functions of DIT were as a reducing agent for the reductase 
activity assay and an activator of the enzyme from regenerating liver 
(see 3. 2. 3). In this study DTI was also found to influence the 
inhibition of CDP reduction by HNE. Table 3.3.2 indicated that when 
the DIT concentration was increased to 15 mM in the reaction 
solution, the enzyme activity was only inhibited about 240/0 by 0.2 mM 
HNE and no significant inhibition was observed by 0.05 mM HNE. 
However when the DIT concentration was 1 mM, the enzyme activity 
was inhibited by 300/0 and 800/0 at 0.05 mM and 0.2 mM HNE, 
respectively. To ensure that this decrease of inhibition was due to the 
direct effect of DTT, and not because of the change of basal reductase 
activity when a high concentration of DTT was present during assay, 
the enzyme activities at different concentrations of DTT were studied. 
The results are shown in Fig. 3.2.6. Using a concentration range of 1 
mM to 15 mM DIT, there was no significant difference in the 
reduction activity. 
If HNE was incubated with DIT before exposure to the enzyme, 
HNE did not inhibit the activity of the enzyme (Table 3.3.3). It can be 
seen that without preincubation with DTf (preincubation with H20 
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Fig. 3.3.6. Inhibitory effect of lINE on the activity of crude 
extract of ribonucleotide reductase from rat liver 
In the absence or presence of HNE, the CDP reductase 
activity of crude enzyme extract was measured under 
standard reaction conditions as described in "Materials 
and Methods". The activity of the control was 22.8 
units/mg protein. Each assay was carried out in at least 
duplicate. 
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Table. 3. 3. 2 lINE effect on RNR activity in the presence of a 
high concentration of DIT 
Concentration of DTI 
1mM 15mM 
Treatment 
Activity inhibition Activity inhibition 
(units/mg prot.) (0/0) (units/mg prot.) ( 0/0) 
Control 204.9+11.0 283.9+5.8 
+HNE 
0.05 mM 140.3+15.0 31.5 274.1+0.1 3.5 
0.2 mM 38.7+7.0 81.1 213.9+2.4 24.7 
In the presence or absence of HNE the activity of enzyme 
was measured under standard reaction conditions as described 
in " Material and Methods ". The concentration of DTT during 
the reaction was 1 mM or 15 mM as indicated. Mean values are 
given + S. D. 
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Table 3.3.3 Effect of preincubation of lINE with DTT on the 
inhibition of lINE 
Treatment 
-HNE 
+0.1 mM HNE (f/ c) 
without preincubation with DTT 
preincubated with DTT 
0.287mM/2.87mM 
(HNE/DTT) 
0.575mM/5.75mM 
(HNE/DTT) 
CDP reductase activity 
(units Im~ protein) 
205.1±19.4 
99.014.2 
186.1±25.8 
179.7±17.9 
HNE was preincubated with DTT (0.287 mM HNE with 2.87mM 
DIT in one experiment and 0.575 mM HNE with 5.75 mM DIT 
in another experiment) at 30°C for 30 min. and then the aliquots 
of this mixture were added to the CDP reduction mixture and the 
enzyme protein to determine the activity of the enzyme. The final 
concentration of HNE and DTT in this assay mixture were 0.1 
mM and 1 mM respectively. Mean values are given ± S.D. 
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instead) 0.1 mM (final concentration) HNE inhibited the enzyme 
activity by about 500/0. However, after incubation with DTf at ratio of 
1:10 for 30 min at 30°C (0.287 mM HNE with 2.87 mM DIT in one 
experiment and 0.575 mM HNE with 5.75 mM DTT in another 
experiments), HNE did not significantly inhibit the activity. If HNE was 
incubated with enzyme protein in the presence of additional DIT, 
HNE failed to inhibit the enzyme activity (Fig. 3.3.7). In this 
experiment the enzyme protein was incubated with 0.1 mM HNE (final 
concentration) and 2 mM additional DTT together at O°C for 1h. Then 
the excess HNE and DIT were removed by using Sephadex-G25 
column and the CDP reductase activity was checked. It can be seen in 
Fig. 3.3.7 that if HNE was incubated with enzyme protein only 0.1 mM 
HNE produced 330/0 inhibition; but if HNE was incubated with enzyme 
protein in the presence of 2 mM DIT, HNE did not damage the 
enzyme. 
In order to study if a high concentration of DIT could reactivate 
the enzyme activity after the enzyme was damaged by HNE, two 
treatments were carried out as outlined below, 
(i) DIT was removed from the enzyme preparation by using a 
Sephadex-G25 column. Then the protein of this DTT-free 
enzyme preparation was incubated with 1 mM HNE at O°C for 1h. 
After removal of HNE, the enzyme protein was incubated with 
5.4 mM DIT (final concentration) at 30°C for 0.5, 1 and 2h. 
Afterwards the CDP reductase activity was checked. The DIT 
concentration in the activity assay was 1 mM and the reaction 
time was 15 min. 
(ii) The original enzyme preparation (without removal of DTI) 
was incubated with 0.1 roM HNE (final concentration) at O°C for 
1h. CDP reductase activity of this treated enzyme was 
160 
250 
100% 100% 
Fig. 3.3.7. Effect of preincubation of lINE with DTT and 
enzyme protein together on the inhibition of 
HNE 
The protein (10 mg) of original enzyme preparation was 
incubated at O°C for Ih with (1) H20, as control ( ~ ); (2) 
0.1 mM HNE (E2]) and (3) 0.1 mM HNE and 2 mM 
additional DTT (mn) in a total volume of 400 ~l. Then the 
mixture was passed down a Sephadex G-2S columns for 
removal of HNE and additional DTT. CDP reductase activity 
was determined under standard conditions except that the 
DTT concentration was 1 mM. The number in the figure 
represents the activity left compared to control. 
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determined following the removal of excess HNE using a 
Sephadex-G25 column. The concentration of DIT in the activity 
assay were 1 mM for control and half the HNE-treated samples 
and 10 mM for the other half of the HNE-treated samples. The 
assay reaction time was 60 min. 
The results are presented in Table 3.3.4 and Fig. 3.3.8. For the first 
treatment, preincubation of HNE-treated enzyme protein with a higher 
concentration of DIT (5.4 mM) up to 1h did not reactivate enzyme 
activity. When the preincubation was for 2h, the enzyme activity was 
totally lost (Table 3.3.4). A Similar result was observed from the second 
treatment. Incubation of HNE-treated enzyme protein with the higher 
concentration of DIT during enzymic reaction did not reverse the 
inhibition either. With exposure of HNE-treated enzyme protein to 10 
mM DIT during 60 min. enzyme reaction for the activity assay the 
enzyme activity was reduced to the same extent as when the enzyme 
activity was tested at 1 mM DIT during assay (Fig. 3.3.8). 
The mechanism of HNE effect on the enzyme activity was also 
investigated. The results in Fig 3.3.9 shows that after incubation with 
HNE, the SH content of the enzyme preparation was decreased. The 
decrease was dependent on the HNE concentration. However 
incubation time above 5 min did not affect this decrease. 
It seems that DIT had a modulating effect on HNE inhibition and 
afforded protection of the enzyme against HNE. Fig. 3.3.10-12 show 
that these two compounds can interact. DIT influenced the spectrum 
of HNE, such that there was decreased absorbance at 223nm(Fig 
3.3.10). At the same time HNE decreased the reactive SH content of 
DIT. The higher the concentration of HNE and the longer the time of 
incubation, the more the decrease of SH content (Figs 3.3.11,12). 
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Table 3.3.4 Effect of DTT on CDP reductase activity of lINE-
treated enzyme 
Treatment 
Control 
1mM HNE treatment 
~thoutincubation 
~th 5.4mM DTI 
incubated with DIT 
30 min. 
60 min. 
120 min. 
CDP reductase activity 
( units/mg prot.) 
49.7 + 3.4 
12.0±1.0 
11.3±1.1 
12.2+1.2 
undetectable 
0/0 of control 
100 
24 
22 
24 
o 
DTI was removed from the enzyme preparation first using a 
Sephadex G-25 column. The protein of the DTT -free enzyme 
preparation (3.8 mg protein) was incubated with 1 mM HNE at 
O°C for 1h in a total volume of 267 ~l. Then this incubation 
mixture was passed down another Sephadex G-25 column for 
removal of HNE. The HNE-free enzyme protein solution was then 
incubated with 5.4 mM DTT. At the time indicated aliquots of 
this incubation mixture were added to the CDP reduction 
mixture to initiate the regular activity assay. The DTT 
concentration in the assay was 1 mM. The reaction time was 15 
min. 
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Fig. 3.3.8. Effect of higher concentration of DTT on CDP 
reductase activity of HNE-treated enzyme 
The enzyme protein (10 mg) was incubated at oce for 1 h in 
the presence or absence (H20 instead) of 0.1 mM HNE in 
total volume of 400 ,.l.l. Then the mixture was passed down 
a Sephadex G-25 column for removal of HNE and eDP 
reductase activity was determined. ( m) control, the 
enzyme protein was incubated with H20. DTT 
concentration in assay was ImM; ( [[] ) the enzyme protein 
was incubated with 0.1 mM HNE. Then DTI concentration 
in assay was ImM; ( ELl ) the enzyme protein was incubated 
with 0.1 mM HNE. DTI concentration in assay was 10 mM. 
The numbers in the figure present the enzyme activity left 
compared to control. 
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Fig. 3.3.9. Effect of incubation with HNE for various times 
on the SH content crude extract of the enzyme. 
The enzyme was extracted with O.lM Tris-HC1(pH7.4) 
containing only 0.25M sucrose. After centrifugation at 
100,000 g at 4°C for 30 min, 200 III supernatant (1.68 mg 
protein) was incubated with 200 III HNE or H20 (as 
control) at 30°C. The SH content of enzyme was checked 
as described in "Materials and Methods". Mean values are 
given + S.D. ( 0) control; (.) 0.05 mM HNE; ( Il ) 0.1 mM 
HNE; ( • ) 0.2 mM HNE; ( [J ) 0.5 mM HNE. 
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Fig. 3.3.10. Reaction of FINE with DTT in Tris/HCl (36.5 mM pH 7.4) 
" 
(A) The spectrum of 0.1 mM HNE after at 30°C for 10 min. in presence 
of different concentration of DTI. (1) Control: 0.1 mM HNE in Tris 
buffer; (2) 0.1 mM HNE in Tris buffer at 30°C for 10 min.; (3) + 0.02 
mM DTI; (4) + 0.04 mM DIT; (5) + 0.1 mM DTT; 6) + 0.2 mM DIT. 
(B) The spectrum of 0.1 mM HNE in presence of 0.04 mM DTI after at 
30°C for different time (1) 0; (2) 10 min.; (3) 30 min.; (4) 60 min. 
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Fig. 3. 3.11. The effect of lINE on the SH content of DTT 
0.1 mM DIT was incubated with HNE in 36.5 mM 
Tris/HCl (pH 7.4) in total volume of 1ml at 30°C for 10 
min. The SH content of DIT was measured as described in 
"Materials and Methods" using GSH as standard. Mean 
values are given + S.D. 
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Fig. 3. 3.12. The effect of incubation time of HNE with 
DTT on the reduction of SH content of 
DTT 
0.1 mM DIT was incubated with 0.5 mM HNE in 36.5 mM 
Tris/HCl (pH 7.4) in total volume of 1 ml at 30°C. The 
method of determination of SH content as described in 
"Materials and Methods". Mean values are given + S.D. 
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4. DISCUSSION 
4. 1. ACTIVATION OF CCl4 IN RAT LIVER MICRO SOMES 
4. 1. 1. Effect of temperature on the activation of CCl4 in rat liver 
microsomes 
Carbon tetrachloride (CCl.J can be metabolically activated in liver 
endoplasmic reticulum to form a reactive intermediate, that was first 
proposed to be the trichloromethyl free radical (CCI3 ') by Slater (1966). 
A number of reactions including covalent binding of CCI3 ' to microsomal 
macromolecules and CCl4 -induced lipid peroxidation are able to show 
indirectly the activation of CCl4 (Fig. 1.1.2). Additionally, CCI3 ' can be 
spin-trapped with phenyl-t-butylnitrone (PBN) to form the PBN-CCI3 ' 
adduct, which is a relatively stable free radical detectable by ESR 
(Tomasi, et al., 1980; Albano, et al~, 1982). The spin trapping of CCI3 ' by 
PBN, covalent binding of radiolabelled CCl4 to microsomal protein and 
CCl4 -dependent MDA formation are all indirect methods for measuring 
the activation of CCl4 (Cheeseman et al., 1985). 
In the present study the temperature (range from 15-40°C) effect 
on the activation of CCl4 by rat liver microsomes was studied. 
Determinations of PBN-CCl3 ' formation, CCl4 covalent binding to protein 
and CCl4 -dependent MDA production have been used to follow the 
course of the activation of CCl4 , 
The ESR spectrum obtained from incubating liver microsomes 
with CCl4 and PBN was a triplet of doublets (Fig, 3.1.1 a), The spectrum 
was identical with those of the PBN-CCl3 ' adduct detected in liver 
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microsomes observed by Tomasi et al. (1980) and Albano et al. (1982). 
Although there was a PBN-CC13 ' adduct-like signals in samples incubated 
without CC14 (Fig. 3.1.1. b), the intensity of signals was much lower than 
that of the samples with CC14. These signals may arise from the 
background free radicals. These free radicals may be lipid free radicals 
produced during the incubation of microsomes. These radicals can be 
trapped by PBN to form the lipid-type radical-PBN adduct (Tomasi et al., 
1980; Albano et al., 1982). 
The incubation temperature was very important for the formation 
of PBN-CC13 ' adduct. It can be seen from Fig. 3.1.2 that only when the 
temperature was ~ 30°C was the level of formation of PBN adduct 
stimulated by CC14 significantly higher than in the control. This result 
indicated that PBN -CC13 ' was significantly formed in microsomes only 
when the temperature was ~ 30°C. Similarly, the production of MDA 
was only stimulated above baseline values by CC14 when the temperature 
was ~ 30°C (Fig. 3.1.6). For the covalent binding of CC14 to microsomal 
protein, temperatures higher than 25°C were required to produce 
specific 14C-CC14-protein (Fig. 3.1.4). Taken together, these results 
indicate that only when the temperature reaches 25-30°C can the 
activation of CC14 start. Figs. 3.1.2, 3.1.4, 3.1.6 also showed that 
formation of PBN-CC13 ', specific covalent binding of 14CC14 and 
production of MDA stimulated by CC14 were increased as the incubation 
temperature was increased up to 37-40°C. 
The metabolic activation of CC14 in rat liver microsomes occurs 
through the NADPH-cytochrome P 450 system (Slater, 1984; Slater et al., 
1985; Cheeseman et al., 1985). It is possible that any factor which 
enhances the ability of this system will increase the activation of CC14· 
This point has been demonstrated by the fact that induction of the 
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microsomal cytochrome P 450 activity by drugs enhances the activation of 
CCl4 (see Introduction 1.1.1.2). Since NADPH:cytochrome P 450 
reductase and cytochrome P 450 are both involved in the activation it can 
be considered that the activation of CCl4 is an enzymic process. 
Temperature is an important factor in enzymic reactions, so it is 
understandable that the activation of CCl4 is increased as the 
temperature increases and starts only at a certain temperature. 
However, the temperature effect on the activation of CCl4 is more 
complicated than this simple explanation. Cytochrome P 450 and 
NADPH:cytochrome P 450 reductase are membrane-bound enzymes. Most 
investigations of the effect of temperature on membrane-bound enzymes 
have shown that there is a break in the Arrhenius plot (Peterson et al., 
1976). The results presented in this thesis are consistent with this 
statement. It can be seen from Figs 3.1.3, 3.1.5, 3.1. 7 that breaks 
appeared in the Arrhenius plots for the activation of CCl4. Previous 
studies have reported the P 450-system-dependent metabolism of drugs, 
like stearic acid nitroxide (Stier and Sackmann, 1973), hexobarbital. 
ethylmorphine (Peterson et al., 1976), benzphetamine, aminopyrine and 
ethanol (Puntarulo and Cederbaum, 1989) were dependent on 
temperature and had breaks in the Arrhenius plots. The break in 
Arrhenius plot has been assumed to be associated with a phase 
transition of the lipids in the membrane. In rat liver microsomes the 
number of P 450 molecules is about 20-30 times greater than that of the 
NADPH:cytochrome P 450 reductase (Depierre and Dallner, 1975). It has 
been suggested that the whole enzyme system is enclosed by a rather 
rigid phospholipid halo which undergoes a crystalline-liquid phase 
transition (Stier and Sackmann, 1973). Cytochrome P 450 molecules are 
clustered around the reductase which is envisioned to randomly reduce 
the cytochrome P 450 molecules immediately adjacent to it (Peterson et 
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al., 1976). If P 450 molecules are not directly associated with the 
reductase, a translational motion of the reductase or P 450 molecules 
through the microsomal membrane is required. In this case the 
Arrhenius plot will exhibit a break. Below the transition temperature the 
membrane is presumably in the gel state, the molecule of drug has to 
penetrate a rigid barrier to reach the reductase and a high activation 
energy will be needed for the activation. Above the transition 
temperature, the membrane is in a rather fluid state, therefore the 
activation energy will decrease (Stier and Sackmann, 1973). Stier and 
Sackmann reported that transition temperature of the rabbit liver 
microsomal membrane was 32°C. The transition temperature for aniline 
and aminopyrine oxidation was 34-36°C and 27 -29°C respectively (Stier 
and Sackmann, 1973). and for P 450-dependent ethanol metabolism in 
liver microsomes it was about 20.3°C (Puntarulo and Cederbaum, 1989). 
The results in the present study showed the transition temperature was 
about 26.7-27.5°C or 34.3°C (Fig. 3.1.3; 3.1.5; 3.1.7). Below the 
transition temperature the energies for PBN-CCl3 · adduct formation, 
specific 14CCl4 binding to protein and CCl4-dependent MDA production 
were 6.8 kcal/mol, 11.83 kcal/mol and 9.8 kcal/mol respectively. Above 
the transition temperature the energies were changed to 1.66 kcal/mol, 
3.36 kcal/mol and 2.83 kcal/mol respectively. 
Using these different methods to measure the activation of CCl4 
obtained different transition temperatures, it was apparent that the data 
were very close when PBN-CCI3 · adduct formation and 14CCl4 covalent 
binding to protein were employed as the indices, giving values of 27.5°C 
and 26.7°C respectively ~ However, the apparent tranSition temperature 
was much higher when CCl4 metabolism was measured by lipid 
peroxidation, with a value of 34.3°C being obtained. This phenomenon 
was consistent with the conclusion that misleading results can be 
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obtained using only one parameter of CCl4 metabolism, especially if that 
parameter is CCl4-dependent lipid peroxidation (Cheeseman 1982 a, b). 
Spin trapping of CCl3 ', the covalent binding of radiolabelled CCl4 to 
microsomal macromolecules and CCl4 -induced lipid peroxidation are all 
indirect indices of CCl4 metabolism. Cheeseman (1982 a, b) suggested 
that the measurement of covalent binding was a better index being more 
direct than CCl4-induced lipid peroxidation assay. Using these two 
methods Cheeseman studied the differences between CCl4 metabolism 
and P 450-dependent drug metabolism as exemplified by aminopyrene 
demethylation in response to inhibitors. He found that a better 
correlation existed between aminopyrene metabolism and 14CCl4 
binding than with aminopyrene metabolism and CCl4-induced MDA 
production. 
There are two processes from CCI3 ' production to PBN -CCI3 ' 
adduct formation and CCl4 covalent binding. However there are three 
processes from CCI3 ' production to CCl4-induced lipid peroxidation (see 
Fig. 1.1.2) and even more processes to MDA production. Temperature 
will affect all of these processes. Therefore, the apparent effect of the 
temperature on CCl4 activation measured by these three methods is the 
sum results of the influence of the temperature on these processes 
together. If there are less indirect processes, the result of the influence 
of the temperature will be closer to the net effect of temperature on 
CCl4 activation. From this point it was suggested that PBN spin trapping 
of CCI3 ' and the covalent binding are the better parameters than CCl4-
induced MDA production. This can explain why the results of the 
transition temperature were very close when CCl4 metabolism was 
measured by PBN-CCl3 ' formation and 14CCl4 covalent binding whilst the 
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datum of the transition temperature obtained by CCl4-dependent MDA 
assay was very different to the previous two. 
In this study the activation of CCl4 was initiated in vitro by using 
the artificial lipid peroxidation model in which the NADPH was 
generated from reaction of glucose-6-phosphate with NADP+. The effect 
of temperature on NADPH generation was also investigated. It can be see 
from Fig. 3. 1.8 that higher temperature enhanced the generation of 
NADPH. 
The activation of CCl4 in microsomes is found to be absolutely 
dependent on the addition of NADPH (Slater and Sawyer 1971a; 1977; 
Kornbrust and Mavis, 1980). Tortoriello et al. (1991) reported that a 
high concentration of NADPH (300-500 ~M) was required for activation 
of CCl4 at maximum rate in liver microsomes. An NADPH generator was 
provided for optimal CCl4 metabolism. The presence of an NADPH 
generator in the reaction system increased the rate and extent of CCl4 
metabolism by two-fold compared to the reaction without a NADPH 
generator system. The NADPH generator can maintain more NADPH in 
its reduced form and therefore preserves a higher concentration of 
NADPH for cytochrome P 450 catalyzed metabolism (Tortoriello et al., 
1991). 
Therefore, an enhancement of the activity of the electron-
transport chain through the changing of membrane lipid phase and an 
increase in the amount of electron donor (NADPH) may both contribute 
to the stimulation of the activation of CCl4 by increasing temperature. 
It was observed that the formation of PBN-adduct decreased after 
the temperature reached 37°C (Fig. 3.l.2) under conditions of both with 
and with<?ut CCI4 . This was probably due to the PBN-spin adduct being 
unstable at higher temperatures. It has been reported that the PBN-
CCI3 · spectrum changes markedly during warming of the sample from 
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-196°C to room temperature. Unstable species appear during the 
warming up (Tomasi. et al.. 1980). The instability of PBN-adduct at the 
high temperature will lead to the underestimation of the activation of 
CCl4 · Increase in the temperature will increase the rate of CCI 4 
activation but also decrease the stability of the PBN-adduct. Therefore. 
there is a limit to the use of PBN-adduct formation as an index of CCl4 
activation. 
4. 1. 2 Effect of selected agents on the activation of CCl4 in rat liver 
micro somes 
Several agents have been chosen for investigation of their effect on 
the activation of CCl4 as evidenced by determination of lipid 
peroxidation which was measured by MDA production. Two inhibitors of 
cytochrome P 450 (pyrazole and imidazole). two sulphydryl reagents. 
Uodoacetamide and N-ethyl maleimide) and glutathione have been used 
for this purpose. 
This was a continuation and completion of the studies initiated by 
Slater and Sawyer (1971 a. b. c) and continued by Cheeseman (1982 a. 
b). In those studies CCl4 -induced lipid peroxidation and 14CCl4 covalent 
binding to microsomal protein were taken as the indices of CC14 
activation and used to compared with typical mixed-function oxidase 
(MFO) activity in terms of the effects produced by inhibitors of MFO. 
The typical MFO activity was exemplified by aminopyrene 
demethylation. The type of inhibitors used in those studies were classiC 
P 450 inhibitors. SH reagents. metal-chelating agents and free radical 
scavengers. It was found in those studies that there were apparent 
differences between aminopyrene demethylation and CCl4 metabolism. 
For instance. the SH reagent pCMB at 0.1 roM moderately inhibited 
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14CC14 binding, strongly stimulated CC14-dependent MDA production 
while aminopyrene demethylation was strongly reduced (Cheeseman, 
1982 a, b; Slater and Sawyer, 1971 b). CC14 is not a typical MFO 
substance, therefore, it is expected that CC14 metabolism respond to 
inhibitory agents in a different way from aminopyrene demethylation 
(Cheeseman et al., 1985). 
Pyrazole is classically used as a inhibitor of alcohol dehydrogenase 
(ADH) , the principal enzyme responsible for the oxidation of ethanol in 
liver (Goldberg and Rydberg, 1969). Imidazole, an isomer of pyrazole, is 
a inhibitor of ADH too (Boiwe and Branden, 1977). Both of these two 
agents can inhibit P 450 enzyme activity (Ingelman-Sundberg and Jomvall 
1977) as exemplified by aminopyrene demethylase (Cheeseman, 1982 
b) and amine oxidase (Terelius and Ingelman-Sundberg, 1986). Pyrazole 
and imidazole can induce isoenzymes of liver microsomal cytochrome 
P 450 and therefore enhance the CC14 -stimulated lipid peroxidation (see 
Introduction) but this property is not relevant to investigations in vitro. 
Pyrazole and imidazole have been used as protective agents in vivo. 
For instance, administration of pyrazole to rats partially prevents the 
CC14-induced loss of microsomal P 450 (Toranzo et al., 1975). 
Pretreatment of rats with pyrazole almost completely abolished the 
ultrastructural effects of CC14 on the liver endoplasmic reticulum at 3h 
after its administration (Bernacchi et al., 1980). Pyrazole protects the 
animal or hepatocytes against glutathione depletion, lipid peroxidation 
and cell damage induced by allyl alcohol (Jaeschke et al., 1987; Silva 
and O'Brien, 1989). Pretreatment of rats with imidazole inhibit the 
metabolic activation of N -nitrosopyrrolidine (NPYR) resulting in the 
reduction of NPYR-derived DNA adduct formation. NPYR is a acute 
hepatoxic and carcinogenic agent to rat liver (Hunt and Shank, 1991). 
The effect of pyrazole and imidazole on activation of CC14 in vitro 
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has been studied by Cheeseman (1982 b) ten years ago. He found that at 
5 mM, pyrazole and imidazole had modest effects on CC14-dependent 
lipid peroxidation and covalent binding of 14CC14 to microsomal protein, 
although aminopyrene demethylase was strongly inhibited by these two 
agents at the same concentration. 
Since pyrazole and imidazole have protective roles against damage 
induced by drug metabolism, and particularly as they have been tested 
as hepatoprotective agents in the CC14 model in vivo and they can inhibit 
p 450 enzyme activity in vitro, their effect on CC14-dependent lipid 
peroxidation in liver micro$omes at higher concentrations (10-20 mM) 
was investigated. The results were shown in Fig. 3.l.9 and Table 1.1.1. It 
can be seen that at the relatively high concentrations these two agents 
eventually produced small inhibitory effects on the lipid peroxidation 
stimulated by CC14. At 10 mM pyrazole inhibited CC14 -dependent MDA 
formation by 300/0. Imidazole showed 29% inhibition at 20 mM. These 
results indicated that the activation of CC14 was inhibited by these two 
compounds at a relatively higher concentration. The mechanism of the 
inhibition may be attributed to their ability to inhibit of P 450 enzyme 
activity. 
Iodoacetamide (I DAM) and N -ethyl maleimide (NEM) are 
sulphydryl reagents that can interact with SH groups of a protein 
resulting in alkylation of the protein (Haenen, et al., 1987; Chen and 
Stevens, 1991). In the present study IDAM and NEM had little effect on 
CC14 -dependent lipid peroxidation in liver microsomes. IDAM inhibited 
MDA production by 150/0 at 10 mM. No increase in inhibition occurred 
when the concentration of IDAM was increased to more than 10mM 
(Fig. 3.1.10). NEM exerted biphasic effects on CC14-stimulated MDA 
formation (Fig. 3.l.11). At 0.5-1.0 mM NEM inhibited MDA production 
by 20 0/0, but higher concentrations of NEM stimulated the lipid 
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perOxidation slightly. 
These results were similar to those obtained by Cheeseman (1982 
b). He observed that IDAM at 10 mM had little effect on MDA 
production whereas the covalent binding of 14CCl4 was inhibited by 290/0 
and aminopyrene demethylase was inhibited to a similar degree. He also 
found that at 3 mM NEM aminopyrene demethylase was inhibited by 
340/0 whereas 10 mM NEM was required to inhibit covalent binding to a 
similar degree. At 10 mM NEM CCl4-dependent MDA production was 
enhanced. 
The effect on CCl4 metabolism of other SH reagents, pCMB, 
mersalyl and dithiobisnitrobenzoate (DTNB) have been studied by Slater 
and Sawyer (1971 b) and Chesseman (1982 a; b). pCMB at the range of 
50-300 ~M inhibited 14CCl4 binding to the microsomal protein. The 
effect of pCMB on CCl4 -dependent MDA production showed a biphasic 
effect but this biphasic pattern was different from NEM. At the lower 
concentration (1 00 ~M) pCMB stimulated CC14 -dependent MDA 
production. At 200 ~M pCMB strongly inhibited CC14-induced lipid 
peroxidation. Mersalyl and DTNB showed the Similar pattern of effects 
to that found with pCMB (Cheeseman, 1982 b). 
SH reagents are believed to inhibit drug metabolism by blocking 
electron transfer to cytochrome P 450 and also by denatUring the 
cytochrome (Franklin and Estabrook, 1971). Since CCl4 is activated at 
cytochrome P 450 it is understandable that IDAM and NEM inhibit CCl4-
mediated lipid peroxidation. However the biphasic effects of NEM is 
difficult to explain. This effect seems to demonstrate the problem of 
using MDA production as an indicator of CCl4 metabolism since, 
simultaneous with enhanced MDA production, decreased covalent 
binding occurs (Cheeseman, 1982 b). 
GSH is a very important and an effective inhibitor of lipid 
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peroxidation. In this study, GSH showed inhibitory effects on lipid 
peroxidation in a concentration-dependent manner. A 500/0 inhibition 
was observed at a concentration of GSH less than 0.2 mM and 1mM GSH 
nearly completely diminished the MDA production (Fig. 3.1.12). GSH 
not only inhibited the extent and rate of CCl4 -dependent MDA 
formation, but also prolonged the initiation period of lipid peroxidation, 
and this effect was concentration-dependent too. In the absence of GSH 
a 3 min. lag phase was seen before the lipid peroxidation started (see 
Fig. 3.1.13). GSH prolonged this lag phase. In the presence of 0.08 mM 
GSH, the induction time of the lipid peroxidation was prolonged to 5 
min. The period of induction of lipid peroxidation was further increased 
to 7 min. when the concentration of GSH was increased to 0.2 mM. 
These results are in agreement with previous work. It has been 
observed that GSH protect hepatocytes (Poli and Gravela, 1982), liver 
mitochondria (Yonaha and Tampo, 1987), nuclei (Tirmenstein and 
Reed, 1989) and microsomes (McCay et al., 1981; Burk, 1982, 1983; 
Burk et al., 1983; Haenen and Bast, 1983; Nagasaka et al., 1989; Wefers 
and Sies, 1989; Palamanda and Kehrer, 1992) against lipid peroxidation. 
GSH delays the onset of lipid peroxidation in liver micro somes induced 
by ascorbate/ ADP /Fe3+ , NADPH and CCl4 . It also decreases the rate and 
extent of CCl4-induced lipid peroxidation in micro somes (Burk et al., 
1983). 
It was observed that GSH effect on the onset of lipid peroxidation 
in liver microsomes was dependent on a heat-labile protein (Burk, 
1983). Burk (1983) suggested that the GSH-dependent protection 
against lipid peroxidation was a result of free radical scavenging. Later it 
was revealed that the protein factor perhaps was vitamin E reductase 
and the protection by GSH against microsomal lipid peroxidation 
through a vitamin E-dependent mechanism (Haenen and Bast, 1983; 
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Wefers and Sies, 1988; Bast and Haenen, 1990). In this mechanism 
vitamin E radicals in the membrane produced by scavenging of a free 
radical by vitamin E are regenerated to vitamin E by a free radical 
reductase at the expense of GSH (Haenen and Bast, 1983; Bast and 
Haenen, 1990; Shan et al., 1990). 
However, these conclusions come from the results obtained by 
using the non-enzymic dependent lipid peroxidation system. So far 
there is no evidence to suggest that the inhibitory effect of GSH on CC14-
induced lipid peroxidation also depends upon a heat-labile factor. This is 
because CCl4-induced lipid peroxidation is P 450 system-dependent and 
requires the native microsomes. Cheeseman (1982 b) and Burk et al. 
(1983) reported that GSH inhibited 14CCl4 covalent binding to 
microsomal protein. These observations are consistent with the 
suggestion that free radical scavenging as the mechanism of protection 
of GSH (Burk, 1983) since covalent binding is produced by CCl3 · radical. 
Based on these observations it could be conSidered that GSH inhibits 
lipid peroxidation induced by CCl4 in microsomes through the same 
mechanism as the GSH dependent inhibition of lipid peroxidation 
induced by the non-enzymic system. 
More evidence is required to determine the mechanism of GSH 
function in CCl4 -induced lipid peroxidation system, such as 
a) the time and concentration courses of GSH effect on 14CC14 
covalent binding and PBN -CCl3· formation for determination of the 
ability of GSH scavenging CCI3 ·; 
b) requirement of vitamin E for GSH function to check if the 
inhibitory effect of GSH is vitamin E dependent (for this research 
vitamin E deficiency microsomes can be employed); 
c) the effect of SH reagents on GSH function to test if there is a 
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protein factor involved in the GSH protection effect; 
d) the effect of addition of GSH peroxidase on GSH function. 
4. 2. RIBONUCLEOTIDE REDUCTASE 
4. 2. 1. Purification of ribonucleotide reductase from 1uvenile normal 
rat liver 
Mammalian ribonucleotide reductase ( RNRase ) contains two 
components, M 1 and M2. The two components are easily separated and 
it is difficult to purify the mammalian RNRase due to its instability 
(Wright, et al., 1989). So far only subunit M1 of the enzyme from calf 
thymus and regenerating rat liver has been highly purified (Enstrom, et 
al.,1979; Thelander et aI., 1980; Youdale et al., 1982). In these studies 
dATP-affinity chromatography was employed as a last or important step 
since dATP specifically binds the M 1 subunit. The liver enzyme is 
completely dissociated by binding to the dATP-affinity column (Youdale, 
et al., 1982). A number of reports describe the separation of the 
mammalian enzyme into two subunits. However, in all cases attempts to 
recombine the subunits or to pUrify the subunits separately resulted in 
very low yields of enzyme activity (Thelander, et aI., 1980). 
An attempt to pUrify the intact rat liver enzyme was made in the 
present work. The purpose was to develop a method of purification for 
obtaining a protein preparation in which the separation of the two 
subunits was minimal and the enzyme preparation was pure enough for 
raising an antibody. Ammonium sulphate fractionation (45% saturation), 
DEAE-cellulose chromatography, ATP-Agarose affinity chromatography. 
pH 5.2 precipitation, CM-Sephadex chromatography have all been 
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utilised for the purification. 
Apart from its stability another maj or problem of purification of 
the enzyme is the low level of reductase present in most eucaryotic 
cells. Here the livers of 3-4 week-old rats have been chosen as the 
source of the enzyme since it is active in the liver at this stage of 
development and it is available in large quantities. 
The protein content and the enzyme activity in different 
preparations of the enzyme from liver are shown in Table 3.2.1. 
Up to the step of chromatography on DEAE-cellulose the enzyme 
protein was purified some 30-fold (Table 3.2.2). This enzyme 
preparation, however, showed more than 10 bands of protein when it 
was analysized by sodium dodecyl sulphate-polyacrylamide gel 
electrophoresis (SDS-page) (Fig. 3.2.2). 
Chromatography on ATP-Agarose affinity and pH 5.2 precipitation 
followed by chromatography on CM-Sephadex were employed in an 
attempt to further purify the enzyme preparation after chromatography 
on DEAE-cellulose. 
ATP-affinity Sepharose has previously been used for purification of 
the phage T 4 induced ribonucleotide reductase in 'E. coG.. but apart from 
ribonucleotide reductase several other proteins which can interact with 
ATP were bound to the ATP-Sepharose column (Berglund and Eckstein, 
1972). ATP-affinity chromatogtaphy has also been used for a simple 
purification of ribonucleotide reductase from human cells (Spector and 
Averett, 1983). In that work the ATP-Agarose column is used for 
removal of nucleoside diphosphate kinase from the enzyme preparation 
without binding ribonucleotide reductase. The aim of using ATP-Agarose 
affinity column in the present purification was to see whether the 
column could remove other proteins which bind to ATP whilst leaving 
the intact ribonucleotide reductase to pass through the column under 
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the experimental conditions. However. this procedure was not 
successful. The resulting enzyme preparation which was eluted from 
ATP-Agarose column with buffer containing no ATP lost 80% of the 
enzyme activity compared to the activity of the DEAE-cellulose fraction 
(Table 3.2.3). The dissociation of the enzyme may be responsible for this 
loss of activity. It was impossible that the intact enzyme was bound to 
the column. like phage T4-induced ribonucleotide reductase since the 
protein fraction eluted with 2 mM ATP showed only one band on SDS-
page (Fig 3.2.2. line 13). This ATP-Agarose-bound protein was unlikely 
to be the protein Ml or M2. Comparing the SDS-page of the protein 
fraction(s) eluted without and with 2 mM ATP (line 12 and line 13 in 
Fig. 3.2.2) it can be seen that there was no this protein left in the 
protein fraction eluted without ATP. however. there still 20% of the 
enzyme activity left in this fraction indicating that the protein which 
tightly bound to the ATP-Agarose column was not essential for the 
enzyme activity. 
DEAE-cellulose is an anion exchanger; CM -Sephadex is a cation 
exchanger. The separation of the enzyme on CM -Sephadex after DEAE-
cellulose chromatography was not successful either. The resulting 
enzyme preparation after chromatography on CM-Sephadex had 282 
units/mg prot. left compared to a starting activity of 973 units/mg prot. 
and the purification was not improved (Table 3.2.3 and Fig. 3.2.2). 
There was an inaccurate estimation of the recovery of total 
enzyme activity after the ammonium sulphate precipitation step (Table 
3.2.2). This was most probably due to the underestimation of the 
enzyme activity of the crude enzyme extract. '!\vo factors contributed to 
this underestimation: 
i) RNA RNA inhibits ribonucleotide reductase activity (Cory. et al .. 
1973) and the crude extract contains a lot of nucleic acids. RNA can be 
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removed after salt precipitation; 
ii) nucleoside kinase (NDP kinase) In the presence of Mg2+. NDP kinase 
catalyzes the transfer of phosphate from nucleoside triphosphates (NTP) 
to nucleoside diphosphates (NDP). NDP are the substrates of 
ribonucleotide reductase and the assay for the activity of ribonucleotide 
reductase requires Mg2+. Thus the substrate and requirement of Mg2+ 
for NDP kinase are satisfied in the RNR assay mixture and since NDP 
kinase activity is much higher than RNR in mammalian cells, NDP 
kinase will quickly convert the radiolabelled NDP (3H-CDP) to NTP (3H-
CTP) resulting in the reduction of substrate for RNR. Most of the NDP 
kinase activity (900/0) can be removed from the crude extract by 
ammonium sulphate precipitation (Spector and Averett 1983). 
It is readily apparent that the development of a method for 
obtaining a highly purified and minimally separated ribonucleotide 
reductase preparation from juvenile normal rat liver was not successful. 
Chromatography on DEAE-cellulose is a common method of protein 
purification, but it is not specific for separation of ribonucleotide 
reductase from the bulk of proteins, like dATP affinity chromatography 
for the M 1 subunit. ATP-affinity Agarose column did not specifically bind 
M1 or M2 and caused the loss of the enzyme activity probably due to the 
separation of the two subunits. Chromatography on CM-Sephadex caused 
the loss of the enzyme activity too and did not improve the purification 
situation. It seems that it is impossible to purify both subunits of 
ribonucleotide reductase together to a very high purity. Purification of 
M1 and M2 separately perhaps is a better way. In the future it would be 
worth trying to use monoclonal antibody technique to obtain the M2 or 
M1 antibody. This protocol includes administration of an M1 or M2-
containing preparation to an appropriate recipient animal, production of 
hybridoma cell lines, cloning of hybrid cell mixtures and screening for 
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M1 or M2 antibody production (Liddell and Cryer, 1991). This 
technology has been applied to prepare antibodies against a vast range of 
antigens including serum proteins, enzymes, cell surface receptors, 
hormones, drugs, tumour specific antigens and differentiation antigens 
(Wilson and Goulding, 1986). A major advantage of using monoclonal 
antibody technology is the extreme confidence with which M 1 or M2 
antibody can be made. A major disadvantage of using this technology is 
that it relies on the random fusion of a heterogeneous population of B 
lymphocytes with myeloma cells, resulting in much time being spent in 
growing and testing hybrids which secrete M 1 or M2 antibody. The 
other disadvantage is the intensive cost of producing the monoclonal 
antibodies (Wilson and Goulding, 1986). 
4. 2. 2. Activity of ribonucleotide reductase in tissues of different 
flrowth states 
Ribonucleotide reductase is a key enzyme for DNA synthesis. It 
catalyzes the conversion of four ribonucleotides into the corresponding 
deoxyribonucleotides that are the precursors of DNA. The reductase 
activity is closely related to the growth rate of normal and neoplastic 
tissues (Thelander and Reichard, 1979; Lammer and Follm ann , 1983; 
Cory, 1989). In the present study, the reductase activity was checked in 
normal dividing and resting rat liver and hepatomas. The results 
demonstrated that the activity of the enzyme was higher in proliferating 
cells. An activity of 215 units/mg prot. existed in juvenile (3-4 weeks 
old) rat livers while no activity was observed in adult (11-12 weeks old) 
rat livers (Table 3.2.4). Similarly, an elevated enzyme activity appeared 
in regenerating liver whilst the enzyme activity was undetectable in 
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livers from sham-operated animals (Fig. 3.2.5). Hepatomas possessed 
higher enzymatic activity (Fig. 3.2.3. 3.2.4) and furthermore. the level of 
the enzyme activity was related to the growth rate of the tissue. The 
activity of the enzyme in the rapid-growing Yoshida hepatoma was 
significantly higher than that in the slower-growing MorriS tumour (Fig. 
3.2.3). All of these results are in agreement with the previous work 
(King and van Lancker. 1969; Elford et al.. 1970; 1972; 1974; Takeda 
and Weber. 1981; Youdale. et al .. 1982). 
The time course of the enzyme activity was investigated in 
cultured Yoshida ascites hepatoma cells during 6 days of culture. The 
enzyme activity was very low at day O. It began to increase after day 1 
and continued to increase over 4 days. The highest activity was found at 
day 4. then the activity decreased abruptly (Fig. 3.2.4). 
Ribonucleotide reductase is related to cell cycle. The enzyme 
activity is very high in S phase and very low in GO / G 1 phase (see 
Introduction). When cultured cells are in the exponential phase, there is 
a large amount of cells in S phase. Therefore. it is expected that 
ribonucleotide reductase activity is increased. When cultured cells are 
in the plateau phase, the portion of cells which are in S phase 
decreases and the portion of cells in GO / G 1 phase increases, thus the 
ribonucleotide reductase activity will decline. According to Carrie 
(personal communication). the exponential growth phase of cultured 
Yoshida cells was beginning at day 1 and lasts for 4 days. This growth 
pattern parallelled the pattern of changes in the activity of CDP 
reductase (Fig. 3.2.4). 
These results are similar to the observation of Chevanne and 
Caldini (1986). They reported that after the Yoshida cells were 
transferred from host rats to the culture medium the enzyme activity 
increased after 2-3h and continued to increase throughout the 18h 
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period. They concluded that this elevated activity was related to the 
transition of the cells from GO-G 1 to S phase. Takeda and Weber (1981) 
also observed that when hepatoma cells (3924A) were freshly plated 
and allowed to grow in lag, log and plateau phases for a 96-hr period the 
CDP reductase increased at 6 hr. The enzyme activity remained at the 
increased level (5.5-6 fold) for 48 hours and then declined to a lower 
level. 
For studying changes in the enzyme activity in regenerating liver. 
the entrained rat model was used here. When the rats are entrained to a 
12h light/12h dark regime, with access to food during the first 8h of 
darkness, liver regeneration is marked by cycles of DNA synthesis and 
cell division at approx. 24h intervals (Hopkins et aI., 1973; Slater et al., 
1990). Using this model to study processes of liver regeneration 
associated with CDP reductase activity, it was found that the enzyme 
activity in regenerating liver exhibits a periodic cycling in time course 
following partial hepatectomy (Fig. 3.2.5). There were two peaks of the 
enzyme activity. one at 48h post operation and another at 72 h post 
operation. This cyclical change in the reductase activity closely 
parallelled the time course of thymidine kinase activity in regenerating 
liver. It has been reported that thymidine kinase activity in regenerating 
liver is high at 24, 48, and 72h post operation, but very low at 12, 36. 
60 and 84h post operation (Cheeseman. et aI .. 1986; Slater et al .. 1990). 
Several previous studies have reported that the ribonucleotide reductase 
activity is increased in regenerating liver (King and Lancker. 1969; 
Elford. 1974; Cory and Fleischerm 1982 b; Takeda and Weber. 1981). 
but none has been with the entrained rat model used here, therefore 
neither showed changes in the ribonucleotide reductase activity with 
cyclical variations. Use of the entrained rat schedule of Hopkins et aI. 
(1973) is better to show the close relationship between DNA synthesis 
187 
and ribonucleotide reductase activity and investigate the mechanism of 
regulation of the enzyme activity in regenerating liver. 
What is the mechanism of regulation of ribonucleotide reductase 
activity in regenerating liver? Earlier work of Cory and Fleischer (1982 
b) showed that two components of ribonucleotide reductase, M 1 and 
M2 were not co-ordinately regulated in regenerating liver. M2 increased 
more rapidly and remains at a high level for a longer period, while the 
M 1 increased later. Cory and Fleischer asked the question: does the 
non -coordinate increase of the two components result from the non-
coordinate synthesis of the protein component or the non-coordinate 
activation of the newly synthesised components? 
Whitfield et al. (1989) believe that non-coordinate synthesis of the 
protein components is involved in the enzyme activity's regulation. They 
suggested that one subunit of the enzyme, MI, controls the enzyme 
activity in regenerating liver. Before the onset of DNA replication, the 
cells start accumulating a large pool of functional ribonucleotide 
reductase M2 subunit. When M2 subunits reach a certain level (when 
the cell is near the end of the G I phase), the cell begins M I gene 
expression, stops inactivating and reduces the degradation of the M I 
products. Then MI and M2 combine to form the active holoenzyme. At 
the end of the S phase, the cell reduces MI gene expression and 
resumes degrading MI subunits. 
The results of this study could not indicate if M I and M2 were 
regulated coordinately or not during periodiC cycling changes in the 
enzyme activity. However, the changes in the enzyme activity in the 
model of regenerating liver used here was the result of the regulation of 
the enzyme activity in vivo and the mechanism of regulation was probably 
through changing the level of the enzyme protein and/or in- and re-
activation of the enzyme activity. This conclusion was from the results 
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shown in Fig. 3.2.5 and Table 3.2.6. The CDP reductase in regenerating 
liver had declined at 60h post operation (Fig. 3.2.5). This phenomenon 
could be explained by three possibilities: 
(i) changing the protein level of the enzyme in vivo, 
(ii) inactivation of the enzyme in vivo, 
(iii) inhibition of the enzyme activity by inhibitors produced in vivo 
or in vitro. 
However, it can be seen from Table 3.2.6 that there was only an additive 
effect when enzymes from 60h and 48h regenerating liver were mixed 
together. This result indicated that there were no inhibitors in the 
enzyme preparation from 60h regenerating liver. Therefore, only 
possibilities of (i) and (ii) would be responsible for the decrease of the 
enzyme activity in 60h regenerating liver. Of course more direct 
evidence is required to make the final conclusion about the regulation 
mechanism in the ribonucleotide reductase activity in the regenerating 
liver model used here. Examination of the activity and the protein level 
of Ml and M2 separately at different time of post operation is required 
for this purpose. 
In the present study, it was found that there were differences 
between the enzyme from juvenile normal rat liver and regenerating 
liver in the optimal DIT concentration for exerting the full CDP 
reduction activity (Fig. 3.2.6). A higher concentration of DIT (10 mM) 
was required for the enzyme from 48h and 60h regenerating rat liver to 
exert the full CDP reductase activity, while 1 mM DIT was enough for 
the CDP reductase from juvenile rat liver to express the activity. The 
enzyme activity of 48h and 60h regenerating liver at 10 mM DTI was 
about 2600/0 and 1810/ 0 of the activity at 1 mM DIT, respectively. 
The differences in the optimal DTI concentration for the full 
activity between enzyme preparations from normal and regenerating 
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liver may due to 
(i) different content of low molecular weight thiols in 
enzyme preparations i.e. higher content of thiols in the 
enzyme preparation from juvenile normal rat liver and lower 
content of thiols in the enzyme preparations from 
regenerating rat liver; 
(ii) the enzymes from normal rat liver and regenerating rat 
liver are different; 
(iii) different rate of consumption of the DTI. 
The results shown in Table 3.2.6 allow one to rule out the first 
possibility. There were no significant differences in acid-soluble thiol 
content between enzyme preparation from 48h regenerating liver and 
normal rat liver or between 60h regenerating liver and normal rat liver. 
The content of acid-soluble thiols in enzyme preparations from 48h 
regenerating liver was significantly higher than that from 60h 
regenerating liver. However, this difference cannot explain the results 
that the enzyme activity from both of 48h and 60h regenerating liver 
was dependent on DTT concentration. In fact, the enzyme from 48h 
regenerating liver required higher DTI concentration for exerting the 
full activity than that the enzyme from 60h regenerating liver did. 
For the second possibility, it is unlikely that the enzymes from 
normal and regenerating rat liver have big differences in their 
properties. Whitfield et ale (1989) reported that both normal and 
regenerating rat liver contained functional protein M 1, 88-90 kDa 
protein and non-functional fragments of Ml, 40 kDa protein; however, 
normal liver contained only faint traces of the 88-90 kDa protein. This 
result indicates that normal and regenerating liver contain the same M 1 
subunit. The experiment here demonstrated that the enzyme from 
normal and regenerating liver had the same sensitivity to the specifiC 
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inhibitor. hydroxyurea. It can be seen from Fig. 3.2.12 that 4 mM 
hydroxyurea inhibited the enzyme activity form three sources by 60-
700/0. At 10 mM hydroxyurea the activity of all the enzymes was nearly 
inhibited by 1000/0. Hydroxyurea destroys the tyrosine free radical of M2. 
Therefore. the M2 of normal and regenerating liver have the same 
properties. 
DTI is necessary for CDP reductase activity as a reducing agent in 
this assay system. As a reducing agent, it would be consumed during the 
enzymic reaction. The higher the enzyme activity. the more the CDP 
reduction and the more the DTI consumption. Therefore, the third 
possibility could explain the results that the enzyme activity from 48h 
regenerating liver required a higher DTI concentration than the 
enzyme from normal rat liver was not (Fig. 3.2.6). The CDP reductase 
activity in 48h regenerating liver was much higher (723 units/mg proL) 
than that in normal juvenile rat liver (185 units/mg prot.) (Fig. 3.2.5, 
Table 3.2.4). It is therefore understandable that 48h regenerating liver 
enzyme needs more DTI for reducing the CDP. This explanation is 
supported by the results shown in Fig 3.2.7. The continual presence of a 
higher DTI concentration was needed to maintain the high activity of 
the enzyme from 48h regenerating liver (Fig. 3.2.7). At 1 mM DTI, the 
level of reduction of CDP was lower compared to that at 10 mM DTI. 
Addition of 10 mM DTI immediately restored the rate of CDP reduction 
even after the reaction had been going for 20 and 40min. (Fig. 3.2.7). 
Since the enzyme activity in normal juvenile liver was only 185 
units/mg prot., 1 mM DTI was a saturating concentration for the 
enzyme to catalyse the CDP reduction. Thus there was no significant 
difference in the normal liver's enzyme activity at the range of 1 mM to 
15 mM DTI. 
However, the third possibility cannot explain the dependence of 
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the enzyme activity from 60h regenerating liver on the DIT 
concentration. The level of the CDP reductase activity in 60h 
regenerating liver was Similar to that in juvenile normal rat liver, that 
was about 110 units/mg prot. There is another explanation. In this 
study, it was found that the higher concentration of DIT had the ability 
to activate the CDP reductase from 48h and 60h regenerating liver (Fig. 
3.2.8, 3.2.9). Preincubation of the enzyme protein from 48h and 60h 
regenerating liver with 10 mM DIT for 20 min enhanced the CDP 
reductase activity by 29% and 1050/0, respectively. However, the activity 
of CDP reductase from normal juvenile rat liver was not activated by high 
concentration of the DIT (Fig. 3.2.10). 
Therefore, DIT had two functions under the present 
experimental conditions, as a reducing agent that would be continuously 
consumed in the reaction and as an initial activator of the enzyme 
activity. The dependence of enzyme activity from 48h regenerating liver 
on DTT concentration may have been due to these two roles of DIT, 
reducing agent and activator. The dependence of enzyme activity from 
60h regenerating liver on DIT concentration, on the other hand, may 
have been only due to the function of DIT of activation. 
What is the mechanism of the activation of ribonucleotide 
reductase by DTf? Previous work has been shown that the tyrosine free 
radical of M2 can be regenerated by DIT and 02. Under the high 
concentration of DIT (5-10 mM) and air, tyrosine radical-free M2 can 
be reactivated to an active M2 containing a M2-specific tyrosine free 
radical (Thelander, et al., 1983; Graslund et al., 1982; Lassmann, et al., 
1989). 
From the discussion above and the results shown in Fig. 3.2.8, 
3.2.9, it can be suggested that some inactive M2 (specific radical-free 
M2) exists in regenerating liver. These inactive M2 subunits can be 
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reactivated by a high concentration of DTT in vitro. 
Does this phenomenon have some physiological meaning in 
regenerating liver? A tentative hypothesis for this phenomenon 
connecting to the regulation of the ribonucleotide reductase activity in 
regenerating liver is given below. As mentioned already. Whitfield et al. 
(1989) suggested that in regenerating liver before the onset of DNA 
replication, the cells start to accumulate a large pool of M2. According 
to the results of this present study it is supposed that these M2 
subunits, all or part, are inactive. When M2 reach a certain level, the 
cells start to synthesis Ml. Then M1 and M2 combine to form a 
holoenzyme. Before or after the combination. the inactive M2 is 
reactivated through regeneration of free radicals and the holoenzyme 
becomes functional. How are these inactive M2 subunits reactivated in 
vivo? They could be reactivated by intracellular thiols, like low molecular 
weight thiols. Fig. 3.2.11 showed that acid-soluble thiol in homogenates 
from regenerating liver exhibit a periodic cycle which is the same as the 
cycle of CDP reductase (Fig. 3.2.5). Possibly. in 48h and 72h 
regenerating liver there are more M2 subunits than in 36h and 60h 
regenerating liver, therefore a higher concentration of thiols is required 
in 48h and 72h regenerating liver for activation of the M2. 
It has been suggested that cells may have a mechanism for 
controlling ribonucleotide reductase activity by generating the free 
radical of M2 (see Introduction 1. 3. 3. 2). 
The activity of CDP reductase from 48h regenerating liver in Figs. 
3.2.6-8 was lower, only 170-250 units/mg prot., compared to that in Fig. 
3.2.5 which was about 700 units/mg prot .. This was because in the 
experiments shown in Fig. 3.2.6-8 the content of enzyme in the assay 
mixture was low, about 0.39 mg in the CDP reduction mixture. Low 
content of enzyme protein will underestimate the enzyme activity since 
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the two subunits of the enzyme are easily separated at low protein 
content. Usually 1 mg enzyme protein is needed for determination of 
the enzyme activity. 
Thymidine kinase is very active in 24h regenerating liver 
(Cheeseman, et al., 1986). However, no peak of the activity of 
ribonucleotide reductase was shown at 24h post operation. Perhaps at 
this time, the dNTP pools in liver is large enough to support the first 
burst of DNA synthesis. Therefore ae novo synthesis of Ml and M2 
subunits is not necessary. 
The present work has confirmed the previous results that 
ribonucleotide reductase activity is very closely related to the tissue 
growth and cell division. The CDP reductase activity can only be 
detected in tissues in which intense cell proliferation occurs, like 
juvenile rat liver, regenerating rat liver and hepatoma cells. 
Furthennore, the level of enzyme activity is closely related to the 
growth rate of these tissues and cells. The enzyme activity in 
regenerating liver exhibits a periodic cycling in time course following 
partial hepatectomy. This phenomenon has been found in thymidine 
kinase. The results in the present study suggested that regulation of M2 
activity through the way of regenerating M2 specific free radical in the 
regenerating liver may play a role in regulation of ribonucleotide 
reductase activity in regenerating liver. However, more detail and 
advanced research on this possible regulation mechanism are required 
in the future. For this purpose M2 subunit from regenerating liver must 
be highly purified in order to be able to check the amount of M2-
specific free radical using ESR spectra and to raise the M2 antibody. 
Then the time courses of the amount of M2-specific free radical, the 
protein level of M2 and M2 activity need to be performed. 
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4. 3. INHIBITORY EFFECT OF HNE ON RIBONUCLEDTIDE REDUCTASE 
HNE is one of the most important products of lipid 
peroxidation having effects at the enzyme, subcellular, and cellular 
level. HNE has the property of inhibition of cell proliferation, but the 
mechanism of this inhibition is still not clear. In the present study, 
the effect of HNE on the activity of ribonucleotide reductase from rat 
liver and the mechanism of the effect have been investigated. 
In this study it was demonstrated the HNE inhibited the 
activity of rat liver CDP ribonucleotide reductase. This inhibition was 
related to the concentration of HNE and the time of incubation (Fig. 
3.3.1 and 3.3.2). High concentrations of HNE and long incubation 
produced more inhibition of the activity of the reductase. HNE at 0.1 
mM produced 500/0 inhibition. Preincubation of HNE with the enzyme 
protein at 30°C for some time before the enzymic reaction started 
increased the extent of inhibition (Table 3.3.1). The preincubation 
time had no significant effect on the enhancement of inhibition. If 
the enzyme protein was exposed to HNE at O°C for 1 hr, the enzyme 
activity could not be recovered after removal of HNE by gel filtration 
(Fig. 3.3.3 and 3.3.4). Since the enzyme preparation contained 2mM 
DTI and DTI had a protective effect on the enzyme protein against 
HNE (see below), so two treatments were carried out for this 
experiment. One was using original enzyme preparation (without 
removal of 2 mM DTI) and standard enzyme reaction condition (Fig. 
3.3.3). Another was using the DTI -free enzyme preparation and 
employed 15 min of the enzymic reaction time. However, the results 
from these two treatments were essentially the same. The activity of 
the HNE-treated enzyme was inhibited and the extent of inhibition 
was dependent on HNE concentration (Fig. 3.3.3 and 3.3.4). All of 
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these results indicate that HNE can inhibit the enzyme activity 
during the enzymic reaction, also it can affect the enzyme protein 
itself and this effect is irreversible. 
Several enzymes have been reported to be inhibited by HNE 
(see Table 1.2.1). HNE possess high reactivity with SH groups. All 
inhibitory effects of HNE can be explained by the inactivation of 
functional SH groups (Benedetti and Comportl, 1987; Esterbauer et 
al., 1988). Ribonucleotide reductase contains several SH groups 
which are essential for the enzyme function (see Introduction). 
Therefore HNE inhibition of CDP reductase activity may be due to the 
blockage of SH groups on the enzyme protein by the aldehyde. 
In this study the following pieces of evidence for this 
explanation have been given: 
(i) DTI has a modulating effect on HNE inhibition and protection of 
enzyme against HNE 
DIT is a reducing agent in the assay for activity in this study. 
The structure of DTI is as below: 
The results show that DTI has a modulating effect on HNE inhibition 
and protection of the enzyme against HNE. In the presence of a high 
concentration of DTT, the degree of inhibition by HNE was decreased 
. significantly (Table 3.3.2). If HNE was incubated with DTT before 
exposure to the enzyme, HNE had no inhibitory effect on the CDP 
reduction (Table 3.3.3). If HNE was incubated with enzyme protein in 
the presence of DTI, HNE did not damage the protein (Fig. 3.3.7). 
These results are consistent with previous work that reported that most 
inhibitory effects of HNE are prevented by the prior addition of thiols 
(Schauenstein, 1982). It is reported that a 0.1 mM solution of HNE is 
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completely consumed by 1 mM glutathione within 30 min. (Esterbauer, 
1982). Therefore, it is understandable that HNE incubated with DIT 
(HNE:DIT = 1: 10) for 30 min. at 30°C lost the ability to inhibit the 
enzyme activity (Table 3.3.3). HNE can discriminate between different 
types of thiols (Schauenstein, 1982), reacting with non-protein thiols 
most avidly. This fact can explain the result that if HNE was incubated 
with enzyme protein and DTT together, HNE failed to inhibit the 
enzyme activity (Fig. 3.3.7). However, DTT did not reactivate the enzyme 
activity after the enzyme was damaged by HNE. Incubation of HNE-
treated enzyme (enzyme exposed to HNE at O°C for 1 h then the HNE 
was removal by gel filtration) with higher concentration of DTT pre- or 
during enzyme reaction, no enzyme activity was recovered (Table 3.3.4, 
Fig. 3.3.8). The reaction of HNE with SH is an alkylation. The end 
product of the reaction is a very stable cyclic hemiacetal (see 
Introduction 1. 2. 1). DIT can reduce S-S bridges. The results here 
showed that DIT cannot reverse HNE-SH binding. 
(ii) HNE decreases the SH content of the enzyme preparation and 
DTT 
As shown in Fig. 3.3.9 HNE decreased the SH content of the 
enzyme. This effect was dependent on HNE concentration, but 
independent of the incubation time. As indicated in Fig. 3.3.10 DTT 
influenced the spectrum of HNE, decreasing the absorbance at 223nm. 
Fig.3.3.11 and 3.3.12 showed that in presence of HNE the SH content of 
DIT decreased. The effect of HNE on the content of SH on DIT was 
proportional to both the HNE concentration and the incubation time. 
(iii) The presence of thiols in the enzyme preparation decreases the 
effect of HNE 
Another piece of evidence is from the result of the inhibitory 
effect of HNE on the enzyme activity of the crude extract. It can be seen 
197 
from Fig. 3.3. land Fig. 3.3.6 that the effect of HNE on crude extract is 
10 times weaker than it was on the partially purified enzyme. The 
explanation is that there is a large amount of thiol in the crude extract 
enzyme. These thiols react with HNE preferentially and protect the 
enzyme against HNE (Dianzani et al., 1990). 
Therefore, under the present experimental conditions, HNE 
inhibits the CDP ribonucleotide reductase in two ways. One was that 
HNE directly affected the enzyme protein. This was the result of 
blocking the essential SH group of enzyme by HNE. This damage was 
irreversible (Fig.3.3.3 and 3.3.4). The concentration of HNE influenced 
this effect (Fig. 3.3.4), but the time of HNE incubation with the enzyme 
protein was not very important since (a) the preincubation time had no 
significant effect on the enhancement of inhibition induced by 
preincubation of HNE with enzyme (Table 3.3.1), and (b) the reduction 
of the content of SH of enzyme by HNE only related to HNE 
concentration, the reaction time had no effect (Fig. 3.3.9). The second 
way was through the interaction of HNE with the reducing agent DIT. 
HNE reacted with DIT and consumed the amount of the DIT. Finally 
this effect affected the enzyme activity. This kind of effect of HNE was 
indirect. It was not only related to the HNE concentration, but was also 
related to the incubation time (Fig. 3.3.11, and 3.3.12). Therefore, 
when HNE was present during the enzymic reaction the overall 
inhibitory effect of HNE on the enzyme activity was related to the 
incubation time (Fig. 3.3.2). 
Ribonucleotide reductase is a key enzyme for DNA syntheSiS. 
Its activity is very closely related to growth rate of tissue and cell 
cycle. HNE is one of the most important products of lipid 
peroxidation. It has been suggested that HNE has a role for regulation 
of cell proliferation (see Introduction). It would be very interesting 
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and worthwhile to investigate the HNE effect on the expression and 
activity of ribonucleotide reductase in vivo. Such research could employ 
cultured cells for studying the relationship between ribonucleotide 
reductase activity and cell proliferation in terms of the effects 
produced by HNE. The effect of HNE on M 1 or M2 gene expression 
and amplification could be investigated by addition of a lower 
concentration of HNE to the cultured cells at different stages of the 
cell cycle. 
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5. CONCLUSION 
1. Temperature is very important for CC14 metabolism. CC14 was 
activated in rat liver microsomes in a temperature-dependent fashion. 
The transition temperature for CC14 activation was 26.7-27.5°C when 
the metabolism was measured by PBN-CC13 · formation and specific 
14CC14 covalent binding to protein. However, the transition temperature 
was shown to be at 34.3°C when CC14-dependent MDA production was 
taken as an index of CC14 metabolism. CC14-dependent lipid peroxidation 
is not a good parameter for the activation of CC14 . 
Two P450 inhibitors (pyrazole and imidazole) and one SH reagent 
(iodoacetamide) had inhibitory effects on CC14 -stimulated MDA 
production only at a relatively high concentrations (10-20 mM). At this 
concentration level they produced 15-300/0 inhibition. GSH strongly 
inhibited lipid peroxidation induced by CC14 in a concentration-
dependent manner. At 0.2 mM it reduced MDA formation by 500/0. GSH 
also delayed the onset of the lipid peroxidation and this effect was also 
dependent on the concentration of GSH. The results suggested that 
GSH inhibited lipid peroxidation possibly by the way of scavenging and 
interaction with intermediates of the activation of CC14 . Another SH 
reagent, N -ethyl maleimide (NEM) showed biphasic effects on CC14 -
stimulated MDA production. NEM at 0.5-1.0 mM inhibited MDA 
formation, but higher concentrations of NEM stimulated the lipid 
peroxidation. This phenomenon may be attributed to the fact that CC14-
dependent lipid peroxidation is a poor index for the activation of CC14· 
2. It was not possible to successfully purify Ml and M2 subunit of 
ribonucleotide reductase together to a highly purified state. It was 
concluded that it would be better to pUrify Ml and M2 separately. 
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Ribonucleotide reductase activity was very closely related to growth 
state and rate of the tissues. The enzyme activity can only be detected in 
the dividing tissues, such as juvenile normal rat liver, regenerating liver, 
liver tumour and hepatoma cells. The level of the enzyme activity in fast-
growing tissue (hepatoma Yoshida cells) was higher than that in slow-
growing tissue (Morris 5123tc tumour). These results have confirmed 
the previous work. The enzyme activity in regenerating liver exhibits a 
periodic cycling in time course follOwing partial hepatectomy. This 
phenomenon has been found in thymidine kinase. The activity of CDP 
reductase from 48h and 60h regenerating liver could be activated by 
higher concentration of DTT (10 mM). It is assumed that the 
regenerating liver's enzyme activity was activated by DTT by 
regenerating the specific free radical of the M2 subunit. The content of 
low molecular weight thiols in regenerating liver exhibited the same 
periodic cycle as the CDP reductase. From these results a possible 
mechanism of regulation of the ribonucleotide reductase activity in 
regenerating liver was tentatively suggested. In regenerating liver, 
before the onset of DNA replication, the cells start to accumulate a large 
pool of ribonucleotide reductase M2 subunit. These M2, all or part, are 
inactive. When M2 reach a certain level, the cells start to synthesis Ml. 
Then M 1 and M2 combine to form holoenzyme. Before or after the 
combination, the inactive M2 is reactivated through regeneration of free 
radicals. Then the holoenzyme becomes functional. It is further 
suggested that low molecular weight thiols in the regenerating liver may 
play the role of regenerating free radicals. 
3. 4-Hydroxynonenal (HNE) inhibited the CDP reductase activity from 
juvenile nonnal rat liver. The inhibition was dependent on the 
concentration of HNE and incubation time. Under the experimental 
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conditions used in the present study. HNE achieved its inhibitory effect 
in two ways. One is direct damage to the enzyme protein by blockage of 
the functional SH groups in the enzyme protein. This effect was 
irreversible and only dependent on HNE concentration. The other one 
is indirect by consuming the DIT in assay mixture through the 
interaction of HNE with SH groups on DIT. and eventually affected the 
enzyme activity. This effect was dependent on both the concentration of 
HNE and the incubation time. Therefore. the overall effect of HNE on 
CDP reductase activity was dependent on both parameters. 
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